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Abstract 
The thesis presented herein is an adaptation of a series of published manuscripts. The 
manuscripts have been peer reviewed and published in high standing journals 
relevant to the field of aquaculture nutrition. The aims of the research were designed 
to generate a thorough understanding of lipid metabolism in the barramundi (Lates 
calcarifer); extending from a more general applied approach through to a complex 
understanding of molecular mechanisms and lipid bioenergetics.  
In the first experiment, a series of five diets with blends of fish (anchovy) oil and 
poultry fat (F100:P0, F60:P40, F30:P70, F15:P85, F0:P100) were fed to 208 ± 4.1 g 
barramundi over a 12-week period. The replacement of fish oil (FO) with poultry fat 
had no impact on growth performance (average final weight of 548.3 ± 10.2 g) or 
feed conversion (mean = 1.14 ± 0.02). Analysis of the whole body composition 
showed that the fatty acid profile reflected that of the fed diet. However, it was also 
shown that there was a disproportional retention of some fatty acids relative to others 
(notably 18:2n-6 and 18:3n-3). By examining the body mass independent retention of 
different fatty acids with differential levels of intake of each, the marginal 
efficiencies were able to be determined. The differential retention of fatty acids in the 
meat was also examined allowing the determination of oil blending strategies to 
optimise meat n-3 long chain – polyunsaturated fatty acid (LC-PUFA) levels. 
In the second experiment, the response of juvenile barramundi (47.0 g/fish initial 
weight) fed isolipidic and isoenergetic diets with 8.2% added oil was tested. The 
experimental test diets were a 2:1 or 1:2 ratio of saturated to monounsaturated fatty 
acids (SFA-D and MUFA-D respectively) compared to a control diet (CTRL-D) fed 
for eight weeks. The diets containing mostly olive oil (diet MUFA-D) and mostly 
refined palm oil (diet SFA-D) did not impact the growth performance or feed 
utilisation parameters of the barramundi. The in vivo beta-oxidation activity was 
consistent with the diet fatty acid composition with the most dominant fatty acids 
being heavily beta-oxidised. Together, the in vivo whole body mass-balance of fatty 
acids showed that n-3 long chain polyunsaturated fatty acids (LC-PUFA) were most 
efficiently utilised in the SFA-D and MUFA-D fed fish. This study provides 
evidence that additional dietary MUFA and SFA are suitable fatty acid classes for 
juvenile barramundi and they are both equally efficient at sparing LC-PUFA from an 
oxidative fate. 
6 | P a g e  
In the third experiment, the response of juvenile barramundi to four diets containing 
either marine- or non-marine derived neutral lipid (NL) or polar lipid (PL) sources 
was assessed for eight weeks in a 2x2 factorial design. The four diets contained 8.2% 
added lipid composed of a 1% fish oil base with 7.2 % test lipid (n-3 NL: Fish oil, n-
3 PL: Krill oil, n-6 NL: Soybean oil, n-6 PL: Soybean lecithin). The results 
demonstrated that the different lipid sources (either n-3 or n-6 omega series from 
either NL or PL class) had significant effects on growth performance and feed 
utilisation with some interaction terms noted. Growth was negatively affected in the 
n-6 NL fish and the feed conversion ratio was highest in the n-6 PL fish. Digestibility 
of total lipid and some specific fatty acids (notably 18:2n-6 and 18:3n-3) were also 
negatively affected in the n-6 PL fish. Analysis of the whole body NL fatty acid 
composition showed that these mirrored those of the diets and significant interaction 
terms were noted. However, the whole body PL fatty acids appeared to be more 
tightly regulated in comparison. The blood plasma biochemistry and hepatic 
transcription of several fatty acid metabolism genes in the n-6 PL fed and to a lesser 
extent in the n-6 NL fed fish demonstrated a pattern consistent with modified 
metabolic function. These results support that there are potential advantages in using 
phospholipid-rich oils, however, there are clear differences in terms of their origin. 
In the fourth experiment, the essential fatty acid requirement (EFA) of juvenile 
barramundi (47.0 g/fish initial weight) fed isolipidic and isoenergetic diets with 8.2% 
added oil was tested. The experimental test diets were either devoid of FO, and thus 
with no n-3 LC-PUFA (FO FREE diet) or with a low inclusion of FO (FO LOW 
diet). These were compared against a control diet containing only FO (FO CTRL 
diet) as the added lipid source, over an eight week period. Interim samples and 
measurements were taken fortnightly during the trial in order to define the aetiology 
of the onset and progression of EFA deficiency. After two weeks, the fish fed the FO 
FREE and FO LOW diets had significantly lower live-weights and after eight weeks 
significant differences were detected for all performance parameters. The fish fed the 
FO FREE diet also had a significantly higher incidence of external abnormalities. 
The transcription of several genes involved in fatty acid metabolism was affected 
after two weeks of feeding, showing a rapid nutritional regulation. This experiment 
documents the aetiology of the onset and the progression of EFA deficiency in 
juvenile barramundi and demonstrates that such deficiencies can be detected within 
two weeks. 
7 | P a g e  
In the fifth experiment, barramundi (initial weight = 10.3 ± 0.03 g; mean ± S.D.) fed 
one of five diets with graded levels of EPA (1, 5, 10, 15 and 20 g/kg) or one of four 
diets with graded levels of ARA (1, 6, 12 and 18 g/kg) were compared against a 
control diet containing fish oil. A six-week feeding trial demonstrated that the 
addition of EPA or ARA did not impact growth performance or feed utilisation. 
Analysis of the whole body fatty acids showed that these reflected those of the diets. 
The ARA retention demonstrated an inversely related curvilinear response to either 
EPA or ARA. The marginal utilisation efficiencies of EPA and ARA were higher 
than expected (62.1 and 91.9% respectively) and a dietary ARA requirement was 
defined (0.012 g/kg0.796/d) in juvenile barramundi. The partial cDNA sequences of 
genes regulating eicosanoid biosynthesis were identified in barramundi tissues, 
namely cyclooxygenase 1 (Lc COX1a, Lc COX1b), cyclooxygenase 2 (Lc COX2) and 
lipoxygenase (Lc ALOX-5). Both Lc COX2 and Lc ALOX-5 expression in the liver 
tissue were elevated in response to increasing dietary ARA, meanwhile expression 
levels of Lc COX2 and the mitochondrial fatty acid oxidation gene Lc CPT1a were 
elevated in the kidney. A low level of EPA increased the expression of Lc COX1b in 
the liver. Consideration should be given to the EPA to ARA balance for juvenile 
barramundi in light of the nutritionally inducible nature of the cyclooxygenase and 
lipoxygenase enzymes. 
A sixth and final experiment was conducted with barramundi to examine the 
allometric scaling effect of individual fatty acids. Six treatment size classes of fish 
were deprived of food for 21 days (Treatment A, 10.5 ± 0.13 g; Treatment B, 19.2 ± 
0.11 g; Treatment C, 28.3 ± 0.05 g; Treatment D, 122.4 ± 0.10 g; Treatment E, 217.6 
± 0.36 g; Treatment F, 443.7 ± 1.48 g; mean ± SD) with each treatment comprising 
fifteen fish, in triplicate. The assessment of somatic losses of energy and lipid were 
consistent with previous studies, validating the methodology to be extended to 
individual fatty acids. Live-weight (LW) exponent values were determined to be 
0.817 ± 0.010 for energy and 0.895 ± 0.007 for lipid. There were significant 
differences among the fatty acids ranging from 0.687 ± 0.005 for 20:5n-3 and 0.954 
± 0.008 for 18:1n-9. The LW exponent values were applied to existing fatty acid 
intake and deposition data of barramundi fed with either 100% fish oil or 100% 
poultry oil. From this the maintenance requirement for each fatty acid was 
determined by extrapolation of the linear regression. The metabolic demands for 
maintenance and growth were then iteratively determined for fish over a range of 
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size classes. Application of these exponent values to varying levels of fatty acid 
intake demonstrated that the biggest driver in the utilisation of fatty acids in this 
species is deposition demand and despite their reputed importance, the long-chain 
polyunsaturated fatty acids had nominal to no maintenance requirement. 
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General Introduction 
1.1 Introduction 
The world supply of wild capture seafood is unable to meet the needs of the growing 
human population. Aquaculture continues to be a rapidly expanding industry 
potentially able to address this problem. However, aquaculture in itself is only part of 
the solution. Over the last three decades world aquaculture production has grown at 
an average rate of 8.8% per annum and for the first time in 2010 exceeded 60 million 
tonnes of edible product (FAO, 2012). Commercially produced diets are feeding this 
rapid expansion which ironically has an insatiable appetite for wild fishery resources 
already stretched to their limits. This resource is primarily based on small pelagic 
forage fish (eg. sardines, herrings, anchoveta, mackerel) targeted specifically for 
rendering into fish meal (FM) and fish oil (FO) which can be used in dietary 
formulations for compound feeds. There is strong debate over the fish-in to fish-out 
ratio (FI:FO) of aquaculture (Naylor et al., 2009; Tacon and Metian, 2008) and also 
the transformation of directly edible fishery products into higher value species 
(Naylor et al., 2000), hence the urgency to find and use alternative ingredients for 
aquaculture.  
Fish and crustaceans grown on commercially produced feeds consume a large 
proportion of the world’s available FM and FO resources. It has become clear that if 
aquaculture is to continue to grow at such levels then alternative plant and animal 
resources must be utilised as feed ingredients. Each year the world supply of FO is 
mostly consumed by the aquaculture industry while the nutraceutical industry 
acquires more FO than ever before compounding the issue (Figure 1.1). As FM and 
FO are finite resources their price and availability relative to alternative ingredients 
will influence their eventual use in aquafeeds. However, for the use of alternative 
ingredients to be a success, a clear understanding of the farmed species nutritional 
requirements must be known (Hardy, 2010). The changing supply and demand 
dynamics for FM and FO resources have led to record high prices putting further 
emphasis on feed companies to reduce costs and become more sustainable.  
Replacement of FM and FO in aquafeeds has been a research priority for 
several decades. The use of many terrestrial plant and animal by-products is now 
widely accepted as nutritionally important cost effective ingredients, however, 
precaution is necessary in dietary formulation for a range of reasons including but 
not limited to: 
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x The health effects on certain farmed aquatic animals caused by anti-
nutritional factors (ANF) present in plant ingredients (Gatlin et al., 
2007).  
x Maintaining high levels of feed utilisation and production efficiencies 
of farmed aquatic animals (Naylor et al., 2009) 
x The functionality of alternative ingredients in terms of their storage 
and processing characteristics (Glencross et al., 2007) 
x Cost benefit, economic viability and supply risks associated with 
transport and availability of ingredients to feed producers compared to 
FM and FO (Gatlin et al., 2007) 
x Maintaining appropriate n-3/n-6 ratios for specific species to maintain 
metabolic homeostasis (Brown and Hart, 2011)   
 
Figure 1.1 Fish oil use over the past four decades. Major growth of the 
aquaculture and the nutraceutical sectors in recent years has changed the 
supply and demand dynamics of FO. Its use in industrial or non-human 
consumption application is now limited (data adapted from 
http://www.IFFO.org). 
The quality of the diets provided to aquatic animals can contribute to 
improved production efficiency leading to shorter grow out periods and potentially 
reduced environmental effects, critical to the aquaculture industry (Turchini et al., 
2009). However, the quality of the diets is defined by their ingredients and 
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alternatives such as those derived from the sources mentioned above are generally 
considered to be inferior to FM and FO and for a range of reasons (Glencross et al., 
2007). Certain nutrients present in FM and FO support ideal growth and health of 
most fish and crustaceans and some of these are considered essential for normal 
metabolic processes to occur (Gatlin et al., 2007).  
The essentiality of a nutrient is often difficult to determine in any animal and 
this is particularly true of fish. However, many research groups have demonstrated to 
varying degrees how essential certain nutrients are to a range of different species 
under different biotic and abiotic conditions. This information is of critical 
importance to the aquafeed industry as they increase the use of non-marine based 
ingredients. For example, most plant protein lacks an amino acid profile similar to 
that of FM, often being deficient in the first limiting amino acids (eg. lysine and 
methionine). If used in complete replacement to FM an obvious deficiency would 
soon manifest in most fish culture systems. Despite these limitations, 
supplementation with crystalline amino acids and blending different plant proteins 
has allowed a gradual decrease in the total FM used for many species (Gatlin et al., 
2007).  
Similarly, the lipid component of the diet is composed of essential fatty acids 
(EFA) and non-essential fatty acids necessary for normal metabolic processes. For 
example the complete replacement of FO with alternative oils from plant or animal 
sources could lead to a deficiency as the essential fatty acids for that species may be 
missing or in a disproportionate combination. Many researchers have investigated the 
options for FO replacement in a range of species for two main reasons, the first being 
the clearly limited supply of FO discussed earlier and secondly the fact that the lipids 
remain the least well understood of all nutrients due to their complexity (Sargent et 
al., 2002). More recently, research groups have approached the question of FM and 
FO replacement simultaneously in an effort to gain an understanding of the 
interactions of both ingredients (Glencross et al., 2016; Panserat et al., 2009; Refstie 
et al., 2001; Torstensen et al., 2011). 
The barramundi (Asian seabass: Lates calcarifer) is typically cultured in the 
Indo-pacific region in relatively small tonnages compared to other species, however, 
it is a culturally important and profitable industry that has potential to expand. In 
light of the perceived image of global aquaculture as a net consumer of seafood 
products, it is important that research continues into the search for and use of 
alternative ingredients. As overall fish consumption increases, the demand on our 
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oceans will be far exceeded by what it can produce and the sustainable production of 
fish for human consumption is expected to meet that need. Research in this area will 
continue to improve dietary formulations and efficient use of available ingredients. 
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1.2 The role of lipids in fish nutrition 
1.2.1 Lipid classes in fish tissues 
With increasing efforts to replace FO from fish diets there is added emphasis on 
understanding the fate of ingested lipid sources as this dietary nutrient is not only an 
important energy source but it also has a bioactive role in many physiological 
functions. Neutral lipid principally in the form of triacylglycerides (TAG) is the most 
abundant form of ‘energy’ lipid in fish tissues. Its chemical structure is represented 
by three fatty acids esterified to different positions on a glycerol backbone with 
saturated (SFA) and monounsaturated fatty acids (MUFA) generally esterified to the 
stereospecific numbering position one and three (sn-1,3) and polyunsaturated fatty 
acids (PUFA) esterified to the sn-2 position (Tocher, 2003). Phosphoglycerides are 
important polar lipids forming the bilayer of cell membranes. Structurally they have 
two fatty acids esterified to phosphatidic acid (L-glycerol 3-phosphate). The major 
phosphoglycerides of animal, including fish, tissues are phosphatidylcholine 
(PtdCho), phosphatidylethanolamine (PtdEtn), phosphatidylserine (PtdSer), and 
phosphatidylinositol (PtdIns) formed by esterification of the phosphatidic acid group 
to different bases such as choline, ethanolamine, serine, and inositol respectively 
(Tocher, 2003). 
 The relative proportion of each major fatty acid is generally related to its 
origins in the environment. Northern hemisphere forage fish typically contain higher 
levels of 20:1n-9 and 20:1n-11 long-chain monounsaturated fatty acids, directly 
related to their diet of marine zooplankton rich in wax esters whereas Southern 
hemisphere forage fish contain typically higher levels of long-chain polyunsaturated 
fatty acids (LC-PUFA) (Sargent and Henderson, 1995). There are other lipid classes 
such as wax esters (neutral lipid; NL), sphingolipids (polar lipid; PL) and sterols that 
are important in vertebrate physiology, however, discussion about these is beyond 
the scope of this review. In the context of feeding fish increasing amounts of 
vegetable oils it has been demonstrated that different fatty acids have markedly 
different fates. In Atlantic salmon (Salmo salar) the shorter chain SFA such as 10:0 
is rapidly catabolised for energetic requirements, whereas the longer chain MUFA 
18:1n-9 is deposited as TAG (Denstadli et al., 2011). 
1.2.2 Fatty acid biochemical structure 
Fatty acids are defined by the International Union of Physical and Applied Chemists 
(IUPAC) as aliphatic monocarboxylic acids that can be hydrolysed from naturally 
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occurring lipids (http://www.IUPAC.org). Systematic chemical names are given to 
each fatty acid and these can be symbolically delta (Δ) classified as X:YΔa, b, c 
where X is the number of carbons in the chain, Y is the level of double (or ethylenic) 
bonds and Δ a, b, c represent the position of each double bond relative to the 
carboxyl group of the fatty acid (Rigaudy and Klesney, 1979). A different lipid 
numbering system is widely used and accepted whereby the number of carbon atoms 
and double bonds are separated by a colon followed by the position of the first 
double bond relative to the methyl terminus represented as n minus x (Glencross, 
2009; Tocher, 2003; Turchini et al., 2009). Trivial common names are also applied to 
fatty acids and they can be further abbreviated. Therefore in the order summarised 
above 5,8,11,14-Icosatetraenoic acid is known also as 20:4Δ5,8,11,14, 20:4n-6, 
arachidonic acid or ARA (Figure 1.2). 
 
Figure 1.2 Chemical structure of long-chain polyunsaturated fatty acids (LC-
PUFA) n-3 (EPA, left) and n-6 (ARA, right) with twenty carbon chain length. 
The five double (ethylenic) bonds of EPA are in the 5, 8, 11, 14 and 17 positions 
and the four double bonds of ARA are in the 5, 8, 11 and 14 positions relative to 
the carboxyl group (adapted from http://www.IUPAC.org).  
1.2.3 Minimum and optimum lipid nutrition 
Defining the role of lipids is a challenging area of research because of the complex 
interaction between cellular function and various lipid types (Dowhan et al., 2008). 
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Dietary lipids are well known to affect the performance and overall nutritional 
quality of fish and this can easily be demonstrated in vivo (Sargent et al., 2002). The 
lipid requirements in fish differs among species and life stages, whereby faster 
growing juvenile fish have higher essential fatty acid (EFA) demands for neural 
tissue development and other physiological processes (Glencross, 2009), while in 
some species the requirement for EFA appears to be proportional to the total dietary 
lipid (Glencross et al., 2002).  
 A recent study by Turchini et al. (2011a) demonstrated that the minimum and 
optimum supply of EFA in salmonid fish is very different. These authors 
demonstrated that in fact salmonid fish can satisfy their EFA requirement provided 
the appropriate amount of precursor fatty acid is present, in this case 18:3n-3 
(linolenic acid; Fig. 1.3). In their study the fish fed on a linseed oil based diet grew at 
the same rate as those fed FO, highlighting the moral dilemma between providing a 
sustainably cultured product with the increasing consumer demand for the 
consumption of LC-PUFA. On the other hand, many studies have shown that marine 
fish are not able to meet their EFA requirements through endogenous biosynthesis 
from dietary precursors as they lack at least one of the enzymes required (Sargent et 
al., 2002). There are few exceptions to this fact; however, marine species of the 
Siganidae family are almost exclusively herbivorous and are able to desaturate and 
elongate dietary precursors to meet their EFA needs (Monroig et al., 2012). Some 
research groups now argue that trophic level is more important in defining a fishes 
capacity to synthesise polyunsaturated fatty acids (PUFA) (Li et al., 2010).  
 The physiological role of lipids in fish becomes increasingly apparent when 
the minimum or maximum limits are approached for an individual species. A range 
of studies on cultured marine species including Atlantic cod (Gadus morhua) 
(Morais et al., 2001), barramundi (Williams et al., 2003), white seabass (Atractoscion 
nobilis) (Lopez et al., 2009), Japanese seabass (Lateolabrax japonicas) (Ai et al., 
2004), European seabass (Dicentrarchus labrax) (Peres and Oliva-Teles, 1999) and 
gilthead seabream (Sparus aurata L.) (Santinha et al., 1999) have shown that optimal 
lipid levels are between 10-20% and growth is energy dependant. In addition, there is 
little or no evidence of a protein sparing effect by lipids in marine species, differing 
markedly from salmonids (Hillestad and Johnsen, 1994). Studies have also drawn 
attention to increased body fat as a result of increased dietary lipid in fish as  
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Figure 1.3 The pathways of LC-PUFA biosynthesis. The Δ12 and Δ15 
desaturase enzymes are only found in photosynthetic plants, hence the 
essentiality of 18 carbon precursors in vertebrates for LC-PUFA biosynthesis 
(Tocher, 2010). The grey pathway is an alternative proposed by Tu et al. (2012) 
for barramundi that bypasses the initial Δ6 desaturation rate limiting step. The 
fatty acids in red font are the biologically important end products for 
vertebrates. Δ, desaturase enzymes; Elovl, Elongation of very long carbon 
chains enzymes; CS, chain shortening by β-oxidation. 
having downstream consequences for seafood processors and human health benefits 
(Hillestad and Johnsen, 1994; Peres and Oliva-Teles, 1999; Williams et al., 2003). 
Therefore, the significance of dietary lipids cannot be overlooked particularly 
when dietary formulations are encroaching on the limits for each species. In 
barramundi, it has been well documented that the digestible protein to digestible 
energy ratio (DP:DE) decreases as the fish grow; however, they are not capable of 
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utilising high dietary lipid as a primary energy source when protein is not adequately 
provided (Williams et al., 2003). Likewise, when levels of lipid are too low 
barramundi begin to exhibit symptoms of a nutrient deficiency (Catacutan and 
Coloso, 1995). 
1.2.4 Alternative oils 
Along with the many advantages of using alternative lipid sources in aquafeeds there 
are some important issues that arise. Most notable are the direct health impacts on the 
cultured species when an imbalance or deficiency exists and then on the final product 
quality for human consumption. For further information on the final product quality 
aspects of fish nutrition refer to Turchini et al. (2009).  
The range of lipids being explored for potential use in animal nutrition is 
expanding. Traditionally, terrestrial oils with abundant n-3 and n-6 PUFA derived 
from oil seeds have been extensively researched in a wide range of vertebrate models 
largely due to their availability and price (Table 1.1).  
 
Table 1. 1 Current world production (MMT) and value (USD/tonne) data of 
major and emerging food grade oils.  
Major lipid sources Production Value 
Fish oil1 1 2650 
Soybean oil 43179 1076 
Canola oil2 23798 1160 
Olive oil3 2869 3960 
Palm oil 53827 770 
Rice bran oil  ~0.5 N/A 
Sunflower oil 13748 1460 
Linseed oil 0.5 1671 
Data are from USDA 2013; www.indexmundi.com; NUTTAB 2010 
www.foodstandards.com.au. 1Crude fish oil, production data 2009, value based on 
FOB vessel in drums  
2Also rapeseed oil 
3Extra virgin 
 
Generally, the plant oils contain a mix of SFA, MUFA and PUFA as either 
16:0 (palmitic acid), 18:0 (stearic acid), 18:1n-9 (oleic acid; OLA), 18:2n-6 (linoleic 
acid) and 18:3n-3 (linolenic acid) and they are characteristically devoid of any LC-
PUFA (Fig. 1.4). In addition to these, less common are plant oils that contain high 
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levels of 18:4n-3 (stearidonic acid; STA). STA in the human diet allows the 
bypassing of the first rate limiting step of eicosapentaenoic acid (EPA) biosynthesis, 
however, its commercial availability is limited (James et al., 2003) and its use in fish 
diets has so far proven to be of limited value (Alhazzaa et al., 2011a; Tocher et al., 
2006b). More recently other products rich in LC-PUFA, including single cell 
heterotrophs such as Schizochytrium sp. (Miller et al., 2007), Crypthecodinium sp 
(Harel et al., 2002), Phaeodactylum tricornutum (Atalah et al., 2007) have been used 
in FO replacement studies in fish. Furthermore, DuPont Applied Biosciences have 
genetically modified a yeast species (Yarrowia lipolytica) to contain high levels of 
EPA in its lipid content (Fig. 1.4) that is yet to be evaluated in fish (Belcher et al., 
2011; Gillies et al., 2012).  
 In addition to these existing alternatives, genetically modified oil seeds are a 
promising alternative to meet the growing LC-PUFA demands and several plant 
varieties now exist or are under development (Alonso and Maroto, 2000; Nichols et 
al., 2010; Robert, 2006). Researchers have been able to develop high- EPA and high- 
docosahexaenoic acid (DHA) producing cultivars of model species such as Nicotiana 
benthemiana (Petrie and Singh, 2011) and Arabidopsis thaliana (Petrie et al., 2012) 
by gene transfer from algae, effectively extending the natural biosynthetic pathways 
found in plants. Commercially relevant production of LC-PUFA rich oil from 
transgenic Camelina sativa was recently made available (Mansour et al., 2014; Ruiz-
Lopez et al., 2014) and evaluated in mice and fish without detrimental effects on 
performance (Betancor et al., 2015; Tejera et al., 2016). These evolving technologies 
are set to greatly improve the sustainability of aquaculture yet many challenges still 
exist including approvals and consumer acceptance.  
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Figure 1.4. Typical fatty acid profiles of oils used in aquaculture and other 
terrestrial animal nutrition. Data are adapted from Belcher et al. (2011); 
Glencross (2009); Glencross and Rutherford (2011) and NUTTAB 2010 
www.foodstandards.com.au. 
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1.3 Barramundi aquaculture nutrition 
1.3.1 Macro nutrient requirements of barramundi 
Macro nutrient requirements in barramundi have been determined over a range of 
size classes and environmental conditions. Past studies have reached different 
conclusions about the dietary strategies to improve production efficiency of 
barramundi. Williams et al. (2003) reported that there was a tendency to spare 
protein for growth particularly in juvenile barramundi whereas Catacutan and Coloso 
(1995) found no protein sparing effect. In agreement, these authors also reported that 
the most appropriate protein to energy ratio was in the range of 25 -27 mg/kJ. 
However, they reported vastly different optimal nutrient specifications with 42.5% 
and 10% (Catacutan and Coloso, 1995) and 60.3% and 18% (Williams et al., 2003) 
protein and lipid respectively. In addition, Glencross and Bermudes (2012) 
demonstrated that optimal DP:DE ratio decreased with increasing size of juvenile 
barramundi. They also demonstrated an increased DP:DE requirement at higher 
temperatures caused by decreased utilisation efficiency highlighting the importance 
of different dietary strategies to improve production.  
An early study into the use of dietary carbohydrate in barramundi found that 
provided that dietary lipid was high then a high level of carbohydrate supported the 
best performance (Catacutan and Coloso, 1997). However, in this study the diets 
were not isoenergetic, nutrient dense nor were they formulated on a digestible basis. 
Moreover, the pellets were produced using cold-screw press technology that would 
not permit the complete gelatinisation of starch therefore reducing the energy 
digestibility of the diets (Glencross et al., 2011a). Recent studies have shown that 
barramundi actually have a poor ability to digest starch (Glencross et al., 2012). 
These authors found that among a range of cereals commonly used in aquafeed, 
wheat starch is one of the least digestible with a digestible value of only 9.6 kJ/g. 
Studies in other carnivorous fish such as rainbow trout have demonstrated that the 
value of carbohydrate is limited as a growth nutrient; however, it does have value as 
an energy source (Saravanan et al., 2012). A similar response was seen in 
barramundi, suggesting that they have a preference for metabolizable energy in the 
form of protein or lipid and they derive little value from carbohydrate in terms of 
growth (Glencross et al., 2014a). 
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1.3.2 Alternative oils for barramundi  
The replacement of FO with alternative oil sources continues to be a high priority for 
aquafeed production worldwide. The barramundi is an obligate carnivorous fish 
central to an expanding aquaculture industry in the Indo-Pacific region with a 
reported LC-PUFA requirement in juvenile fish of around 1.2% (Williams et al., 
2006). However, variable responses of barramundi to FO replacement studies have 
led to questions being raised about the upper limits of FO substitution in this species 
(Glencross and Rutherford, 2011; Morton et al., 2014; Raso and Anderson, 2003; Tu 
et al., 2013). Poultry fat (PF) is produced as a by-product of the chicken processing 
industry and is characterised by its high 18:1n-9 and 18:2n-6 content (Turchini et al., 
2009). Poultry fat is commonly used to replace FO in fish diets providing an 
excellent source of energy, however, it is characterised by a lack of n-3 LC-PUFA 
(Turchini et al., 2009). 
Depletion of LC-PUFA in the diet of barramundi can potentially lead to 
reduced productivity and the onset of essential fatty acid deficiency symptoms 
(Catacutan and Coloso, 1995; Glencross and Rutherford, 2011; Williams et al., 
2006). Moreover, a lack of dietary LC-PUFA will also likely be reflected in the flesh, 
diminishing the human nutritional value of the product (Turchini et al., 2009). It is 
well established that the regular consumption of food rich in n-3 LC-PUFA is a 
fundamental part of a balanced diet and the Food and Agricultural Organisation 
(FAO) recommend the consumption of 250 to 2000 mg/d (EPA and DHA) for adults 
(FAO, 2010). 
Highly variable or disproportionate retention of lipid or indeed specific fatty 
acids may indicate metabolic changes as a direct result of the fed diet. Thomassen et 
al. (2012) found that Atlantic salmon consuming a diet containing rapeseed oil with 
supplemental EPA (20:5n-3) oil had significantly higher DPA (22:5n-3) retention via 
elongation pathways. Moreover, these fish selectively retained DHA (22:6n-3) 
efficiently and in absolute terms the proportion of DHA was significantly improved 
when compared to those fish fed only rapeseed oil with no supplemental EPA. 
Similarly, a dramatic reduction of LC-PUFA retention was demonstrated in both 
barramundi and Atlantic salmon as dietary LC-PUFA increased (Glencross and 
Rutherford, 2011; Glencross et al., 2014b). In contrast, Atlantic cod retained more 
LC-PUFA as intake increased (Hansen et al., 2008). 
Efficient feed utilisation has a determinant effect on costs and outputs in 
aquaculture systems. In economics, a future return on an investment is estimated 
34 | P a g e  
based on financial inputs and is termed the marginal efficiency of capital (Kalecki, 
1937). Similarly, this concept can be applied in aquaculture nutrition in order to 
better understand the relationship between dietary inputs and fish outputs over time. 
It differs from deposition or retention in that it is not just a mass-balance model but 
rather is a bioenergetic approach based on the weight independent relationships 
between the intake and gain of a specific nutrient. The exact fate of ingested nutrients 
is difficult to measure, however, calculation of the marginal (partial) efficiency can 
provide a clearer understanding of the discrete contributions of a dietary nutrient. 
The slope coefficient of the linear relationship is termed the efficiency of utilisation 
for production (kpf), protein (kp) and lipid (kf) and this can be used to estimate the 
response over a range of nutrient intake levels independent of mass (NRC, 2011). 
Moreover, the slope of the regression can be further extrapolated until recovered 
energy for growth is equal to zero thus providing an estimate of nutrient maintenance 
requirements (NRC, 2011). 
A number of studies have used this bioenergetic approach in determining the 
marginal efficiencies and estimating maintenance requirements of energy, lipid and 
protein in a variety of fish species. The marginal efficiencies of protein (kp) and lipid 
(kf) of a range of species including Atlantic salmon, rainbow trout (Oncorhynchus 
mykiss), European seabass, gilthead sea bream, white grouper (Epinephelus aeneus) 
and yellow-tail kingfish (Seriola lalandi) generally range between kp 0.53 - 0.64 and 
kf 0.72 - 0.91 (Booth et al., 2010; Bureau et al., 2006; Helland et al., 2010; Lupatsch 
et al., 2003). In barramundi, Glencross and Bermudes (2010) showed that over a 
range of temperatures from 25 to 32 °C the partial efficiency of energy (kpf) was 
relatively consistent at 0.56 and protein (kp) was relatively consistent at 0.51. Despite 
the apparent importance of EFA the energetic efficiencies and maintenance 
requirements of these nutrients do not appear to have been investigated in fish using 
a bioenergetics approach. 
1.3.3 Different fatty acid class use by barramundi 
In the context of feeding fish alternative oils, many studies have focused on the 
essential fatty acids and their bioactive long-chain derivatives, EPA and DHA. 
However, it is suggested that SFA and MUFA are preferred substrates for β-
oxidation in fish, sparing the more essential fatty acids for their functional and 
biological roles (review by Henderson 1996). As alternative oils are being 
increasingly used in aquafeeds it is important to understand the effect of increasing 
dietary levels of SFA and MUFA, which are generally abundant in such oils, on lipid 
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metabolism in fish. Carnivorous fish such as barramundi, rely heavily on β-oxidation 
of lipid for their energetic requirements. Past studies have consistently shown 
positive responses to the replacement of FO with a range of alternative oils such as 
soybean, canola, rapeseed, Echium, usually included as blends (Alhazzaa et al., 
2011a; Raso and Anderson, 2003; Williams et al., 2006).  
Atlantic salmon also performed well when fed diets with either low n-3 
PUFA and high MUFA and in addition MUFA were found to be good substrates for 
β-oxidation (Menoyo et al., 2003). In the same species, β-oxidation was found to be 
dependent on energy demand and that when fatty acids were provided in excess to 
synthetic demands they were increasingly β-oxidised for energy production 
(Stubhaug et al., 2007; Torstensen et al., 2004). Denstadli et al. (2011) found that the 
medium chain length decanoic acid (10:0) was rapidly oxidised for energy 
production whereas OLA was primarily deposited in the intramuscular fat in Atlantic 
salmon. In other species such as Atlantic cod reduced lipid deposition in the liver 
was likely caused by selective β-oxidation of 16:0 and 18:0 SFA present in PO and 
rapeseed oil (Jobling et al., 2008). In agreement, polka dot grouper (Cromileptes 
altivelis) more readily oxidised lipid in diets containing SFA (coconut fat) for energy 
rather than MUFA (olive oil); however, this was at the expense of efficient growth 
(Smith et al., 2005). Further to this, the authors of a recent study on European sea 
bass speculated that a single fatty acid (eg. OLA) might be more efficient at sparing 
LC-PUFA from β-oxidation than oil blends (Eroldogan et al., 2013). 
Using an in-vivo whole-body fatty acid balance approach for determining 
fatty acid metabolism in rainbow trout, Turchini and Francis (2009) found that the 
most heavily oxidised fatty acids were also the most dominant. However, in the fish 
oil fed trout the most predominant dietary fatty acid (16:0) was not readily oxidised 
for energy production, but rather was preferentially elongated to 18:0 or desaturated 
to 16:1n-7. The same research group also found that the rate of β-oxidation of LC-
PUFA was reduced when Murray cod (Maccullochella peelii peelii) were fed diets 
containing MUFA and SFA, which are generally abundant in alternative oils 
(Turchini et al., 2011b). Moreover, a recent study on hybrid striped bass (White Bass 
Morone chrysops × Striped Bass M. Saxatilis) concluded that diets containing SFA-
rich lipid and to a lesser extent MUFA-rich lipid were able to conserve tissue fatty 
acid profiles possibly due to preferential β-oxidation (Trushenski et al., 2015).  
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1.3.4 Different lipid class use by barramundi 
The phospholipids form the structural bilayer of cell membranes providing integrity 
and fluidity (Hazel and Williams, 1990; Tocher et al., 2008). Also central to their 
biological importance is their association with apoproteins (forming lipoproteins) 
that assist in the extracellular transport of lipids thus improving parameters such as 
growth, survival and health throughout the organism (Tocher et al., 2008). However, 
the total lipid content in fish is mostly composed of neutral lipid in the form of TAG 
(Glencross, 2009). 
There is evidence to suggest that most larval and early juvenile fish have a 
dietary requirement for intact phospholipids as endogenous biosynthesis is not 
sufficient (Coutteau et al., 1997). Coutteau et al. (1997) reported that the 
phospholipid requirement of fish and crustaceans varied depending on the life stage 
and history. Freshwater fish generally have lower dietary requirements, of around 2% 
whereas marine fish generally have higher requirements up to 7%. Early studies 
found that in both rainbow trout and Atlantic salmon the phospholipid requirement of 
first swim-up sized fish (<0.2 g) was 4% supplied in the form of soybean lecithin 
(Poston, 1990a; b). However, larger salmon (~7.5 g initial) showed no improvement 
in terms of growth suggesting that endogenous synthesis of phospholipid is sufficient 
to support the requirement of the fish and that high dietary levels had a negative 
effect on survival (Poston, 1990a). It should also be noted that the latter study, and 
possibly others, refer to a requirements based on the use of phospholipid containing 
ingredients rather than the precise phospholipid content which is often unclear. 
There are very few studies on the effect of dietary phospholipids in juvenile 
fish greater than 5 g as it is generally accepted that they don’t have a requirement 
based on the historical evidence presented for Atlantic salmon (Poston, 1990a). 
Recently, the influence of dietary phospholipid from either krill oil or soybean 
lecithin was investigated in Atlantic salmon from first feeding up to smolt (0 to 70 g 
range) (Taylor et al., 2015). These authors demonstrated a range of improvements 
among the parameters tested and concluded that Atlantic salmon have a dietary 
requirement for intact phospholipid particularly in early development. Therefore, 
with the continual reduction of FM and FO in commercial feeds and the complex 
biochemistry of the phospholipids particularly in juvenile fish, further investigation 
is warranted.  
In barramundi, some notable effects on the phospholipid composition of 
tissues have been identified, which may suggest that juvenile barramundi have a 
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requirement for intact phospholipids (Alhazzaa et al., 2011b; Tu et al., 2013). It 
appears that when dietary PL are not sufficient then very selective retention of tissue 
phospholipids occurs in barramundi and other species, until depletion, this being a 
mechanism to prevent the onset of phospholipid deficiency and secondary 
pathologies as a result (Skalli and Robin, 2004; Tocher et al., 2008; Tu et al., 2013). 
1.3.5 Essential fatty acids in barramundi 
Nutrient deficiency in any species can be difficult to determine accurately due to the 
difficulties in feeding a deficient diet. Early studies have specifically looked at fatty 
acid deficiency in fish (Castell et al., 1972) while others studying nutrient 
requirements have reached conclusions about deficiency signs and symptoms 
(Catacutan and Coloso, 1995). There is a vast amount of literature on lipids and their 
constituent fatty acids in fish diets and a focal point has been on their complexity, 
uniqueness and biological importance (Sargent et al., 2002). The barramundi are 
reported to have limited de novo capability to synthesise LC-PUFA (Alhazzaa et al., 
2011a; Mohd-Yusof et al., 2010; Tu et al., 2013). Moreover, the requirement of total 
lipid and LC-PUFA is thought to be low based on the compositional status of wild 
caught specimens compared to that of cultured barramundi (Nichols et al., 1998; 
Nichols et al., 2014). 
Clinical signs of nutrient deficiency become an important indicator of fish 
health and productivity. If fish are fed a diet that is deficient in a particular nutrient 
that cannot be synthesised endogenously, then their physical condition will begin 
deteriorating once all body reserves become depleted. Further, secondary 
pathological conditions may take hold as the animal becomes compromised and 
without treatment premature death often follows. To avoid this situation arising, 
commercially produced feeds need to ensure an adequate supply of all essential 
nutrients, often achieved by the addition of FM and FO. However, global supply of 
these resources is under increasing environmental and economic pressure. Therefore 
it is important to determine critical inclusion levels of all essential nutrients in dietary 
formulations for cultured species. 
Several studies have induced EFA deficiency in a range of fish species. One 
of the earliest was that of Castell et al. (1972) who documented the feeding of 
rainbow trout over a prolonged time-course. These authors described a range of 
deficiency symptoms such as; poor growth, fin erosion, changing pigmentation, 
swollen livers and hearts and fainting or shock syndrome. A later study by Ruyter et 
al. (2000) observed that Atlantic salmon exhibited poor growth, increased mortality 
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and altered blood chemistry and liver condition after one month of feeding an EFA 
deficient diet. In other species such as channel catfish (Ictalurus punctatus) (Satoh et 
al., 1989), red drum (Sciaenops ocellatus) (Lochmann and Gatlin, 1993), turbot 
(Psetta maxima) (Bell et al., 1985) and gilthead sea bream (Ibeas et al., 1996), signs 
of EFA deficiency include a consistent range of symptoms, with the most prominent 
being reduced growth performance and survival. 
The precursors to LC-PUFA, 18:2n-6 and 18:3n-3 are considered essential or 
at least conditionally essential in all vertebrates, including fish, as they lack the 
desaturase enzymes required for their synthesis (Cunnane, 2003; Tocher, 2003). 
Typically, freshwater and some diadromous species, are able to synthesise sufficient 
LC-PUFA from these precursor fatty acids while in most marine fish species the 
pathway of fatty acid biosynthesis is incomplete (Tocher, 2003). However, there are 
distinct differences that exist between the marine fish in their capacity to 
biosynthesise fatty acids. Recently, the presence of an alternative delta-4 pathway to 
LC-PUFA was identified in the herbivorous marine fish Siganus canaliculatus (Li et 
al., 2010). Cell lines of the marine fish turbot were used to demonstrate that 
elongation activity was limiting whereas in gilthead sea bream delta-5 desaturase 
activity was limiting the conversion of precursor fatty acids to LC-PUFA (Ghioni et 
al., 1999; Tocher and Ghioni, 1999). The barramundi also lacks delta-5 desaturase 
activity and is known to have a desaturase with delta -6/delta-8 dual activity in vitro 
(Mohd-Yusof et al., 2010; Tu et al., 2013). Therefore, this evidence supports that in 
vivo this species should succumb to EFA deficiency due to this inability to produce 
the reputedly required LC-PUFA including EPA, DHA and ARA. 
The lipid, and to a lesser degree the fatty acid requirements were examined in 
barramundi by a number of studies, yet there is still no clear documentation of the 
onset and progression of deficiency symptoms. Early studies demonstrated that 
performance of larval barramundi was improved by incorporating preformed LC-
PUFA into enriched live prey (Dhert et al., 1990; Rimmer et al., 1994). Other 
juvenile barramundi studies have reported signs of EFA deficiency such as abnormal 
reddening of the fins and reduced growth performance associated with low levels of 
n-3 LC-PUFA (Buranapanidgit and Boonyaratpalin, 1988; Catacutan and Coloso, 
1995). More recently, Williams et al. (2006) demonstrated improvements in 
barramundi productivity with increasing n-3 LC-PUFA at either 20 or 29 °C. 
Williams et al. (2006) described a ‘fainting attack’ from a small number of their fish 
and this effect has also previously been observed in rainbow trout fed EFA deficient 
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diets (Castell et al., 1972). Glencross and Rutherford (2011) showed for the first time 
that barramundi performance was clearly affected by the presence or absence of 
certain EFA. These authors also reported symptoms such as reddening of the fins and 
the opercular region, however, this was attributed to increasing DHA in the absence 
of an equivalent increase of EPA. 
1.3.6 EPA, ARA and eicosanoid metabolism in barramundi 
Eicosapentaenoic acid (EPA; 20:5n-3) and arachidonic acid (ARA; 20:4n-6) are 
important for many metabolic and physiological functions, and are precursor 
molecules for the production of eicosanoid hormones that play a role in the 
inflammatory response, immune function and regulation as well as ionic regulation 
and reproduction in fish and mammals (Rowley et al., 1995). In humans, the 
incidence of diseases involving inflammatory processes can be related to the 
production of these eicosanoids, for example prostaglandin E2 (PGE2) and 
leukotriene B4 (LTB4) that are derived from high cellular concentrations of ARA 
(Wall et al., 2010). The cyclooxygenase (COX; prostaglandin G/H synthase) and 
lipoxygenase (LOX; arachidonate 5-lipoxygenase) enzymes interact and compete for 
the EPA and ARA substrates and as such the eicosanoids produced are determined 
by their availability (Calder, 2012; Tocher, 2003).  
The COX enzyme catalyses 20-carbon chain fatty acids (ARA or EPA) 
through bis-dioxygenation and subsequent reduction to produce 2 - and 3 - series 
prostaglandins (PGG2/3 and PGH2/3) that are substrates for the synthesis of 
biologically active prostaglandins, prostacyclins and thromboxanes (Calder, 2012; 
Rouzer and Marnett, 2009; Rowley et al., 1995). While the LOX enzyme catalyses 
the same substrates to yield biologically active metabolites of hydroperoxy-
eicosatetraenoic acid (HPETE), such as leukotrienes and lipoxins (Matsumoto et al., 
1988; Rowley et al., 1995). Unlike most vertebrates, the COX enzyme system in 
teleost fish is complicated by an evolutionary duplication event that led to alternative 
chromosomal regions of COX genes, often identified as ‘a and b’ isoforms of either 
the COX-1 or -2 series, but rarely both (Ishikawa and Herschman, 2007; Ishikawa et 
al., 2007). There is also an accepted paradigm that COX-1 is constitutively expressed 
whereas COX-2 is inducible, however, this is now widely viewed as an 
oversimplified view (Breder et al., 1995; Olsen et al., 2012; Rouzer and Marnett, 
2009). 
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In many fish species, EPA and ARA are required for important metabolic and 
physiological functions, and the dietary requirements are well understood (Bell and 
Sargent, 2003; Izquierdo, 1996; Tocher, 2015). The consumption of diets rich in oils 
that contain eicosanoid inhibiting or regulating substrates (Eg. EPA, 20:4n-3, 18:4n-
3) can have significant downstream modulatory effects on the fish (Ghioni et al., 
2002). However, without discounting the importance of ARA, there is great potential 
for this fatty acid to affect growth, stress response, immune response and survival, 
particularly at early life stages (Atalah et al., 2011; Bell and Sargent, 2003; Castell et 
al., 1994; Montero et al., 2015b; Yuan et al., 2015). 
Information on the EPA and ARA requirements in the barramundi or Asian 
seabass are scarce In the only study available thus far, a single diet with a higher 
inclusion of ARA in the absence of EPA showed negative effects on fish health, 
including disproportionate tissue LC-PUFA retention and pathophysiological effects 
such as subcutaneous haemorrhaging and disrupted ionic regulation (Glencross and 
Rutherford, 2011). There is evidence to suggest that wild barramundi (either from 
fresh or salt water) can contain ARA levels more than 5-fold higher than EPA in 
their muscle tissue (Nichols et al., 2014). The increasing use of alternative oils in 
farmed fish, often containing high levels of omega 6 fatty acids which can act as 
ARA precursors (e.g. soybean oil, sunflower oil), and simultaneous reduction of 
dietary fish oil, may impact the final ARA/EPA ratio in fish tissues, with possible 
resulting issues associated with modified lipid metabolism (Brown and Hart, 2011). 
1.3.7 Allometric scaling effects of LC-PUFA 
A range of different approaches have been used to predict or determine growth as 
well as feed requirements based on the dynamic flow of nutrients in aquatic systems 
(Bar et al., 2007; Cho and Bureau, 1998; Glencross, 2008; Lupatsch and Kissil, 
1998; Machiels and Henken, 1986). Predictive models started out as relatively simple 
approaches such as the ubiquitous specific growth rate and thermal growth 
coefficient calculations; however, progressive extensions of these models now exist 
that consider the many biological properties of fish (Birkett and Lange, 2007; Dumas 
et al., 2010). In addition, mass-balance models have also been developed and used in 
understanding specific nutrient and metabolite flows in a range of model species 
(Cunnane and Anderson, 1997; Turchini et al., 2006; Turchini et al., 2007) as well as 
a whole ecosystem approach (Sawyer et al., 2016).  
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There is a growing body of evidence regarding the essential fatty acid requirements 
of many species generally determined by various forms of in vivo feeding 
assessments (NRC, 2011). The efficient utilisation of fatty acids within an organism 
depends on a number of factors and there are many complex interactions among 
specific fatty acids potentially affecting their utilisation efficiency (Glencross, 2009; 
Tocher, 2015). Despite the numerous studies to date, relatively little is known about 
the maintenance requirements and utilisation efficiencies associated with specific 
fatty acids and how these may be used in nutrient modelling. An obvious step in the 
further development of these models is the incorporation of empirically derived 
utilisation efficiency values. Maintenance requirements of protein, lipid and energy 
typically described by linear equations of intake to gain ratios can give an insight 
into the partitioning of production and maintenance costs (Bureau et al., 2006; NRC, 
2011; Pirozzi et al., 2010). Similarly, it should be possible to determine estimates of 
productivity for specific fatty acids using derived body weight scaling exponent 
values to provide a size independent response (Bar et al., 2007; Glencross and 
Bermudes, 2011; White, 2011).  
 
1.4 Thesis structure 
The thesis presented herein is an adaptation of a series of published manuscripts. The 
manuscripts have been peer reviewed and published in high standing journals 
relevant to the field of aquaculture nutrition. The following (second) chapter 
summarises the materials and methodology utilised during experimentation. This 
section is divided to cover key areas including experimental diet production, 
experimental methodologies and experimental analyses. The second chapter also 
includes an ethical statement encompassing all research chapters using live animals. 
Chapter three to chapter eight are the six experimental research chapters that have 
been adapted from published and submitted manuscripts. Each provides the reader 
with a concise aims and methods section followed by detailed results and discussion. 
The ninth chapter is a general summary followed by a general conclusion.  
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General methodology 
2.1 Diet production  
The following methods were used during the experiments conducted as part of this 
thesis. 
2.1.1 Ingredient preparation 
This method applies to all of the experiments with the exception of Chapter 8 as 
there were no diets produced. The dry ingredients were passed separately through a 
hammermill (Mikro Pulverizer, type 1 SH, New Jersey, USA) such that the 
maximum particle size was less than 750 μm. All ingredients were then thoroughly 
mixed using an upright commercial mixer (Bakermix, Model 60 A-G, NSW, 
Australia). Fish meal was defatted prior to use in experimental Chapter 4, Chapter 5, 
Chapter 6 and Chapter 7. This was achieved by manually mixing hexane and fish 
meal (2:1) in a large drum. The mix was left to soak for 3h before draining the excess 
hexane and repeating the process a second time. The fish meal was then oven dried 
overnight at 60 °C to a constant dry matter. 
2.1.2 Diet preparation by screw press technology 
This method applies to Chapter 4, Chapter 5 and Chapter 6. A single basal diet was 
formulated and prepared without the addition of dietary lipids. The basal diet was 
then separated into smaller batches and aliquots of lipid (8.2% diet) were added to 
form the treatment diets. Fresh water was added at approximately 30% of dry mash 
weight and mixed to form a consistent dough, then the dough was subsequently 
screw pressed through a 4 mm die Dolly Pasta Extruder (La-Monferrina, 
Sant’Ambrogio di Torino, Italy). The pellets were dried overnight at 60 °C to a 
constant dry matter. Pellets were then stored at -20 °C until required. 
2.1.3 Diet preparation by extrusion technology 
This method applies to Chapter 3 and Chapter 7. The pellets were produced using a 
laboratory-scale twin-screw extruder with intermeshing, co-rotating screws (MPF24, 
Baker Perkins, Peterborough, United Kingdom). The following parameters were 
used, however, these are only examples and vary depending on the formulation 
across experiments. 
The dry mash was delivered into the barrel at a feed rate of around 400 g/min. 
Barrel temperatures were set for each of the four zones from drive to die at 60, 80, 
100 and 110 °C respectively. The following methodology was based on Glencross et 
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al. (2016). The extruder barrel was a smooth-walled, open clam design with twin 
screws measuring 24 x 600 mm (diameter x length). The screws were configured 
with a series of feed screws (FS), forward paddles (FP) and lead screws (LS) 
arranged to defined barrel diameters (D). The configuration was 16D FS, 2D FP, 1D 
FS, 2D FP, 1D LS, 1D FP, 2D LS: to the die. Feeds were extruded through a 2 mm Ø 
die with the machine running at c. 326 rpm. Water was peristaltically pumped 
(Baoding Longer Precision Pump Co., Ltd, Hebei, China) into the barrel at 24 
mL/min. Pellets obtained a 1.5-fold increase in diameter by expansion were cut off at 
lengths of ~4 mm using a variable speed 4-blade cutter and dried overnight at 60 °C 
to a constant dry matter. 
2.1.4 Vacuum infusion of lipid 
Prior to vacuum infusion the lipid sources were warmed at 60 °C to ensure a 
homogeneous blend of the lipids as liquefied oils before the prescribed allocation of 
dried pellets was placed into a large mixing bowl and oil slowly added while mixing 
to ensure even coating. A perspex lid was then placed on the bowl with a rubber seal 
and vacuum pump was then connected through a small fitting. Suction was applied to 
achieve a maximum of 100 kPa pressure or until all visible signs of air escaping the 
pellets had ceased at which point the suction was released and the oil infused as the 
chamber re-equilibrated to atmospheric pressure. Pellets were then stored at -20 °C 
until required. 
2.2 Experimental methodology 
2.2 Ethical statement 
Ethical clearance was approved for each of the experimental procedures by the 
CSIRO Animal Ethics Committee (Chapter 3.0 A09/2011; Chapter 4.0 A12/2013; 
Chapter 5.0 A11/2013; Chapter 6.0 A10/2013; Chapter 7.0 A05/2014; Chapter 8.0 
A3/2015). All manipulations with animals were conducted in adherence of the 
ethical conditions. Wherever possible the use of animals was minimised and those 
remaining after experimentation were returned to a stock holding facility.  
2.3 Barramundi husbandry 
For each experiment, juvenile barramundi (Lates calcarifer) were sourced from the 
Betta Barra fish hatchery (Atherton, QLD, Australia), on-grown in a 10,000L tank 
and fed a commercial diet (Marine Float; Ridley Aquafeed, Narangba, QLD, 
Australia). Prior to commencement of the experiment the selected fish were 
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transferred to a series of experimental tanks with flow-through heated seawater at a 
flow rate of about 3 L/min being supplied to each of the tanks. There were 20 
individually weighed fish per tank used in Chapter 3, 26 individually weighed fish 
per tank used in Chapter 4, Chapter 5 and Chapter 6, 30 individually weighed fish 
per tank used in Chapter 7 and 15 individually weighed fish per tank used in Chapter 
8. Photoperiod was constant at 12L:12D. Three experimental systems were used 
during experimentation; 300 L aquaria were used for Chapter 4, Chapter 5 and 
Chapter 6; 600 L aquaria were used for Chapter 3, and Chapter 8; and 1000 L aquaria 
were used for Chapter 7. In each case, the experimental diets were randomly 
distributed amongst the tanks with each treatment having three replicate tanks. 
Depending on the experimental design, the fish were managed according to one of 
the following protocols. 
1) The diets were fed once daily to apparent satiety as determined over three separate 
feeding events, for eight weeks. Any uneaten feed was collected shortly after and a 
correction factor was applied (Helland et al., 1996). Briefly, the correction factor was 
calculated as the proportion of soluble losses after immersion in water for 1 h 
(Chapter 3, Chapter 4, Chapter 5 and Chapter 6). 
2) The fish were restrictively fed, once daily, a sub-satietal (approximately 80%) 
pair-feeding regime in order to avoid the potentially confounding issue of 
unregulated feed intake (Chapter 7) (Glencross et al., 2003a).  
3) At the beginning of the experiment the tanks held six treatment size classes of 
fish, which were randomly distributed among the tanks with each treatment having 
three replicate tanks. The fish were then starved for 21 days (Chapter 8). 
2.4 Sample collection techniques 
For each experiment six fish of similar size from the original stock were euthanized 
by an overdose of AQUI-S™ (Lower Hutt, New Zealand) at the beginning of the 
experiment and stored at -20 ºC until analysis. Upon termination of the experiment, a 
further six fish were sampled from each tank. A sample of whole blood was removed 
from the caudal vein of three fish using 1 mL pre-heparinised syringes and an 18 G 
needle. Blood from the three fish was pooled in a single Vacutainer™ tube and then 
centrifuged at 10,000 rpm for 5 min to settle the erythrocytes. The plasma was then 
drawn off and transferred to a 1.5 mL Eppendorf™ tube and frozen at -80 °C before 
being sent for chemical analysis at the West Australian Animal Health Laboratories 
(South Perth, Western Australia). From the same three fish and three from the initial 
stock, a sample of liver tissue for molecular analysis was removed upon termination 
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or at each fortnightly sampling event. We anticipated relatively minor changes in 
gene expression and therefore we only included the control and extreme dietary 
treatments for analysis. Samples were placed into 1.5 mL screw-top vials and kept on 
dry ice before being transferred to a -80 °C freezer until analysis. All sampling 
procedures occurred 24 h after feeding in the post absorptive phase (Wade et al., 
2014). If interim samples were required individual fish (n=3 per tank) were collected 
in the same fashion after each fortnightly period and upon termination of the 
experiment. Any remaining fish returned to their respective tank after a short 
recovery. 
2.5 Abnormalities and behaviour assessment 
This method only applies to Chapter 6. The physical condition of all the individual 
fish was recorded at each fortnightly sampling event. Any fish that had symptoms 
such as erosion of the fins, reddening of the fins and extremities, gross lesions and 
physical deformities were recorded. For the assessment, fish were considered either 
normal or abnormal based on the presence or absence of at least one symptom. A 
percentage score was given to each tank and each tank was used as a replicate within 
each treatment. The behaviour of each tank of fish was assessed by an operator 
holding a hand over the corner of a tank to simulate commencement of a feeding 
event. Fish activity was scored as being either cryptic (0), ambivalent to the hand (1) 
or actively searching for food (2). This assessment was carried out prior to feeding 
on the same day of each week by the same operator to maintain consistency and the 
results were averaged across time to give a repeated measures response to each tank. 
Each tank was used as a replicate within each treatment (Glencross and Rutherford, 
2011). 
2.6.1 Digestibility analysis – settlement 
Yttrium oxide was used in each diet formulation at 1g/kg as an inert marker for 
digestibility analysis. Two different methods of faecal collection were used during 
experimentation. The settlement method applies to Chapter 4, Chapter 5 and Chapter 
6. Prior to the termination of the growth assay, faeces were collected using the 
established settlement protocol described below (Blyth et al., 2014). Briefly, a 
collection chamber was filled with water and frozen then attached to the evacuation 
line of a swirl separator and left overnight. The following morning, the collection 
chamber was removed and the chilled faeces were captured in a plastic sample 
container and stored at -20 °C until analysis. 
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2.6.2 Digestibility analysis - abdominal stripping 
This method applies to Chapter 7. Upon termination of the growth assay, faeces were 
collected using established abdominal stripping protocols (Blyth et al., 2014). 
Briefly, the fish were netted from their tanks and anesthetised, then gentle abdominal 
pressure was applied to the distal intestine to extract the faeces. Care was taken by 
the operator to avoid contamination of the sample with foreign material and hands 
were rinsed after each stripping. The faecal sample was placed into a small plastic 
vial on ice before being stored in a freezer -20 °C until analysis. 
2.7 Experimental analyses 
2.7.1 Chemical analysis 
These methods apply to all experiments. Prior to analysis the diets were each ground 
to a fine powder using a bench grinder (KnifeTec™ 1095, FOSS, Denmark). The 
initial and final fish were processed using the following method. The whole fish were 
passed through a commercial meat mincer (MGT – 012, Taiwan) twice to obtain a 
homogeneous mixture. A sample was taken for dry matter analysis and another 
sample was freeze-dried along with the faecal samples until no further loss of 
moisture was observed (Alpha 1-4, Martin Christ, Germany). Dry matter was 
calculated by gravimetric analysis following oven drying at 105ºC for 24 h. Crude 
protein was calculated after the determination of total nitrogen by organic elemental 
analysis (CHNS-O Flash 2000, Thermo Scientific, USA), based on N x 6.25. Total 
lipid content was determined gravimetrically following extraction of the lipids using 
chloroform:methanol (2:1) following Folch et al. (1957). Gross ash content was 
determined gravimetrically following loss of mass after combustion of a sample in a 
muffle furnace at 550 °C for 24 h. Gross energy was determined by adiabatic bomb 
calorimetry (Parr 6200 Calorimeter, USA). Total yttrium concentration in the diets 
and faeces was determined after nitric acid digestion in a laboratory microwave 
digester (Ethos One, Milestone, Italy) using inductively coupled plasma-mass 
spectrophotometry (ICP-MS) (ELAN DRC II, Perkin Elmer, USA).  
2.8.1 Biochemical analysis – Lipid transesterification 
These methods apply to all experiments. Fatty acid composition was determined 
following the methods of Christie (2003). Lipids were esterified by an acid-catalysed 
methylation and 0.3 mg of an internal standard was added to each sample (21:0 
Supelco, PA, USA). The fatty acids were identified relative to the internal standard 
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following separation by gas chromatography (GC). An Agilent Technologies 6890N 
GC system (Agilent Technologies, California, USA) fitted with a DB-23 (60 m x 
0.25 mm x 0.15 μm, cat 122-2361 Agilent Technologies, California) capillary 
column and flame ionisation detection was used. The temperature program was 50–
175 ºC at 25 ºC /min then 175–230 ºC at 2.5 ºC /min. The injector and detector 
temperatures were set at 250 ºC and 320 ºC, respectively. The column head pressure 
was set to constant pressure mode at 170 kPa using hydrogen as the carrier gas. The 
peaks were identified by comparing retention times to the internal standard and 
further referenced against known standards (37 Comp. FAME mix, Supelco, PA, 
USA). The resulting peaks were then corrected by the theoretical relative FID 
response factors (Ackman, 2002) and quantified relative to the internal standard.  
Lipid extracts were applied to silica Sep-Pak® (Waters, Massachusetts, USA) 
columns and separated into neutral (non-phosphorus) lipid and polar (phosphorus) 
lipid following (Juaneda and Rocquelin, 1985). Briefly, Sep-Pak® columns were 
pre-conditioned with 4 mL of hexane before a 30 mg sample of lipid dissolved in 
chloroform was applied to each column. The neutral lipid was first eluted with 20 
mL of chloroform and followed by 5 mL of chloroform:methanol (49:1). The polar 
lipid was then eluted with 30 mL of methanol. The proportion of either neutral or 
polar lipid was quantified gravimetrically and then an aliquot was further esterified 
and separated into fatty acids following the protocol above. 
2.8.2 Biochemical analysis – Plasma chemistry 
These methods only apply to Chapter 5 and Chapter 6. Plasma samples were sent to 
the West Australian Animal Health Laboratories (South Perth, Western Australia) for 
enzyme and chemistry assessment. The assays were run on an Olympus AU400 
automated chemistry analyser (Olympus Optical Co. Ltd). Each of the assays used 
was a standard kit developed for the auto-analyser. The tests performed included 
alanine aminotransferase (ALT, EC 2.6.1.2) (Olympus kit Cat. No. OSR6107), 
creatine kinase (CK, EC 2.7.3.2) (Olympus kit Cat. No. OSR6179), glutamate 
dehydrogenase (GLDH, EC 1.4.1.2) (Randox kit Cat. No. GL441), total protein 
(Olympus kit Cat. No. OSR6132), creatinine (Olympus kit Cat. No. OSR6178), 
alkaline phosphatase (Olympus kit Cat. No. OSR6004), glucose (Olympus kit Cat. 
No. OSR6121), haemoglobin (Randox kit Cat. No. HG1539) and haptoglobin 
(Randox kit Cat. No. HP3886). Trace elements were determined after mixed acid 
digestion using inductively coupled plasma mass spectrometry (ICP-MS). 
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2.9.1 Molecular analysis - Cloning of putative prostaglandin G/H synthase 
(COX) and arachidonate 5-lipoxygenase (LOX) genes 
These methods only apply to Chapter 7. Sequences of the prostaglandin G/H 
synthase and arachidonate 5-lipoxygenase (COX1a, COX1b, COX2 and ALOX-5) 
genes from several teleost species were identified in the Genbank database. Highly 
conserved regions from protein alignments across species were used to design pairs 
of degenerate primers that were subsequently synthesised by Sigma-Aldrich (Table 
3). PCR primers specific to each target gene were designed using PerlPrimer v.1.1.17 
(Marshall, 2004). Pooled barramundi liver cDNA (1000 ng) was amplified in 
reactions, with each degenerate primer pair (F and R; 10 μM) using platinum TAQ 
mix (Thermofisher). Polymerase chain reaction (PCR) conditions including an initial 
denaturation step at 90 °C for 2 min followed by 35 cycles of 94 °C/10 s, 50 °C/30 s 
(50% ramp speed) and 72 °C/30 s with a final extension step of 72 °C/5 min were 
used. The amplification products were separated by size using electrophoresis on a 
1% agarose gel and then excised and extracted using the QIA quick gel extraction kit 
(QIAGEN). The target was then ligated using the pGEM-T Easy vector system 
(Promega). Ligation reactions were then transformed onto One Shot TOP10 
chemically competent Escherichia coli cells (Thermofisher) which were then 
cultured overnight on LB ampicillin plates (100 μg/mL). Positive clones were 
selected by PCR amplification with primers flanking the multiple cloning site (M13F 
and M13R), using an initial denaturation step at 94 °C/5 min followed by 35 cycles 
of 94 °C/20 s, 55 °C/30 S, 72 °C/1.5 min with a final extension step of 72 °C/5 min. 
Randomly selected positive clones were prepared for sequencing with a QIAprep 
Miniprep kit (QIAGEN) and then the plasmid insert was sequenced using the 
BigDye® Terminator V3.1 sequencing kit (Applied Biosystems) with an ABI 3130 
Automated Capillary DNA Sequencer (Applied Biosystems). 
2.9.2 Molecular analysis - Sequencing analysis 
These methods only apply to Chapter 7. Multiple alignments of the target genes (Lc 
COX-1a, Lc COX-1b, Lc COX-2 and Lc ALOX-5) were made using the CLC 
Genomics Workbench software (CLC Bio, Aarhus, Denmark). The ORF and amino 
sequence alignment and analysis were conducted using the Create Alignment tool, 
and confirmed as the target gene sequence using the BLASTX algorithm 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi). Sequence analysis of the previously 
unreported Lates calcarifer COX and LOX genes identified expressed sequence tags 
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(EST) of between 752 and 999 base pairs, open reading frame protein alignments 
showing similarity with other teleost fish are presented in Appendix -Supplementary 
Figures 1 a-d. 
2.9.3 Molecular analysis - RNA extraction and normalisation 
These methods apply to Chapter 5, Chapter 6 and Chapter 7. Total RNA was 
extracted from the liver samples using TRIzol reagent (Invitrogen) according to the 
manufacturer’s instructions. RNA was precipitated using equal volumes of 
precipitation solution (1.2 M sodium chloride and 0.8 M disodium citrate) and 
isopropyl alcohol (Green and Sambrook, 2012). To eliminate any residual traces of 
DNA, total RNA was DNase digested with the Turbo DNA free kit (Applied 
Biosystems). To verify that RNA was not contaminated, an aliquot of DNase 
digested RNA from each sample was pooled and later PCR amplified as a negative 
control. A NanoDrop spectrophotometer (NanoDrop Technologies) was used to asses 
RNA quantity and a Bioanalyser (Agilent Technologies) using RNA nanochips 
(Agilent #5067-1511) was used to asses RNA quality. All RNA samples were 
normalised to 200 ng/μl. 
2.9.4 Molecular analysis - Quantitative real time reverse transcription 
polymerase chain reaction (qRT-PCR) 
These methods apply to Chapter 5, Chapter 6 and Chapter 7. Reverse transcription 
was performed on 1 μg of total RNA using Superscript III (Invitrogen) with 25 μM 
oligo (dT)20 and 25 μM random hexamers (Resuehr and Spiess, 2003). Expression of 
a range of genes involved in fatty acid metabolism was analysed by real-time PCR as 
described below. Real-time PCR primers specific to each target gene were designed 
using PerlPrimer v.1.1.17 (Marshall, 2004). Real-time PCR amplification reactions 
were carried out using 2X SYBR Green PCR Master Mix (Applied Biosystems), 0.2 
μM of Real-Time PCR primers specific to each gene and the equivalent of 7.5 ng of 
reverse-transcribed RNA. Of the genes examined in Chapter 5 and Chapter 6, fatty 
acid elongation 5, fatty acid desaturation 6 and elongation factor 1α (GQ214180.1, 
GQ214179.1, GU188685) are contained within the public nucleotide database. The 
remaining genes were previously identified and reported following next generation 
sequencing of barramundi liver tissue and BLAST similarity searches (Wade et al., 
2014). The raw sequence read data are made available online through the CSIRO 
Data Access Portal (http://doi.org/10.4225/08/55E799BA0F73E). Amplification 
cycle conditions were 2 min at 50 °C, 10 min at 95 °C followed by 40 cycles of 15 s 
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at 95 °C and 40 s at 60 °C. After amplification, a melt curve analysis was routinely 
performed to verify the specificity of the target gene. Reactions were setup using the 
epMotion 5070 robot (Eppendorf) and run in triplicate on a Viia7 real-time PCR 
system (Applied Biosystems). Changes in expression levels of each gene were 
determined by normalising the cycle threshold values for each gene to elongation 
factor 1 alpha (EF1α) and Luciferase reference genes. The EF1α and Luciferase 
genes are routinely used as a reference in this species (De Santis et al., 2011; Wade 
et al., 2014). 
2.10 Calculations 
The following equations have been used for the calculation of results during 
experimentation.  
1) Differences in the ratio of dry matter, protein, lipid and energy to yttrium in the 
diet and faeces were calculated to determine the apparent digestibility coefficients 
(ADC) using the formula: 
ܣܦܥ ൌ ൭ͳ െ ቆ ௗܻ௜௘௧ ൈ ܲܽݎܽ݉݁ݐ݁ݎ௙௔௘௖௘௦
௙ܻ௔௘௖௘௦ ൈ ܲܽݎܽ݉݁ݐ݁ݎௗ௜௘௧ቇ൱ൈ ͳͲͲ 
Where Y diet and Y faeces represent the yttrium content in both the diet and faeces, 
respectively and Parameter diet and Parameter faeces represent the nutritional parameter 
(dry matter, protein, lipid and energy) in the diet and faeces, respectively (Maynard 
and Loosli, 1979). 
2) Nutrient deposition efficiencies were calculated as the ratio of the nutrient or 
specific fatty acid gained relative to their respective consumption during the study 
period using the formula:  
ܴ݁ݐ݁݊ݐ݅݋݊ሺΨሻ ൌ ൬݂ܰ െ ܰ݅ܰܿ ൰ ൈ ͳͲͲ 
Where Nf and Ni are the final and initial nutrient composition (g/fish) of the fish on a 
wet basis, respectively, and Nc is the amount of the nutrient consumed (g/fish) during 
the study period (Maynard and Loosli, 1979).  
3) Maintenance demands and utilisation efficiencies were then determined from the 
regression of marginal fatty acid intake against marginal fatty acid gain on a 
transformed live-weight basis following (Glencross, 2008) using the formula:  
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ܯܽݎ݈݃݅݊ܽܫ݊ݐܽ݇݁݋ݎܩܽ݅݊ ൌ ܫ݊ݐܽ݇݁݋ݎܩܽ݅݊ி஺Ȁܩܯܹ௫Ȁ݀ 
Where Intake FA or Gain FA is the specific fatty acid consumed or gained (g/fish) on a 
weight specific (geometric mean live-weight g/fish) basis then transformed to a fatty 
acid specific exponent. The duration of the study period in days is defined as d. 
4) The assessment of somatic losses was based on the formula previously reported by 
Glencross and Bermudes (2011): 
ܮ݋ݏݏሺ݇ܬȀ݀ܽݕሻ ൌ ܹ݅ כ ܧ݅ െܹ݂ כ ܧ݂ݐ  
Where the Wi and Wf are the initial and final weights of the fish respectively. Ei and 
Ef are the initial and final energy content of the whole fish on a live-weight basis 
respectively. The time of the assessment is denoted as t. The determination of lipid 
and fatty acid loss was calculated in the same way by substituting the appropriate Ei 
and Ef values with the corresponding values for either lipid or fatty acids.  
5) The computation of apparent in vivo fatty acid elongation, desaturation and β-
oxidation was performed using the whole-body fatty acid balance method 
(WBFABM) following Turchini et al. (2007). Briefly, this involved determination of 
the appearance/disappearance of specific fatty acids by mass balance. The resulting 
values of net appearance/disappearance were then transformed to a molecular weight 
basis per gram of body weight per day (nmol/g fish/d). Subsequent back calculations 
along the known fatty acid bioconversion pathways were used to determine the fate 
of specific fatty acids 
2.11 Statistical interpretation 
All data are expressed as mean ± standard error of the mean (SEM) or mean with 
pooled standard error mean unless otherwise specified. All data were checked for 
normal distribution and homogeneity of variance by qualitative assessment of 
residual and normal Q-Q plots. Growth performance data were analysed using a 
range of statistical tests including polynomial contrasts, repeated-measures analysis, 
linear regression, two-way factorial ANOVA, one-way ANOVA, or paired t-test, 
Holm adjusted. Levels of significance were compared using Tukey’s HSD a 
posteriori test.  
Energy, lipid and fatty acid losses were examined relative to the geometric 
mean weight in grams of the initial and final fish from each treatment size class. All 
relationships were examined using a power function (y=aXb) or a logarithmic 
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function (y=b ln(x)+a). Microsoft Excel (Microsoft Office 2007) was used to 
generate the equations and figures. A bootstrapping approach was used to generate 
replications of coefficient and exponent values of energy, lipid and fatty acid loss in 
order to analyse the data statistically.  
The RStudio package v.0.98.501was used for all statistical analyses (R Core Team, 
2012). Any percentage data were arcsine transformed prior to analysis. Significance 
among the treatments defined as P < 0.05. 
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Experimental Chapters 
3.0 Marginal efficiencies of long chain-polyunsaturated fatty acid 
use by barramundi (Lates calcarifer) when fed diets with varying 
blends of fish oil and poultry fat 
 
 
 
 
 
 
Adapted from 
Salini, M.J., Irvin, S.J., Bourne, N., Blyth, D., Cheers, S., Habilay, N., Glencross, 
B.D., 2015. Marginal efficiencies of long chain-polyunsaturated fatty acid use by 
barramundi (Lates calcarifer) when fed diets with varying blends of fish oil and 
poultry fat. Aquaculture. 449, 48-57  
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3.1 Aims 
It was hypothesised that barramundi would reach a critical limit of FO substitution 
when absolute levels of dietary LC-PUFA dropped below estimated requirement of 
around 1.2% (Williams et al., 2006). Therefore a series of diets were developed to 
examine the effects of diluting fish oil with poultry fat on the growth and feed 
utilisation performance of juvenile barramundi and to determine the consequences of 
this on the fillet fatty acid profiles. This study also aimed to develop a strategy for 
fish oil replacement with defined impacts on meat n-3 LC-PUFA levels. 
3.2 Materials and Methods 
The methodology used in the present experiment are detailed in the section 2.0 
General methodology. Ethical clearance was approved for the experimental 
procedures by the CSIRO Animal Ethics Committee (Application A09/2011). The 
chemical composition of the main dietary ingredients is presented in Table 3.1. The 
formulation and chemical composition of the five diets are presented in Table 3.2. 
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Table 3. 1 Chemical composition of key ingredients. All data are g/kg DM unless 
otherwise stated. Fatty acid data are expressed as a percentage of total fatty 
acids (%). 
  FM WF LM WG PM FO PF 
Dry matter 933 868 903 921 953 998 997 
Crude protein 706 112 432 816 671 9 7 
Lipid 101 18 76 97 164 949 996 
Ash 139 6 28 4 137 1 0 
Gross energy (MJ/kg) 20.0 16.5 18.9 21.3 21.0 39.2 38.7 
14:0 5.2 0.2 0.2 0.1 1.5 8.3 1.1 
16:0 24.1 20.3 12.1 20.2 27.3 19.0 23.0 
18:0 7.2 1.5 5.5 1.2 8.6 3.7 6.1 
16:1n-7  5.3 0.4 0.1 0.1 6.4 10.3 5.6 
18:1n-9  13.2 14.4 0.0 12.4 41.3 10.1 42.8 
18:2n-6  1.5 56.5 41.3 59.4 8.9 1.6 16.2 
18:3n-3  0.8 3.5 4.9 2.8 0.7 0.7 2.0 
20:4n-6  0.1 0.0 0.0 0.0 0.0 1.1 0.0 
20:5n-3  9.0 0.4 1.5 0.6 0.0 17.3 0.6 
22:5n-3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
22:6n-3  17.3 0.0 0.0 0.0 0.0 13.6 0.0 
SFA 39.1 22.4 18.5 22.1 37.8 33.3 30.1 
MUFA 24.2 16.6 33.5 14.7 51.3 24.9 51.0 
PUFA 3.5 60.0 46.3 62.2 9.5 5.2 18.2 
LC-PUFA 30.3 0.4 1.5 0.6 0.2 32.0 0.6 
n-3 28.7 4.0 6.4 3.4 0.7 35.3 2.6 
n-6 5.2 56.5 41.3 59.4 9.1 2.7 16.2 
FM fish meal, WF wheat flour, LM lupin meal, WG wheat gluten, PM poultry meal, FO fish 
oil, PF poultry fat 
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Table 3. 2 Experimental diet formulation and composition. All data are g/kg 
DM unless otherwise stated. Fatty acid data are expressed as a percentage of 
total fatty acids (%). 
  
F100: 
P0 
F60: 
P40 
F30: 
P70 
F15: 
P85 
F0: 
P100 
Formulation      
Fish meal a  150 150 150 150 150 
Fish oil b 85 51 25 12 0 
Wheat flour c 119 119 119 119 119 
Wheat gluten d 85 85 85 85 85 
Lupin meal e 100 100 100 100 100 
Poultry meal f 455 455 455 455 455 
Poultry fat g 0 34 59 72 85 
Premix h 5 5 5 5 5 
Yttrium oxide i 1 1 1 1 1 
Composition      
Dry matter 908.2 921.7 977.6 977.6 981.3 
Crude protein 518.8 536.9 543.8 531.3 539.5 
Crude lipid 149.7 151.2 157.0 159.4 161.9 
Ash 92.9 90.3 91.3 94.9 93.8 
Gross energy (MJ/kg) 21.9 22.4 22.6 22.7 22.6 
14:0 4.7 3.4 2.4 1.9 1.4 
16:0 21.1 22.0 22.7 22.8 22.9 
18:0 5.6 6.1 6.5 6.6 6.7 
16:1n-7  7.7 6.8 6.0 5.7 5.4 
18:1n-9  24.0 30.0 34.8 36.7 38.9 
18:2n-6  8.9 11.6 13.9 14.8 15.6 
18:3n-3  1.1 1.4 1.5 1.6 1.7 
20:4n-6  0.9 0.8 0.7 0.6 0.5 
20:5n-3  8.8 5.9 3.3 2.3 1.2 
22:5n-3 1.2 0.9 0.0 0.0 0.0 
22:6n-3  7.6 5.4 3.5 2.7 1.8 
SFA 33.7 27.1 25.6 25.4 24.9 
MUFA 36.9 46.8 50.8 52.3 54.3 
PUFA 11.7 14.0 16.0 16.8 17.4 
LC-PUFA 17.3 12.1 7.5 5.5 3.5 
n-3 19.4 13.7 9.0 7.0 4.7 
n-6 10.0 12.4 14.5 15.3 16.2 
a Fish meal; Ridley aquafeeds, Narangba, QLD, Australia 
b Fish (anchovy) oil; Ridley aquafeeds, Narangba, QLD, Australia 
c Plain wheat flour; Manildra Group, Rocklea, QLD, Australia 
d Wheat gluten; Manildra Group, Rocklea, QLD, Australia 
e Lupinus angustifolius cv. Coromup; Coorow Seeds, WA, Australia. 
f Poultry meal; Ridley aquafeeds, Narangba, QLD, Australia 
g Poultry fat; Ridley aquafeeds, Narangba, QLD, Australia 
h Vitamin and mineral premix includes (IU kg-1 or g/kg of premix): vitamin A, 2.5MIU; 
vitamin D3, 0.25 MIU; vitamin E, 16.7 g; vitamin K3, 1.7 g; vitamin B1, 2.5 g; vitamin B2, 
4.2 g; vitamin B3, 25 g; vitamin B5, 8.3; vitamin B6, 2.0 g; vitamin B9, 0.8; vitamin B12, 
0.005 g; biotin, 0.17 g; vitamin C, 75 g; choline, 166.7 g; inositol, 58.3 g; ethoxyquin, 20.8 
g; copper, 2.5 g; ferrous iron, 10.0 g; magnesium, 16.6 g; manganese, 15.0 g; zinc, 25.0 g 
i Yttrium oxide; Stanford Materials, Aliso Viejo, California, United States 
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3.3 Results 
3.3.1. Growth performance and feed utilisation 
During the 82 d growth period, the fish responded to the experimental diets, growing 
consistent with the predicted model growth (Glencross and Bermudes, 2012). 
Survival was 100% in all treatments. No significant differences were observed 
among the treatment diets in terms of growth performance (Table 3.3). During the 
growing period, there was greater than 2.5-fold increase in weight among the groups 
of fish with final fish weights ranging between 545 to 553 g. Similarly, there were no 
significant differences in feeding parameters with FCR values ranging from 1.12 to 
1.15 (Table 3.3). The diet dry matter, protein, lipid and energy digestibility were also 
unaffected by the modified lipid profile of the treatment diets (Table 3.3). The 
digestibility of individual fatty acids was not significantly affected by treatment 
(Table 3.3). 
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Table 3. 3 Growth, feed utilisation and nutrient deposition parameters. 
  
F100: 
P0 
F60: 
P40 
F30: 
P70 
F15: 
P85 
F0: 
P100 
P 
SEM 
Regression 
R2, P# 
Fish performance        
Initial (g/fish) 208.8 211.2 208.6 207.1 207.5 1.13 0.04, 0.48 
Week-12 (g/fish) 545.0 546.4 553.6 546.6 549.7 4.20 0.01, 0.70 
Gain (g/fish) 336.2 335.1 345.0 339.5 342.2 4.08 0.03, 0.57 
Growth rate (g/d) 4.1 4.0 4.2 4.1 4.1 0.05 0.03, 0.55 
Feed Intake (g/fish) 384.4 386.0 394.6 380.6 382.6 4.54 0.00, 0.93 
FCR (feed/gain) 1.14 1.15 1.14 1.12 1.12 0.01 0.11, 0.22 
Survival (%) 100.0 100.0 100.0 100.0 100.0 0.00 0.50, 0.10 
Diet digestibility (%)       
Dry matter 57.5 55.3 53.9 56.7 59.1 4.00 0.00, 0.94 
Protein   76.2 74.2 74.5 76.2 77.6 2.20 0.00, 0.84 
Lipid    93.7 91.7 93.5 92.9 92.4 0.65 0.02, 0.67 
Energy 71.7 69.4 68.4 70.6 70.4 2.41 0.00, 0.85 
16:0 88.6 86.8 91.1 91.6 89.7 1.17 0.06, 0.45 
18:0 81.7 80.4 86.6 88.1 84.5 1.74 0.11, 0.30 
18:1n-9  95.0 94.4 96.3 96.4 96.7 0.48 0.22, 0.12 
18:2n-6  93.6 93.4 95.5 95.9 97.2 0.78 0.29, 0.07 
18:3n-3  96.5 95.3 96.4 97.4 97.8 0.66 0.07, 0.42 
20:4n-6  95.0 100.0 97.4 100.0 93.2 1.32 0.00, 0.91 
20:5n-3  99.2 98.5 99.4 95.3 97.0 0.82 0.13, 0.25 
22:5n-3 100.0 100.0 100.0 100.0 100.0 0.00 0.45, 0.14 
22:6n-3  98.0 96.1 96.0 94.9 94.8 0.99 0.14, 0.23 
SFA 90.9 89.7 93.0 92.0 90.9 0.86 0.01, 0.72 
MUFA 91.5 90.7 93.9 93.1 93.2 0.69 0.14, 0.23 
PUFA 94.8 94.1 95.7 96.2 97.2 0.67 0.18, 0.17 
LC-PUFA 98.6 97.7 97.6 95.6 95.3 0.89 0.18, 0.17 
n-3 98.6 97.3 97.6 95.9 96.4 0.74 0.13, 0.25 
n-6 93.9 93.9 95.5 96.1 97.0 0.75 0.25, 0.10 
Nutrient deposition (%)       
Protein   33.5 31.0 33.7 34.2 35.2 0.01 0.04, 0.47 
Lipid    64.2 82.1 73.9 87.2 81.5 0.03 0.31, * 
Energy 36.7 42.1 40.6 42.3 40.1 0.01 0.12, 0.22 
P SEM, Pooled standard error of the mean; # Linear regression of all replicates with 1,13 df 
P < 0.05 * 
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When compared to the initial samples the dry matter, lipid and gross energy 
content of the carcass of all treatments were numerically higher upon termination of 
the experiment (Table 3.4). However, there were no significant differences in the 
final whole body composition of the fish fed the treatment diets. In terms of the fatty 
acid composition, some significant effects among the dietary treatments were 
observed (Table 3.4). The fatty acid composition of the whole body was in most 
cases a reflection of the dietary treatments and changed accordingly. DPA was the 
only exception to this as it was not detected in the diets containing less than 30% FO, 
while whole body DPA levels were maintained at levels similar to that of the initial 
fish (R2 = 0.76, P < 0.001). There was a significant difference in whole body ARA 
(R2 = 0.47, P < 0.05) and this fatty acid appears to be well conserved compared to the 
initial fish. Both EPA and DHA whole body proportions were significantly reduced 
by the dietary treatments (R2 = 0.90, P < 0.001 and R2 = 0.76, P < 0.001, 
respectively).There was no significant difference in SFA composition despite the 
altered dietary profiles.  
There were no significant differences in protein or energy retention efficiency 
in the whole body among the treatment groups (Table 3.3). However, there was a 
slight increase in lipid retention efficiency values with increasing PF. Whole body 
retention efficiency of linoleic acid was not significantly affected by increasing 
intake and the values ranged between 55% to 86% (y = 0.03x – 0.49, R2 = 0.13, P = 
0.55, Figure 3.1a). Similarly, the retention efficiency of 18:3n-3 was not significantly 
affected by increasing intake with the retention efficiency values ranging between 
45% and 69% (y = 0.65x – 0.10, R2 = 0.65, P = 0.13, Figure 3.1b). There was 
disproportionate retention of LC-PUFA’s including arachidonic acid (ARA), EPA 
and DHA which are presented in Figures 3.1c-e. The ARA retention efficiency in the 
whole body decreased sharply from 74% to 47% with increasing intake while the 
dietary intake values of ARA were very low (y = -1.08x + 1.03, R2 = 0.81, P < 0.05). 
Similarly, the retention efficiency of EPA decreased from 49% at the lowest dietary 
inclusion to 32% at the highest inclusion (y = -0.04x + 0.52, R2 = 0.90, P < 0.05). 
The whole body retention efficiency of DHA was 73% at the lowest dietary inclusion 
levels then showed a curvilinear decline to around 37% (y = 0.72x-0.44, R2 =0.97, P < 
0.05).  
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Table 3. 4 Whole body chemical composition of the experimental fish on a live-
weight basis. All data are g/kg unless otherwise stated. Fatty acid data are 
expressed as a percentage of total fatty acids (%). 
  Initial 
F100: 
P0 
F60: 
P40 
F30: 
P70 
F15: 
P85 
F0: 
P100 
P 
SEM 
Regression 
R2, P# 
Dry matter 28.9 33.2 35.7 35.5 35.4 35.2 0.01 0.24, 0.06 
Crude protein 20.9 20.3 22.1 21.0 20.6 21.1 0.01 0.58, 0.10 
Crude lipid 5.3 9.1 10.6 10.1 11.5 11 0.01 0.58, 0.10 
Gross energy 
(MJ/kg) 6.3 8.1 8.9 8.9 9.1 8.7 0.18 0.15, 0.16 
14:0 2.7 4.3 3.6 2.4 2.0 1.6 0.29 0.94, *** 
16:0 22.9 23.8 26.1 23.6 23.2 23.6 0.32 0.02, 0.65 
18:0 7.3 7.0 7.9 7.3 7.3 7.4 0.10 0.08, 0.36 
16:1n-7  5.7 7.5 6.0 4.2 5.7 3.0 0.76 0.01, 0.71 
18:1n-9  37.6 32.6 39.6 39.3 40.2 42.5 1.05 0.77, *** 
18:2n-6  10.9 8.2 10.1 11.7 12.1 13.2 0.52 0.96, *** 
18:3n-3  1.1 0.8 0.9 1.2 1.2 1.4 0.06 0.71, *** 
20:4n-6  0.6 0.7 0.5 0.6 0.5 0.5 0.03 0.47, * 
20:5n-3  1.7 3.9 2.3 1.9 1.3 0.8 0.36 0.90, *** 
22:5n-3 1.0 1.3 0.9 0.9 0.7 0.6 0.09 0.76, *** 
22:6n-3  3.8 4.2 2.7 2.7 2.2 1.9 0.33 0.76, *** 
SFA 34.1 36.6 38.9 34.3 33.3 33.3 0.59 0.30, 0.06 
MUFA 44.8 41.8 41.9 44.9 47.2 46.6 0.74 0.76, *** 
PUFA 13.0 10.2 11.7 13.7 13.9 15.2 0.53 0.91, *** 
LC-PUFA 7.8 10.7 7.0 6.8 5.4 4.6 0.80 0.80, *** 
n-3 8.2 11.3 7.7 7.5 6.0 5.2 0.81 0.82, *** 
n-6 12.5 9.6 11.0 13.1 13.2 14.7 0.53 0.91, *** 
P SEM, Pooled standard error of the mean; # Linear regression of all replicates with 1,13 df 
P < 0.05 *; P < 0.01 **; P < 0.001 *** 
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(a) 
(c) 
(e) 
(d) 
(b) 
Figure 3. 1 Whole-body retention of 
polyunsaturated fatty acids a) 18:2n-6 (y 
= 0.03x + 0.49, R2 = 0.13, P = 0.55) and b) 
18:3n-3 (y = 0.65x + 0.10, R2 = 0.60, P = 
0.13) and whole-body retention of long-
chain polyunsaturated fatty acids c) ARA 
(y = -1.08x + 1.03, R2 = 0.81, P < 0.05) , d) 
EPA (-0.04x + 0.52, R2 = 0.90, P < 0.05) 
and e) DHA (y = 0.72x-0.44, R2 = 0.97, P < 
0.05). 
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3.3.2. Nutrient marginal efficiencies 
The marginal efficiencies of nutrient utilisation were calculated using a bioenergetic 
approach to determine the discrete effects on nutrient utilisation and maintenance 
requirements for juvenile barramundi (Figures 3.2 a-e). The marginal efficiency of 
18:2n-6 (k18:2n-6) was determined as 82% (y = 0.82x – 0.03, R2 = 0.75) and the 
maintenance requirement estimated at 0.068 g/kg0.9/d. Similarly, the marginal 
efficiency of 18:3n-3 (k18:3n-3) was determined as 104% (y = 1.04x – 0.01, R2 = 0.88) 
and the maintenance requirement was estimated at 0.012 g/kg0.9/d. The marginal 
efficiencies of the LC-PUFA’s were contrasting to those of the PUFA’s. The 
marginal efficiency of ARA (kARA) was low at 19% (y = 0.19x + 0.005, R2 = 0.43) 
and the regression suggests there was no maintenance requirement for this fatty acid. 
Similarly, the marginal efficiencies of EPA and DHA (kEPA and DHA) were also low at 
30% (y = 0.30x + 0.0, R2 = 0.95) and 27% (y = 0.27x + 0.01, R2 = 0.95), respectively 
and the regression model suggested that there was also no maintenance requirement 
for these LC-PUFA’s. A summary of the marginal efficiencies and the intake to gain 
ratio of key fatty acids are presented in Table 3.5. 
3.3.3. Fillet quality assessment 
The consequence of changing dietary lipids in juvenile barramundi was evaluated in 
terms of fillet quality using a standard sample of flesh (NQC). There were no 
significant differences in macro nutrient composition of the NQC samples (Table 
3.6). Overall, the dietary fatty acid profiles were closely reflected in the flesh with 
the exception of DPA which was barely present in the diets F100:P0 and F60:P40 
and not detected in the other diets. Consequently, some significant differences in 
NQC fatty acid composition were observed (Table 3.6). Myristic acid (14:0) was the 
only saturate affected showing a reduced concentration with increasing FO 
substitution (R2 = 0.80, P < 0.001). Oleic acid (OLA; 18:1n-9) was significantly 
increased with FO substitution (R2 = 0.50, P < 0.01). Both 18:2n-6 and 18:3n-3 
composition increased with increasing FO substitution (R2 = 0.65, P < 0.001 and R2 
= 0.58, P < 0.01, respectively). ARA composition in the fillet did not change; 
however, n-3 LC-PUFA (EPA and DHA combined) deposition in the flesh showed 
an increasing curvilinear response relative with increasing intake (Figure 3.3). 
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Table 3. 5 Summary of marginal efficiencies of specific fatty acids by juvenile 
barramundi when fed diets with varying blends of fish oil and poultry fat. 
Fatty acid Efficiency constant k R2 Intake:gain ratio 
18:2n-6; Linoleic acid 0.82 0.75 1.2:1 
18:3n-3; Linolenic acid 1.04 0.88 1.0:1 
20:4n-6; Arachidonic acid 0.19 0.43 5.3:1 
20:5n-3; Eicosapentaenoic acid 0.30 0.95 3.3:1 
22:6n-3; Docosahexaenoic acid 0.27 0.95 3.7:1 
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Table 3. 6 Fillet (NQC) composition on a live-weight basis. All data are g/kg 
unless otherwise stated. Fatty acid profiles of NQC samples from each 
treatment are expressed as mg/100g meat. 
  
F100: 
P0 
F60: 
P40 
F30: 
P70 
F15: 
P85 
F0: 
P100 
P 
SEM 
Regression 
R2, P# 
Dry matter 33.2 35.7 35.5 35.4 35.2 0.01 0.20, 0.10 
Crude protein 26.5 28.5 28.3 28.3 27.4 0.01 0.08, 0.30 
Crude lipid 4.9 5.2 5.6 6.3 5.4 0.01 0.15, 0.16 
Gross energy (MJ/kg) 8.2 8.8 8.9 9.1 8.8 0.13 0.24, 0.06 
14:0 4.0 2.9 2.1 1.8 1.5 0.24 0.80, *** 
16:0 22.9 23.0 22.4 22.8 23.1 0.13 0.11, 0.22 
18:0 7.1 7.4 7.2 7.3 7.4 0.09 0.14, 0.17 
16:1n-7  7.1 6.2 5.6 5.4 5.1 0.18 0.15, 0.15 
18:1n-9  30.9 34.4 37.8 39.3 40.8 0.96 0.50, ** 
18:2n-6  8.4 10.3 11.9 12.6 13.2 0.46 0.65, *** 
18:3n-3  0.9 1.1 1.2 1.3 1.2 0.04 0.58, ** 
20:4n-6  1.0 0.9 0.8 0.7 0.7 0.03 0.15, 0.15 
20:5n-3  5.2 3.7 2.4 1.7 1.0 0.41 0.84, *** 
22:5n-3 1.7 1.4 1.1 0.9 0.7 0.10 0.62, *** 
22:6n-3  6.2 5.2 4.0 3.4 2.8 0.36 0.61, *** 
SFA 35.0 34.1 32.4 32.5 32.7 0.35 0.02, 0.57 
MUFA 39.5 41.9 44.8 45.9 47.1 0.75 0.38, * 
PUFA 10.6 12.5 14.1 14.7 15.1 0.45 0.56, ** 
LC-PUFA 14.2 11.2 8.5 6.7 5.2 0.90 0.71, *** 
n-3 15.1 12.2 9.4 7.6 5.8 0.93 0.67, *** 
n-6 9.6 11.5 13.3 13.9 14.5 0.48 0.64, *** 
P SEM, Pooled standard error of the mean; # Linear regression of all replicates with 1,13 df 
P < 0.05 *; P < 0.01 **; P < 0.001 *** 
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Figure 3. 2 The linear relationship 
between the mass-independent intake 
relative to mass-independent gain 
(marginal efficiency) of specific fatty 
acids by juvenile barramundi. For 
comparative purposes the dotted line 
indicates the slope of 1.0 (y = x). a) 
18:2n-6 (y = 0.82x - 0.03, R2 = 0.75) b) 
18:3n-3 (y = 1.04x - 0.01, R2 = 0.88) c) 
ARA (y = 0.19x + 0.005, R2 = 0.43) d) 
EPA (y = 0.30x + 0.007, R2 = 0.95) e) 
DHA (y = 0.27x + 0.01, R2 = 0.95). 
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Figure 3. 3 Fillet (NQC) LC-PUFA deposition in juvenile barramundi expressed 
relative to intake (y = -1.54x2 + 56.33x + 75.23, R2 = 0.99) as mg/100 g meat. By 
extrapolation the dotted line indicates that a formulation of ~11% total LC-
PUFA (EPA and DHA combined) would achieve a fillet composition of 500 
mg/100 g. 
 
3.4 Discussion 
The benefits of regular consumption of seafood rich in n-3 LC-PUFA are well 
known. These fatty acids are implicated in a range of physiological and metabolic 
processes and many studies have demonstrated their positive benefit in the 
prevention and management of cardio-vascular disease and inflammation (Calder, 
2012). The FAO’s guideline to consume a dose of 250 mg/d EPA and DHA is an 
achievable yet rarely met target due to the production and subsequent consumption 
of the predominant vegetable oils including soybean, palm and canola (FAO, 2010). 
This study investigated the potential effects of fish oil substitution with poultry fat in 
diets fed to juvenile barramundi and provides empirical support for the development 
of a strategy to manage the LC-PUFA content in the fillet. However, in addition to 
this objective the study also provides some unique insights into fatty acid metabolism 
in this species based on understanding the marginal utilisation of these nutrients and 
comparing that with what we know about similar parameters for utilisation of other 
nutrients. 
This study demonstrated that the growth and feed utilisation of barramundi 
was not significantly affected by the complete replacement of fish oil with poultry 
fat. Until recently, variable responses to fish oil replacement and fatty acid 
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requirement studies have led to further questions being raised about lipid metabolism 
in this species (Catacutan and Coloso, 1995; Glencross and Rutherford, 2011; 
Morton et al., 2014; Raso and Anderson, 2003; Williams et al., 2006). The fish in 
this study achieved a minimum 2.5-fold increase in weight over the twelve week 
study period. Experimental duration is of particular interest in the realm of fatty acid 
nutrition as the increasing use of alternative oils has a definitive influence on flesh 
quality (Robin et al., 2003). The NRC (2011) suggest that 300% or a 3-fold increase 
in weight should be respected and a range of other studies suggest different methods 
of assessment (Glencross et al., 2003b; Jobling, 2004; Morton et al., 2014; Robin et 
al., 2003). Clearly the fish in this study achieved sufficient biological turnover as 
evidenced by the whole fish and flesh fatty acid profiles mirroring the diets similar to 
that of other studies (Glencross et al., 2014b; Tu et al., 2013; Turchini et al., 2011b). 
Moreover, past studies have demonstrated that fatty acid profiles of fish can be 
manipulated in as little as two weeks (Castell et al., 1994; Skonberg et al., 1994). 
Poultry fat (PF) is a commonly utilised alternative lipid source for aquafeeds 
in Australia, having been widely used for over a decade, despite containing little or 
no n-3 LC-PUFA. In this study, FO substitution with PF covered a range of LC-
PUFA inclusion from 22.0 to 4.8 g/kg, theoretically surpassing the reported 
minimum requirement of 12 g/kg LC-PUFA (Williams et al., 2006). It is noteworthy 
that this species is a catadromous, obligate carnivore and the reduced levels of LC-
PUFA fed in this study should probably have induced a range or EFA deficiency 
symptoms similar to those previously reported (Catacutan and Coloso, 1995; 
Glencross and Rutherford, 2011). Indeed, when other marine carnivorous fish were 
fed diets with high levels of FO substitution, this led to growth retardation 
(Glencross et al., 2003b; Izquierdo et al., 2005; Montero et al., 2005). We suggest 
that the absence of problems seen in the present study may be reflective of the use of 
larger fish which had previously been raised on high LC-PUFA diets and therefore 
their underpinning n-3 LC-PUFA requirements in the demanding early juvenile 
growth phase had already been met and that there was limited subsequent turnover. 
Alternatively, it may also be that the actual requirement for EFA by this species is 
much lower than previously thought. In this study, the digestibility of lipid and 
individual fatty acids were not significantly affected. Further suggesting that despite 
the contrasting differences in fatty acid profiles of PF and FO, the diets were digested 
by barramundi equally efficiently.  
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The LC-PUFA content of the F0:P100 diet was only 3.5% of the total lipid 
(equivalent to 4.8 g/kg diet) with this residual LC-PUFA coming from the fish meal 
appearing sufficient to maintain biological functions in the fish. The inclusion of 
15% fish meal in the present study is based on the findings of Glencross et al. 
(2011b) as the use of a fully purified diet containing no fish meal was shown to be a 
risky approach and lacks practical application (Tu et al., 2013). In light of this, the 
results of this study demonstrate that in terms of growth performance, 100% of the 
FO can be effectively replaced by poultry fat in growing barramundi, however, 
discrete effects on deposition and marginal efficiencies of specific fatty acids were 
apparent. 
Bioenergetic models have come a long way to understanding how different 
nutrients are deposited in the body of an animal and that macro nutrients such as 
protein and lipid have different energetic efficiencies (Bureau et al., 2006). The 
individual fatty acids have vastly different metabolic fates and hence are likely to 
have different energetic efficiencies. For example, the n-3 and n-6 series 
eicosapolyenoic fatty acids are implicated in a competing nature for the synthesis of 
the autocrine hormones (Tocher, 2003). Arguably they may also have different 
allometric relationships, as do protein and lipid, and this remains to be explored 
(Glencross and Bermudes, 2011). In the present study we have relied on the 
determined exponent of total lipid utilisation of LW0.90 to define the energetic 
relationships of the different fatty acids, though we acknowledge that this is still an 
assumption.  
The present study demonstrated that the marginal efficiencies of LC-PUFA 
(kDHA, kEPA and kARA) were 0.27, 0.30 and 0.19, respectively and the PUFA (k18:3n-3 
and k18:2n-6) were significantly higher at 1.04 and 0.82, respectively. At first glance, 
the examination of the retention and marginal efficiencies of LC-PUFA in this study 
gives further evidence to the hypothesis that barramundi are unable to elongate and 
desaturate precursor FA to form essential LC-PUFA (Mohd-Yusof et al., 2010). This 
is evidenced by the direct accumulation of those fatty acids (18:2n-6 and 18:3n-3) in 
a manner directly reflective of their intake levels, indicating no loss of these nutrients 
from what was consumed. 
Clearly in the case of DHA, EPA and ARA, retention efficiency in the whole 
body decreased as dietary intake of those nutrients increased (Figure 1c-e). In 
agreement, the marginal efficiencies of these nutrients were low compared to other 
the shorter-chain and more saturated FA. These responses are likely due to the 
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physiological requirements of these nutrients in growing barramundi and suggest that 
they were catabolised into other forms or used for energy. The strong conservation of 
DHA in the whole body at low dietary intakes may be indicative of a priority for 
retaining this nutrient (essentiality) as the organism attempts to retain what it has to 
sustain necessary functions, but from our data it is implied that these necessary 
functions require a transformation of the nutrient into another metabolite or energy 
(Tocher, 2003). However, by extrapolating the marginal efficiency of the DHA 
regression it appears as if there is no maintenance requirement for LC-PUFA in the 
barramundi. This is contrasting to that identified for many other nutrients (and 
energy), each of which have clear maintenance requirement levels.  
This observation may be partly explained by the extrapolation method in 
itself which has been found to slightly underestimate maintenance requirements 
compared to a factorial approach (Bureau et al., 2006). However, it is also likely that 
the dietary formulations in this study all supplied LC-PUFA in excess or at least 
beyond the point of sensitivity for this species. Given that the barramundi is clearly 
very effective at selective LC-PUFA retention it probably has a very low requirement 
for these specific fatty acids. As discussed earlier, we are also assuming that the 
relationships of the different fatty acids to animal live-weight is consistent with that 
of total lipid (LW0.90), though this needs to be further validated and this, and other 
further evidence may still be required to draw conclusions on the use of this method 
to estimate baseline metabolic requirements of individual LC-PUFA. 
Recent fatty acid studies have demonstrated similar metabolic responses for a 
range of species. In Atlantic salmon (Glencross et al., 2014b; Torstensen et al., 
2004), barramundi (Glencross and Rutherford, 2011) and gilthead seabream 
(Montero et al., 2001) there was a curvilinear decline in the retention efficiency of 
DHA in response to increasing DHA level in the diet. In contrast, DHA and EPA 
retention efficiency in the Atlantic cod (Gadus morhua) increased in response to 
increasing dietary supply (Hansen et al., 2008) . In the latter example, the authors 
argued that DHA was probably used as a substrate for energy production at lower 
dietary intake. Many studies have demonstrated that despite up regulation of genes 
involved in FA synthesis pathways, most fish species are unable to completely 
compensate for a lack of dietary LC-PUFA (Alhazzaa et al., 2011b; Betancor et al., 
2014; Francis et al., 2007; Geay et al., 2010; Tu et al., 2013). Interestingly in this 
study, the reduced retention of EPA may be attributable in part, to the apparent 
concomitant appearance of DPA via elongation of C20 to C22. This is a likely 
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scenario as the barramundi attempts to synthesise DHA from dietary precursor fatty 
acids in response to the treatment diets. However, to achieve this goal it requires a 
Δ5 desaturation enzyme that probably does not exist in the species hence the building 
up of DPA (Mohd-Yusof et al., 2010). Another possible explanation for the 
accumulation of DPA may be that the animal is β-oxidising available DHA to EPA 
for eicosanoid production and DPA is an intermediate in this process.  
Moreover, the high retention and low marginal efficiency of ARA and EPA 
could be related to the requirement for eicosanoid production under inadequate or 
stressful dietary conditions. The eicosanoids particularly the n-6 series are implicated 
in a range of physiological roles such as ion transfer and osmoregulation (Castell et 
al., 1994) and the n-3 series eicosanoids have an anti-inflammatory role (Wall et al., 
2010). In addition, the majority of eicosanoid products are derived from ARA in fish 
adding to the idea that ARA may be implicated in a range of biological processes in 
barramundi (Henderson, 1996; Tocher, 2003). Few studies have investigated ARA 
metabolism in barramundi, however, current evidence suggests that ARA may be 
implicated in reduced growth and increased sub-clinical signs of essential fatty acid 
deficiency (Glencross and Rutherford, 2011). In agreement, the results of the present 
study emphasized the relative importance of ARA and future work in this area is 
warranted. 
Much awareness is now placed on the consumption of seafood, rich in LC-
PUFA, in an attempt to ameliorate a range of largely preventable diseases (Calder, 
2012; Wall et al., 2010). Many nutritional feeding studies have focused on the 
replacement of FO with alternative oils and also how this translates to the flesh 
(Sales and Glencross, 2011; Turchini et al., 2009). Past studies have demonstrated 
that fish fillet adiposity can be altered by the use of common vegetable oils (Bell et 
al., 2002); however, the same response in this study was not found with poultry fat. 
Fillet lipid levels remained constant among the treatment groups and the fillet fatty 
acid profiles were largely reflective of the diets. The fatty acids deposited in the flesh 
of barramundi were clearly proportional to their respective diet with few exceptions 
which is typical of most fish (Turchini et al., 2009).  
Given the limited ability of barramundi to desaturate and elongate precursor 
FA to EPA and then DHA it was not surprising that these FA were strongly related to 
the dietary composition. However, the relationship was best described as curvilinear 
and the fillet concentration of LC-PUFA plateaued as the dietary concentration 
exceeded 6% (Figure 3). There was a linear decrease in the fillet EPA concentration 
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with increasing replacement of the fish oil that appeared to be related to a slight 
increase in DPA relative to the diet. The accumulation of DPA in the fillet is likely to 
be a result of chain length modification in the liver followed by transport to the 
adipose tissue for storage or eventual secondary processing, however, the effect was 
minimal. Similarly, the fillet DHA concentration also decreased linearly with 
increasing fish oil replacement, however, it was selectively retained in the meat at 
levels higher than the dietary supply. Similarly, studies have shown that fillet DHA 
levels in Atlantic salmon (Bell et al., 2001; Bell et al., 2002), European seabass 
(Mourente and Bell, 2006), gilthead sea bream (Izquierdo et al., 2005) and Murray 
cod (Turchini et al., 2011b) can be elevated relative to the diet. Possible mechanisms 
underpinning this selective retention among species may be attributable to the high 
specificity of fatty acyl transferases for DHA (Bell et al., 2001) and reduced 
catabolism due to the complex peroxisomal β-oxidation required for the DHA 
molecule (Tocher, 2003). Furthermore, this study showed that OLA and palmitic 
acid (16:0) dominated within the flesh and these FA are known to be heavily 
oxidised as energy substrates, potentially promoting more efficient accumulation of 
other FA (Codabaccus et al., 2012; Turchini et al., 2011b). 
By extrapolation, the results of this study allow the estimation of fillet FA 
composition of barramundi (Figure 3). These observations are of practical use for 
predicting the outcome of feeding diets with reduced levels of FO to barramundi and 
promoting the most efficient use of the FO resource. It is estimated that feeding 
barramundi with approximately 11% LC-PUFA would result in a fillet concentration 
of 500 mg/100 g. The FAO recommend a minimum daily consumption of 250 mg of 
n-3 LC-PUFA (FAO, 2010). In recognition of the FAO guideline, a 350 g fillet 
portion would theoretically meet the weekly needs of adult consumers, aiming to 
maintain a healthy and balanced diet. 
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4.0 Effect of dietary saturated and monounsaturated fatty acids in 
juvenile barramundi Lates calcarifer 
 
 
 
 
 
 
Adapted from 
Salini, M.J., Turchini, G.M., Glencross, B.G., 2015. Effect of dietary saturated and 
monounsaturated fatty acids in juvenile barramundi Lates calcarifer. Aquac. Nutr. 
doi: 10.1111/anu.12389 
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4.1 Aims 
Consistent responses of a range of fish species indicate that SFA and MUFA 
provided in surplus are heavily oxidised as substrates for energy, effectively sparing 
LC-PUFA for biological needs and deposition. Likewise, it is unfavourable to 
provide excess n-3 LC-PUFA, typical of FO, as these FA can also be readily β-
oxidised (Torstensen et al., 2000; Turchini et al., 2013). Recent studies have shown 
that barramundi are capable of utilising poultry oil, characterised by high MUFA 
content, however, to what extent SFA are preferentially utilised or able to ‘spare’ 
LC-PUFA remains unclear (Salini et al., 2015a). The proposed experiment examined 
the effect of diets containing a 2:1 or 1:2 ratio of SFA to MUFA in the lipid as it was 
hypothesised that these fatty acid classes would be metabolised differently. The 
digestibility of the diets was also measured and mass-balance computations used to 
estimate the fatty acid metabolism in vivo.  
4.2 Materials and methods 
The methodology used in the present experiment is detailed in the section 2.0 
General methodology. Ethical clearance was approved for the experimental 
procedures by the CSIRO Animal Ethics Committee (Application A12/2013). The 
chemical composition of the main dietary ingredients is presented in Table 4.1. The 
formulation and chemical composition of the three diets are presented in Table 4.2. 
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Table 4. 2 Formulation and composition of experimental diets. All values are 
g/kg DM unless otherwise stated. 
    
CTRL-D 
(Fish oil) 
SFA-D  
(Palm oil) 
MUFA-D  
(Olive oil) 
Formulation       
  DF Fish meal a 150 150 150 
  Poultry meal a 150 150 150 
  Soy protein isolate b 150 150 150 
  Wheat gluten b 150 150 150 
  Wheat flour b 109 109 109 
  Casein c 100 100 100 
  Pregelled wheat starch b 80 80 80 
  DL-Methionine c 10 10 10 
  Di-calcium phosphate 10 10 10 
  Pre-mix vitamins and minerals d 8 8 8 
  Yttrium oxide e 1 1 1 
  Fish oil a 82 41 41 
  Olive oil f 0 0 41 
  Palm Oil f 0 15 0 
  Palm Flake f 0 26 0 
Composition as analysed       
  Dry matter (g/kg) 940 952 979 
  Protein 598 601 585 
  Ash 64 63 60 
  Lipid 126 137 135 
  CHO # 204 192 217 
  Gross energy (MJ/kg DM) 21.5 21.6 22.2 
Fatty acids (%) ^       
 Total FA (mg/g lipid) 801.7 734.7 717.4 
  16:0 22.9 32.0 18.4 
  18:0 5.5 16.1 4.8 
  18:1 22.7 20.6 42.6 
  18:2n-6 10.0 10.5 13.3 
  18:3n-3 1.3 1.0 1.3 
  20:4n-6 1.2 0.7 0.7 
  20:5n-3 8.1 4.1 4.0 
  22:5n-3 1.6 0.9 0.9 
  22:6n-3 10.6 5.4 5.4 
  SFA  34.5 51.8 26.4 
  MUFA  31.3 25.0 47.3 
  C18PUFA 12.7 12.1 15.3 
  LC-PUFA 21.5 11.0 10.9 
  n-3  22.9 12.0 12.2 
  n-6  11.3 11.1 14.0 
# CHO, carbohydrate calculated by difference (eg. CHO = 1000 – (protein + lipid + 
ash). ^ refer to Table 4.1 for details.  
a Ridley aquafeeds, Narangba, QLD, Australia  
b Manildra Group, Rocklea, QLD, Australia 
c Bulk Powders, www.bulkpowders.com.au  
d Vitamin and mineral premix (IU kg-1 or g/kg of premix): vitamin A, 2.5MIU; 
vitamin D3, 0.25 MIU; vitamin E, 16.7 g; vitamin K3, 1.7 g; vitamin B1, 2.5 g; 
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vitamin B2, 4.2 g; vitamin B3, 25 g; vitamin B5, 8.3; vitamin B6, 2.0 g; vitamin B9, 
0.8; vitamin B12, 0.005 g; biotin, 0.17 g; vitamin C, 75 g; choline, 166.7 g; inositol, 
58.3 g; ethoxyquin, 20.8 g; copper, 2.5 g; ferrous iron, 10.0 g; magnesium, 16.6 g; 
manganese, 15.0 g; zinc, 25.0 g 
e Yttrium oxide; Stanford Materials, Aliso Viejo, California, United States  
f Sydney Essential Oil Co. (Sydney, NSW, Australia) 
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4.3 Results 
4.3.1 Growth and feed utilisation 
During the 56 d growth assay, the fish in all treatments responded readily to the 
experimental diets and growth in the CTRL-D group was consistent with the 
predicted model growth, achieving 106% of the modelled potential (Glencross and 
Bermudes, 2012). Live-weight measurements were conducted after four weeks of 
feeding and then again after eight weeks and although there was a tendency towards 
lower growth in the SFA-D and MUFA-D fish at both time points, there were no 
significant differences (Table 4.3). The same trend was observed in terms of daily 
feed intake and growth rate with no significant differences and there was no 
difference in FCR values (Table 4.3). There were no differences in terms of survival 
with only one fish that died and was removed from the system over the term of the 
experiment (Table 4.3). 
The apparent digestibility of macro nutrients and specific fatty acids was 
affected by the diets (Table 4.4). Both dry matter (DM) and lipid were significantly 
less digestible in the SFA-D fed group of fish. There were no significant differences 
in either protein or gross energy (GE) digestibility among the treatments (Table 4.4). 
There were no significant differences in the digestibility of individual and total LC-
PUFA among the diets, each showing almost complete digestion in most cases. 
Similarly, there were no significant differences in the digestibility of individual and 
total PUFA and 18:1. However, the saturated fatty acids were significantly affected 
with 18:0 and 16:0 being less digestible in the SFA-D fed fish compared to the other 
treatments. The total SFA digestibility was also significantly reduced in the SFA-D 
fed fish (Table 4.4). 
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Table 4. 3 Growth performance and feed utilisation of juvenile barramundi fed 
experimental diets for eight weeks. All data (n=3 per treatment) are presented 
as mean ± SEM. 
  CTRL-D SFA-D MUFA-D TEST ^ 
Week 0 weight (g) 46.9 ± 0.1 47.3 ± 0.2 47.1 ± <0.1 F=2.2, P=0.20 
Week 4 weight (g) 139.2 ± 1.5 135.3 ± 7.8 136.0 ± 3.0 F=0.9, P=0.45 
Week 8 weight (g) 238.3 ± 1.2 231.2 ± 9.0 230.9 ± 6.2 F=0.4, P=0.66 
Feed intake (g/fish) 209.6 ± 2.7 202.4 ± 5.0 200.7 ± 4.9 F=0.6, P=0.58 
Growth rate (g/fish/d) 3.4 ± <0.1 3.3 ± 0.2 3.3 ± 0.1 F=0.5, P=0.65 
FCR 1.10 ± <0.1 1.12 ± <0.1 1.09 ± <0.1 F=2.0, P=0.21 
Survival (%) 98.0 ± 0.1 100.0 ± 0.0 100.0 ± 0.0 F=1.0, P=0.42 
Protein retention (%) 34.1 ± 1.1 29.8 ± 1.9 32.5 ± 0.9 F=2.5, P=0.16 
Lipid retention (%) 48.6 ± 4.5 40.2 ± 1.7 45.9 ± 0.7 F=2.4, P=0.17 
Energy retention (%) 37.8 ± 0.6a 33.5 ± 1.0b 34.4 ± 0.3b F=10.1* 
Values <0.1 are reported as <0.1. 
^ One-way ANOVA, DF 2,6, post-hoc Tukey’s HSD. P<0.05 *. Superscript letters 
indicate different levels of significance between treatment diets, percentage data 
were arcsine transformed prior to analysis. 
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Table 4. 4 Apparent digestibility coefficients of macro nutrients and specific 
fatty acids of experimental diets fed to juvenile barramundi. All data (n=3 per 
treatment) are reported as apparent digestibility percentage (%) 
  CTRL-D SFA-D MUFA-D TEST ^ 
Macro nutrient digestibility (%)    
   Dry matter  64.3 ± 1.6ab 60.3 ± 1.5b 69.4 ± 0.2a F=9.6* 
   Protein  91.1 ± 0.4 92.0 ± 1.2 92.1 ± 1.8 F=0.2, P=0.85 
   Lipid  91.0 ± 0.9a 73.7 ± 2.6b 92.9 ± 1.4a F=21.8** 
   Gross energy 87.3 ± 0.4 82.4 ± 3.3 89.2 ± 2.0 F=1.6, P=0.31 
Fatty acid digestibility (%)    
  16:0 82.1 ± 1.7a 59.2 ± 3.8b 86.6 ± 2.1a F=17.7* 
  18:0 77.5 ± 4.1a 42.4 ± 5.4b 82.1 ± 3.2a F=15.5* 
  18:1 92.4 ± 0.3 89.2 ± 1.5 94.3 ± 1.2 F=3.6, P=0.12 
  18:2n-6 96.0 ± 0.1 94.3 ± 0.8 96.3 ± 1.1 F=1.5, P=0.33 
  18:3n-3 98.6 ± 1.4 100.0 ± 0.0 97.7 ± 0.8 T=0.6, P=0.60 
  20:4n-6 100.0 ± 0.0 100.0 ± 0.0 100.0 ± 0.0 N/A 
  20:5n-3 99.1 ± <0.1 100.0 ± 0.0 98.6 ± 0.5 T=0.9, P=0.45 
  22:5n-3 100.0 ± 0.0 100.0 ± 0.0 100.0 ± 0.0 N/A 
  22:6n-3 98.5 ± 0.2 100.0 ± 0.0 97.3 ± 1.0 T=1.1, P=0.35 
   SFA  82.9  ± 2.0a 55.6 ± 4.2b 86.4 ± 2.2a F=18.3** 
   MUFA  92.9 ± 0.5 90.0 ± 1.3 94.3 ± 1.2 F=2.9, P=0.17 
   C18PUFA 96.7 ± 0.1 95.0 ± 0.7 96.6 ± 1.0 F=1.2, P=0.38 
   LC-PUFA  98.9 ± 0.1 100.0 ± 0.0 98.1 ± 0.7 T=1.1, P=0.40 
   n-3  98.9 ± <0.1 100.0 ± 0.0 98.1 ± 0.7 T=1.2, P=0.36 
   n-6  96.4 ± 0.1 94.6 ± 0.8 96.5 ± 1.1 F=1.5, P=0.32 
Values <0.1 are reported as <0.1. 
^ P<0.05*, P<0.01**, P<0.001***; One-way ANOVA, DF 2,6, post-hoc Tukey’s 
HSD; T-test, DF 4, was used to test two variables; Superscript letters indicate 
different levels of significance between treatment diets, percentage data were arcsine 
transformed prior to analysis. 
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4.3.2 Biochemical analysis 
The whole-body DM, protein and lipid composition on a wet weight basis was not 
significantly affected by the diets; however, the GE was significantly lower in the 
SFA-D fed fish (Table 4.5). Whole-body total fatty acids were not significantly 
different; however, there were some significant differences between the specific fatty 
acids. Among the LC-PUFA the whole-body 22:6n-3 and 22:5n-3 was significantly 
higher in the CTRL-D fish compared to the MUFA-D fish. The whole-body 18:2n-6 
was significantly highest in the MUFA-D and lowest in the CTRL-D (Table 4.5). 
The whole-body 18:1 was significantly highest in the MUFA-D fed fish whereas 
18:0 and 16:0 were lowest in the MUFA-D fed (Table 4.5). The total LC-PUFA and 
the total n-3 fatty acids were significantly lowest in the MUFA-D fed fish (Table 
4.5).  
The liver fatty acid composition was affected in a similar fashion to that of 
the whole-body where 22:6n-3, 22:5n-3, 20:5n-3 and 20:4n-6 had significantly 
higher composition in the CTRL-D fed fish. However, there were no significant 
differences among the MUFA-D or SFA-d diets (Table 4.5). There was no 
significant difference in PUFA composition of the liver. The total LC-PUFA and n-3 
composition were significantly higher in the CTRL-D fish and there was no 
significant difference in n-6 composition of the liver (Table 4.5). 
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4.3.3 Mass-balance computations  
There were no significant differences in protein or lipid retention, however, there 
was significantly higher energy retention in the CTRL-D fish (Table 4.3). There was 
significantly higher β-oxidation of specific n-3 series fatty acids (22:6n-3, 20:5n-3 
and 18:4n-3) and n-6 series fatty acids (20:4n-6) in the CTRL-D diet compared to the 
other treatment diets (Table 4.6). There was no recorded β-oxidation for any of the 
dominant saturates (including 12:0, 14:0, 16:0 and 18:0); however, there was a 
significant increase in β-oxidation of n-7 series FA (16:1n-7 and 18:1n-7) in the 
CTRL-D diet compared to the other treatment diets (not shown). There was a 
significant increase in the β-oxidation of 18:1 fatty acids in the MUFA-D diet 
compared to the other treatment diets (Table 4.6). 
There was significantly higher fatty acid de novo production of 12:0 
(neogenesis) in the MUFA-D fed fish compared to the other treatment diets (Table 
6). The recorded elongation activity of 14:0 was significantly higher in the CTRL-D 
and MUFA-D fed fish while the elongation of 16:0 was highest in the CTRL-D and 
SFA-D fed fish. Elongation of 20:5n-3 to 22:5n-3 was only recorded in the fish fed 
the SFA-D and MUFA-D diets and there was no significant difference (Table 4.6). 
The Δ-9 desaturation activity was significantly highest in the SFA-D fed fish 
followed by the control fed fish and there was none recorded in the MUFA-D fed 
fish (Table 4.6). There was no Δ-5 or Δ-6 desaturation activity detected in any of the 
diet treatments (data not presented).  
Relative to the total intake of specific fatty acids, there was a significantly 
greater proportion of total LC-PUFA deposited in the SFA-D and MUFA-D fed fish; 
however, there was no difference between these two groups (Table 4.7). Likewise, 
there was proportionally less β-oxidation in the SFA-D and MUFA-D fish; however, 
there was no difference between these two groups (Table 4.7). There was only a 
minor proportion of the consumed LC-PUFA converted or excreted in the groups of 
fish.  
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Table 4. 6 Whole-body fatty acid mass balance computations of β-oxidation, 
elongation and desaturation activity of juvenile barramundi fed experimental 
diets for eight weeks. All data (n=3 per treatment) are reported on a nmol/g 
fish/d basis. 
ND, not detected, N/A, not analysed, values <0.1 are reported as <0.1. 
# Computations following Turchini et al (2007). Refer to Table 4.1 for details. 
^ P<0.05*, P<0.01**, P<0.001***; One-way ANOVA, DF 2,6, post-hoc Tukey’s 
HSD; T-test, DF 4, was used to test two variables. Superscript letters indicate 
different levels of significance between treatment diets, percentage data were arcsine 
transformed prior to analysis.  
    CTRL-D SFA-D MUFA-D TEST ^ 
β-oxidation # 
  16:0 ND ND ND N/A 
  18:0 ND ND ND N/A 
  18:1 54.0 ± 2.8a 7.7 ± 3.9a  580.4 ± 48.6b F=127.6*** 
  18:2n-6 298.3 ± 16.8 312.5 ± 27.4 240.5 ± 14.5 F=3.5, P=0.09 
 18:3n-3 ND ND ND N/A 
  20:4n-6 64.3 ± 3.3a 25.8 ± 1.3 b 27.6 ± 0.7b F=108.0*** 
  20:5n-3 482.9 ± 23.9a 183.7 ± 12.8b 167.7 ± 4.8b F=125.0*** 
  22:5n-3 25.7 ± 9.9 ND ND N/A 
  22:6n-3 631.3 ± 50.9a 220.5 ± 17.3b 187.9 ± 3.7b F=63.0*** 
 SFA ND ND ND N/A 
 MUFA 348.4 ± 12.9b 38.5 ±13.8c 639.9 ± 60.9a F=69.8*** 
 C18PUFA 558.1 ± 32.0a 382.9 ± 44.0b 492.7 ± 19.8a F=7.3* 
 LC-PUFA 1623.6 ± 115.5a 574.1 ± 37.9b 508.6 ± 15.4b F=78.4*** 
 n-3 1616.3 ± 116.4a 560.1 ± 38.3b 494.7 ± 15.1b F=78.2*** 
 n-6 565.4 ± 31.1a 396.9 ± 43.6b 506.6 ± 20.1a F=7.1* 
Neogenesis # 
 12:0 188.3 ± 31.6a 166.0 ± 29.8a 312.3 ± 22.6b F=7.7* 
Elongation # 
  12:0 202.6 ± 28.8 184.9 ± 29.9 285.5 ± 22.4 F=3.1, P=0.12 
  14:0 350.8 ± 30.0b 241.4 ± 30.2a 363.7 ± 20.0b F=6.1* 
  16:0 216.8 ± 17.7b 235.9 ± 15.6b 107.2 ± 3.6a F=25.4** 
  20:5n-3 ND 13.9 ± 4.8 12.9 ± 1.1 T=0.5, P=0.55 
Δ-9 desaturation #  
  18:0 98.0 ± 22.7b 288.3 ± 28.6a ND T=5.2** 
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Table 4. 7 Calculated summary of LC-PUFA flux in juvenile barramundi. All 
data are (n=3) reported as a percentage based on the total intake of each fatty 
acid (nmol/g fish/d).  
  CTRL-D SFA-D MUFA-D TEST ^ 
22:6n-3# % Converted ND ND ND N/A 
 % Oxidised 58.1 ± 5.1a 38.6 ± 3.5b 36.7 ± 0.4b F=10.9* 
 % Excreted 1.5 ± 0.1 ND 2.7 ± 0.6 
T=2.0, 
P=0.11 
 % Deposited 40.4 ± 5.0 a 61.4 ± 3.5 b 60.6 ± 0.3 b F=11.4** 
22:5n-3 % Converted ND ND ND N/A 
 % Oxidised 20.5 ± 8.0 ND ND N/A 
 % Excreted ND ND ND N/A 
 % Deposited 79.5 ± 8.0 100 ± 0.0 100 ± 0.0 N/A 
20:5n-3 % Converted ND 3.5 ± 1.2 3.6 ± 0.3 
T=0.1, 
P=0.96 
 % Oxidised 63.4 ± 3.7 a 47.3 ± 3.9 b 47.3 ± 1.1 b F=8.7* 
 % Excreted 1.0 ± 0.1 ND 1.4 ± 0.2 
T=1.5, 
P=0.21 
 % Deposited 35.6 ± 3.6 a 49.2 ± 2.7 b 47.6 ± 0.7 b F=7.8* 
n-3 LC-PUFA % Converted ND 1.2 ± 0.4 1.2 ± 0.1 
T=0.1, 
P=0.96 
 % Oxidised 47.3 ± 5.6 a 28.6 ± 2.5 b 28.0 ± 0.5 b F=9.7* 
 % Excreted 0.8 ± 0.1 ND 1.4 ± 0.3 
T=1.8, 
P=0.14 
 % Deposited 51.8 ± 5.5 a 70.2 ± 2.1 b 69.4 ± 0.2 b F=9.2* 
ND, not detected, N/A, not analysed. 
^ P<0.001***  P<0.01**  P<0.05*; One-way ANOVA, DF 2,6, post-hoc Tukey’s 
HSD; T-test, DF 4, was used to test two variables; Superscript letters indicate 
different levels of significance between treatment diets, percentage data were arcsine 
transformed prior to analysis. 
#Assumed that no further conversion occurs (Turchini et al 2007).  
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4.4 Discussion 
The present study demonstrated that the inclusion of a 2:1 or 1:2 ratio of either SFA 
or MUFA, did not affect the growth performance of juvenile barramundi. The 
simultaneous reduction of dietary LC-PUFA (~11% LC-PUFA in SFA- and MUFA-
D vs 21.5% LC-PUFA in CTRL-D), provided that they were still above reported 
requirements of 1.2% LC-PUFA, also had no effect on performance (Williams et al., 
2006). Moreover, the feed intake and FCR values were unaffected. This is consistent 
with a range of species showing that substitution of FO with lipid rich in either SFA 
or MUFA does not affect fish growth performance (Turchini et al., 2009). The fish in 
the present study more than tripled in size suggesting that trial duration or nutrient 
turnover was not a confounding issue. The fish in the SFA-D and MUFA-D 
treatments did show a numerical reduction in growth; however, this was not 
confirmed statistically. It is uncertain whether longer trial duration would have 
resulted in significant differences as recent studies with barramundi have 
demonstrated that changes to the lipid profile of the diets can have rapid metabolic 
effects (Salini et al., 2015c). Lipid and in particular the saturated fatty acids are 
generally less digestible at lower environmental temperature and as a result less 
energy is available for growth (Ng et al., 2004; Olsen and Ringø, 1998). The 
barramundi is a tropical species adapted to high water temperature and potentially 
better able to cope with dietary SFA and MUFA rich lipid.  
The replacement of FO with MUFA rich lipid such as that from poultry oil 
had no effect on growth or FCR in a range of species including rainbow trout 
(Oncorhynchus mykiss) juveniles (Fonseca-Madrigal et al., 2005), post-smolt 
Atlantic salmon (Salmo salar) (Bell et al., 2002) or large 1.5 kg Atlantic salmon 
(Torstensen et al., 2000), juvenile red hybrid tilapia (Oreochromis sp.) (Bahurmiz 
and Ng, 2007) humpback grouper (Cromileptes altivelis) (Shapawi et al., 2008) and 
African catfish (Clarias gariepinus) (Ng et al., 2003). However, consistent among 
these studies when FO was completely replaced by MUFA rich lipid was the 
modified tissue FA profile resulting in reduced concentration of the beneficial n-3 
LC-PUFA. The same effect was clearly noted in the present study. However, 
proportional to the LC-PUFA intake, the results of most studies and those of the 
present study conclude that MUFA rich lipid is an ideal energy source capable of 
‘sparing’ the more valuable LC-PUFA from β-oxidation.  
An important consideration when formulating with SFA rich palm oil (PO) is 
the fraction used (Ng and Gibon, 2011). Past studies demonstrated that growth 
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performance (Ng et al., 2003; Shapawi et al., 2008) and digestibility of a range of 
species was not affected by different PO fractions (Bahurmiz and Ng, 2007) while 
the digestibility of palm products was significantly reduced compared to FO. Recent 
studies have also concluded that other sources of lipid rich in SFA such as beef 
tallow did not affect the growth of Atlantic salmon (Emery et al., 2014) or rainbow 
trout (Trushenski et al., 2011). Consistent with these reports, the present study 
demonstrated that the blend of palm products used did not compromise growth 
performance in barramundi while there were notable reductions to the lipid and 
specific fatty acid digestibility.  
In the present study, the digestibility of total lipid was significantly reduced 
in the SFA fed fish and this did not lead to a reduction in energy availability or any 
changes in whole-body lipid composition or retention. The reduction in lipid 
digestibility was evidently a result of the greatly reduced digestibility of the 
saturates, including both 16:0 and 18:0 FA. This is in agreement with other studies 
showing that the digestibility of the saturated fatty acids was reduced when a range 
of species were fed SFA rich oil (Caballero et al., 2002; Ng et al., 2004; Torstensen 
et al., 2000; Turchini et al., 2013). Moreover, in the present study the digestibility of 
SFA decreased with increasing chain length, consistent with other studies (Caballero 
et al., 2002; Johnsen et al., 2000; Ng et al., 2004). The reduced rate of lipolysis and 
absorption of longer chain SFA, such as 18:0 is caused by the lower ability of these 
FA to form lipid emulsions prior to digestion (Olsen et al., 1998).  
In contrast to the present study, negative effects of the high level inclusion of 
SFA (e.g. as occurs with high level use of PO) have been reported and that these 
effects are arguably more pronounced in carnivorous and/or marine fish with higher 
n-3 LC-PUFA requirements. Fountoulaki et al. (2009) found that gilthead sea bream 
growth was negatively impacted by reduced digestibility of SFA rich lipid over an 
extended growth trial of six months. Japanese seabass (Lateolabrax japonicas) 
growth performance was significantly reduced with a high inclusion of SFA rich 
lipid after only 50 days of growth and similarly reduced digestibility was inferred to 
be the cause (Gao et al., 2012). In agreement, Turchini et al. (2013) found that over a 
long duration (27 weeks) rainbow trout fed SFA rich lipid (at 75% replacement level) 
showed depressed performance compared to that of a control diet.  
An in vivo whole-body fatty acid balance method (WBFABM) was used in 
the present study in order to understand the apparent fate of specific fatty acids 
(Turchini et al., 2007). Theoretically, β-oxidation of specific fatty acids should be 
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recorded if they are provided in excess (Eroldogan et al., 2013; Stubhaug et al., 2007; 
Turchini et al., 2013). However, in the present study there was no recorded β-
oxidation of any SFA despite the relatively high proportion of SFA in all three diets. 
This effect is likely to be caused by the low lipid levels of all three diets, a strategy 
that was intended to highlight the potential effects of the lipid classes. Based on the 
β-oxidation results, it appears that MUFA are marginally better at sparing LC-PUFA 
from β-oxidation (Table 4.6) which is in agreement with past studies (Codabaccus et 
al., 2012; Turchini et al., 2011b). However, in the present study the final composition 
of the fish suggests that the SFA-D fed fish were significantly more efficient at 
depositing or ‘sparing’ LC-PUFA in the whole body (Table 4.5). To resolve this 
discrepancy, it is necessary to look at the net intake and total intake budgets to clarify 
the situation (Table 4.7). When expressed proportional to FA intake, the SFA-D and 
MUFA-D fed fish consequently deposited almost exactly the same n-3 LC-PUFA 
and the differences between the two diets were insignificant.  
Previous studies have demonstrated that limited de novo FA production 
(neogenesis) occurs when diets with adequate SFA were fed to Atlantic salmon 
(Emery et al., 2014) or rainbow trout (Turchini et al., 2013). However, neogenesis 
was evident in MUFA rich (canola oil) fed trout (Turchini et al., 2013). This is 
broadly similar to the results obtained in the present study in that neogenesis in 
barramundi was significantly higher in the MUFA fed fish. This may be partly 
explained by the up-regulation of genes related to lipogenic activity in response to 
vegetable oil observed in other species (Bell et al., 2001; Bell et al., 2002; Tocher et 
al., 2002). In contrast, dietary PUFA clearly led to a suppression of the lipogenic 
enzyme, fatty acid synthase (FAS) in the rat (Blake and Clarke, 1990). Moreover, in 
rainbow trout hepatocytes, FAS expression was strongly inhibited by PUFA (18:3n-3 
and 20:5n-3). These results and those of the present study confirm that the 
energetically expensive process of initial synthesis of palmitic acid from acetyl- and 
malonyl-CoA is avoided by the presence of dietary SFA thus allowing energy to be 
utilised more efficiently for growth and other cellular processes. 
Elongation and desaturation activity also occurred in the CTRL-D fed fish 
suggesting that the total lipid content of the diet was limiting as intended based on 
the optimal specification of at least 18% for growing barramundi (Glencross et al., 
2013). However, there was clearly adequate n-3 LC-PUFA in the diets based on the 
known requirement data for barramundi of around 1.2% (Glencross and Rutherford, 
2011; Williams et al., 2006). Consistent with Glencross and Rutherford (2011), there 
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was no elongation of 20:5n-3 to 22:5n-3 in the control fed fish. However, in the 
SFA-D and MUFA-D fed fish, there was a slight increase in the elongation of 
available 20:5n-3 to 22:5n-3 possibly in an attempt to achieve 22:6n-3 synthesis. 
However, barramundi, like most marine fish are not equipped with the complete set 
of enzymes required to endogenously synthesise sufficient LC-PUFA from precursor 
FA (Mohd-Yusof et al., 2010). Moreover, a recent study also demonstrated a similar 
increase in 22:5n-3 from 20:5n-3, lending further support to the elongation results 
obtained in the present study (Salini et al., 2015a).  
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5.0 The effect of marine and non-marine phospholipid rich oils when 
fed to juvenile barramundi (Lates calcarifer) 
 
 
 
 
 
 
Adapted from 
Salini, M.J., Wade, N.M., Bourne, N., Turchini, G.M., Glencross, B.D., 2016. The 
effect of marine and non-marine phospholipid rich oils when fed to juvenile 
barramundi (Lates calcarifer). Aquaculture. 455, 125-135 
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5.1 Aims 
Most phospholipid requirement studies to date have used soybean lecithin containing 
high levels of n-6 PUFA, while others have used egg lecithin or various other marine 
sources such as fish roe lecithin (Cahu et al., 2009). Recent studies have clearly 
demonstrated the potential of marine derived phospholipid sources to improve larval 
and juvenile fish performance (Betancor et al., 2012; Taylor et al., 2015). To date, 
information is scarce on the effect of phospholipid in juvenile barramundi diets. 
Therefore, an experiment was designed to compare the metabolic effect of marine 
and non-marine neutral lipid (NL) and polar (PL) sources using a two-by-two 
factorial approach in juvenile barramundi. The biochemical and molecular 
mechanisms underpinning the role of phospholipids was also investigated.  
5.2 Materials and methods 
The methodology used in the present experiment are detailed in the section 2.0 
General methodology. Ethical clearance was approved for the experimental 
procedures by the CSIRO Animal Ethics Committee (Application A11/2013). The 
chemical composition of the main dietary ingredients is presented in Table 5.1. The 
formulation and chemical composition of the four diets are presented in Table 5.2. 
The neutral and polar lipid composition of the experimental diets are presented in 
Table 5.3. Genes involved in fatty acid metabolism were analysed by real-time qPCR 
as described and are presented in Table 5.4. 
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Table 5. 2 Formulation and composition (as analysed) of experimental diets, all 
values are g/kg DM unless otherwise stated. 
  
n-3 NL 
(Fish) 
n-3 PL 
(Krill) 
n-6 NL 
(Soybean) 
n-6 PL 
(Lecithin) 
Formulation         
  Fish meal a 150 150 150 150 
  Poultry meal a 150 150 150 150 
  Soy protein isolate b 150 150 150 150 
  Wheat gluten b 150 150 150 150 
  Wheat flour b 109 109 109 109 
  Casein c 100 100 100 100 
  Pregelled wheat starch b 80 80 80 80 
  DL-Methionine 10 10 10 10 
  Di-calcium phosphate 10 10 10 10 
  Pre-mix vitamins d 8 8 8 8 
  Yttrium oxide e 1 1 1 1 
  Fish oil a 82 10 10 10 
  Krill Oil f 0 72 0 0 
  Soy oil g 0 0 72 0 
  Soy lecithin g 0 0 0 72 
Composition          
  Dry matter (g/kg) 940 933 959 952 
  Protein(g/kg DM) 598 613 597 593 
  Digestible protein (g/kg DM) 547 561 559 555 
  Ash (g/kg DM) 64 65 67 70 
  Lipid (g/kg DM) 122 124 122 118 
  Carbohydrate (g/kg DM) 212 198 214 219 
  Gross energy (mJ/kg) 21.5 21.1 21.8 21.0 
  Digestible energy (mJ/kg) 18.9 18.4 19.8 18.6 
a Ridley Aquafeed, Narangba, QLD, Australia. Fish meal defatted (see methods 2.2.1). 
b Manildra Group, Rocklea, QLD, Australia. 
c Bulk Powders, Moorabbin, Victoria, Australia. 
d Vitamin and mineral premix (IU kg-1 or g/kg of premix): vitamin A, 2.5MIU; 
vitamin D3, 0.25 MIU; vitamin E, 16.7 g; vitamin K3, 1.7 g; vitamin B1, 2.5 g; 
vitamin B2, 4.2 g; vitamin B3, 25 g; vitamin B5, 8.3; vitamin B6, 2.0 g; vitamin B9, 
0.8; vitamin B12, 0.005 g; biotin, 0.17 g; vitamin C, 75 g; choline, 166.7 g; inositol, 
58.3 g; ethoxyquin, 20.8 g; copper, 2.5 g; ferrous iron, 10.0 g; magnesium, 16.6 g; 
manganese, 15.0 g; zinc, 25.0 g 
e Yttrium oxide; Stanford Materials, Aliso Viejo, California, United States  
f Sydney Essential Oil Co. (Sydney, NSW, Australia) 
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Table 5. 3 Neutral and polar lipid composition of experimental diets, all values 
are mg/g lipid unless otherwise stated. 
    Diets       
   
n-3 NL 
(Fish) 
n-3 PL 
(Krill) 
n-6 NL 
(Soybean) 
n-6 PL 
(Lecithin) 
Lipid class (% total lipid)         
  Neutral 91.5 67.5 89.7 51.1 
  Polar 8.5 32.5 10.3 48.9 
Neutral lipid fatty acids ^         
 16:0 190.9 186.7 137.7 207.6 
  18:0 45.9 34.0 44.0 52.3 
  18:1n-9 194.6 223.6 252.9 225.4 
  18:2n-6 48.0 69.7 351.5 183.5 
  18:3n-3 10.2 10.8 40.3 22.2 
  20:4n-6 10.9 5.6 0.0 6.2 
  20:5n-3 79.4 92.6 13.1 35.0 
  22:5n-3 14.4 5.0 3.6 7.3 
  22:6n-3 117.5 71.8 19.7 54.7 
  SFA  298.6 304.0 195.1 291.5 
  MUFA  284.0 293.1 274.7 278.4 
  C18PUFA 58.3 97.7 395.7 210.9 
  LC-PUFA 222.2 175.1 36.4 103.3 
  Total n-3  211.2 186.7 40.2 102.3 
  Total n-6  69.2 86.1 391.9 211.9 
  Total fatty acids 863.1 869.9 901.8 884.0 
Polar lipid fatty acids ^         
 16:0 139.5 147.3 121.4 118.7 
  18:0 44.1 18.4 35.9 27.7 
  18:1n-9 101.8 87.0 109.0 68.1 
  18:2n-6 121.4 55.3 150.9 317.6 
  18:3n-3 7.7 7.0 11.6 37.3 
  20:4n-6 10.1 ND 6.9 ND 
  20:5n-3 27.5 87.8 29.3 5.9 
  22:5n-3 7.4 4.4 4.9 ND 
  22:6n-3 60.0 68.2 41.6 12.1 
  SFA  204.8 188.9 166.1 146.4 
  MUFA  144.9 110.4 128.5 71.6 
  C18PUFA 129.1 71.6 162.5 354.9 
  LC-PUFA 105.0 160.4 82.6 18.0 
  Total n-3  94.9 169.7 75.7 18.0 
  Total n-6  139.2 62.3 169.4 354.9 
  Total fatty acids 583.8 531.2 539.7 591.0 
n-3 NL, Fish oil; n-3 PL, Krill oil; n-6 NL, Soybean oil; n-6 PL, Soybean lecithin. 
ND, not detected. 
^ Refer to Table 5.1 for details.  
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5.3 Results 
5.3.1 Growth and feed utilisation 
In the present study the two levels of omega status were defined as n-3 and n-6 and 
the two levels of lipid class were defined as neutral lipid and phospholipid. There 
was no difference in the initial weight of the fish among the treatments; however, 
there were significant differences in the growth and feed utilisation parameters (as 
final weight, feed intake and FCR) upon termination of the 56 d growth assay (Table 
5.5). There were significant interaction terms indicating that the effectiveness of 
phospholipid-rich ingredients was found to be dependent on the omega status for the 
final weight, feed intake and FCR. The lowest growth performance and feed intake 
was seen in the fish fed n-6 NL (soybean oil) and the FCR was reduced in the n-6 PL 
fed fish (soybean lecithin). There were no differences in terms of survival with only 
three fish removed from the system. There were no significant differences in either 
protein or lipid retention (Table 5.5). 
There were no differences in apparent digestibility of dry matter, protein or 
gross energy (Table 5.6). There was a significant interaction effect indicating that the 
digestibility of total lipid in the phospholipid-rich treatments was dependent on the 
omega status with the lowest lipid digestibility in the n-6 PL (soybean lecithin) 
treatment. There was a significant interaction in the digestibility of 16:0 which 
showed that the highest digestibility in the n-6 NL treatment was dependent on the 
lipid class. There was also a significant interaction noted for the digestibility of 
18:2n-6, total C18PUFA and total n-6 showing that the digestibility of fatty acids 
from phospholipid-rich ingredients was dependent on the omega status. In each case 
the digestibility was lowest in the n-6 PL treatment (soybean lecithin). Similarly, the 
digestibility of 18:3n-3 was significantly lower in the n-6 PL fed fish. 
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5.3.2 Biochemical analysis 
As intended, the neutral and polar composition of the diets was reflective of the lipid 
composition of the ingredients used (Table 5.3).There were no significant differences 
in the neutral and polar lipid composition of the whole fish with all treatments in the 
range of 89.4 to 94.0% neutral lipid (Table 5.7). Fatty acid analysis of the neutral and 
polar fractions revealed several significant differences among the treatments. 
Significant interaction terms were noted for many of the neutral lipid fatty acids. 
Most notably, the effect of phospholipid-rich ingredients on LC-PUFA (specifically 
22:6n-3, 22:5n-3 and 20:5n-3) composition in the whole fish were found to be 
dependent on the omega status with the highest levels present in the n-3 treatments. 
Of the polar lipid fatty acids, the18:2n-6 composition was significantly higher in the 
n-6 treatments whereas the 16:0, 20:5n-3 and 22:6n-3 composition was highest in the 
n-3 treatments. 
There was several significant interaction terms noted on the apparent in-vivo 
β-oxidation activity (Table 5.8). The phospholipid-rich ingredients were found to be 
effective in modifying the β-oxidation of MUFA in the n-6 PL fed fish; however, this 
was not the case for the n-3 PL fish. There was a significant interaction term noted in 
the β-oxidation C18PUFA and Total n-6 with the highest activity in the phospholipid-
rich lipid being dependent on the omega status. There was also a significant 
interaction for the β-oxidation of LC-PUFA and Total n-3 which was dependent on 
the omega status with the highest activity in the n-3 NL treatments. 
There was a significant interaction indicating that elongation activity of SFA 
was highest in the n-6 NL treatment and lowest activity was in the n-3 NL treatment 
(Table 5.8). There was no detectable elongation activity of the LC-PUFA or Total n-
3 in the n-3 NL fed fish; however, when analysed by one-way ANOVA there was 
significantly greater activity in the n-3 PL fed fish compared to both of the n-6 
treatments. There was also a significant interaction in the delta-9 (Steroyl CoA 
desaturase) desaturation activity with greatest activity recorded in the n-6 NL and the 
lowest activity in the n-3 NL treatment.  
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There was a significant interaction in the plasma GLDH enzyme with an 
elevated level present in the n-6 PL treatment which was dependant on the omega 
status (Table 5.9). Similarly, there was a significant interaction noted on plasma 
creatinine levels with an elevated level in the n-6 PL fish which was dependent on 
the omega status. The plasma cholesterol level was significantly elevated in the n-3 
PL treatment and lowest in the n-6 NL and n-6 PL treatments. Circulating protein 
levels in the plasma were significantly higher in the phospholipid class treatments. 
Among the haematological parameters, Hb was significantly elevated in the n-3 NL 
fish and haptoglobin was significantly elevated in the n-6 PL fish (Table 5.9). 
5.3.3 Gene expression 
Several significant differences were observed in the expression of genes related to 
fatty acid metabolism (Figure 5.1). There was a significant interaction in the relative 
gene expression of Lc ACYL, Lc FAS and Lc FADS2 with increased expression in the 
n-6 PL treatment that was dependent on the lipid class. The expression of these genes 
was at least 1.5-fold higher in the n-6 PL compared to the n-3 PL treatments. There 
was also a significant interaction effect in the modification of Lc CPT1α expression 
by the phospholipid-rich ingredients which was dependent on the omega status. The 
expression of Lc CPT1α was down regulated by approximately 1.5-fold in the n-3 PL 
compared to the control. Similarly, the expression of Lc SCD was significantly up 
regulated in the n-6 treatments compared to the n-3 treatments and there was no 
interaction effect observed. The expression of Lc ELOVL5 in all treatments was 
down regulated compared to the initial fish levels and there were no significant 
differences among the treatments. 
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Figure 5. 1 Hepatic gene expression of selected lipid metabolism genes in 
juvenile barramundi (Lates calcarifer) after eight weeks of feeding. Relative 
expression is calculated for each gene using cycle threshold values, normalised 
to control genes (Elongation factor 1a and Luciferase). Values are shown as log-
2 fold change relative to the initial fish. Letters above error bars indicate 
significant differences between the treatments. Analysed by two-way factorial 
ANOVA, df 1,1,1,8, post-hoc Tukey's HSD. 
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5.4 Discussion 
It is well established that larval and early juvenile fish have a dietary requirement for 
intact phospholipids that can lead to long term improvements in many growth 
performance parameters (Coutteau et al., 1997; Tocher et al., 2008). Historically 
most phospholipid studies were conducted with commercial phospholipid 
preparations of commonly available emulsifying agents such as lecithin from 
soybeans or corn (Tocher et al., 2008). However, in some cases the use of these 
products has potentially led to unclear requirement data as the composition of polar 
lipid and polar lipid classes is seldom reported and there are other potential 
interacting effects of the ingredients themselves. The aims of the present study were 
to provide an up to date assessment of the physiological and metabolic effect of 
commercially available preparations of phospholipid-rich ingredients such as krill oil 
and soybean lecithin against neutral lipid-rich ingredients such as fish oil and 
soybean oil in juvenile barramundi. 
Based on the performance data of the present study, it is clear that for 
barramundi in the range of ~47 to ~238 g, a response to the lipid ingredients was 
evident. It should be noted that each of the diets were prepared with a minimum (1% 
diet) inclusion of FO in order to prevent the onset of essential fatty acid deficiency 
(Salini et al., 2015c). The growth, feed intake and FCR of the n-3 NL and n-3 PL fed 
fish were nearly identical. Despite the n-6 PL fed fish being statistically the same 
weight as the two n-3 diets they consumed significantly more feed which resulted in 
a higher FCR. Many studies have clearly demonstrated that growth potential is 
driven by the demand for energy (derived mostly from protein and lipid) in this 
species (Glencross et al., 2013). However, the diets in the present study were 
equivalent in digestible energy and the n-6 PL fish consumed more feed to maintain 
growth, comparable to the control (n-3 NL) fish suggesting that the difference in 
FCR is attributable to the lipid ingredients. Therefore this suggests that the lecithin 
was poorly utilised by the fish as also supported by numerically lower lipid retention 
in this treatment. There may be other features of the soybean lecithin that contributed 
to the results observed, however, investigation of these was beyond the objectives of 
the present study. 
A recent study on dietary phospholipids in Atlantic salmon over a range of 
sizes (from first feeding to ~60 g) found that at 2.6% phospholipid in the form of 
soybean lecithin reduced growth performance and FCR (Taylor et al., 2015). 
However, the most profound negative effect of soybean lecithin on growth rate 
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(SGR) was in early phase (first feeding to 2.5 g) rather than the latter stages of 
growth studied. It should be clearly noted that the diets used in the present study 
included 7.2% added lipid to a base of 1% fish oil. Based on the analysed 
composition of the diets used in the present study, the determined level of 
phospholipid in the lecithin diet was around 5.8% and the krill diet was around 4.0%. 
It is unclear whether this level of inclusion could have influenced the growth 
performance of the n-6 PL fed fish. In the study of Taylor et al. (2015), the inclusion 
of krill oil above 2.6% phospholipid led to a decrease in the growth of Atlantic 
salmon; however, no effect of krill oil was seen in the present study. They reasoned 
that the difference could be due to the reduced energy availability of phospholipid-
rich oils compared to that of neutral lipid oils that are mostly triacylglycerol (Taylor 
et al., 2015).  
In larval fish, the digestibility of diets containing phospholipids is 
consistently better than control diets, mostly owing to their emulsifying effect 
leading to better absorption by the developing gut system (Coutteau et al., 1997; 
Tocher et al., 2008). In contrast, the juvenile barramundi fed soybean lecithin in the 
present study had the lowest total lipid digestibility potentially owing to its physical 
characteristics rather than its chemical composition. However, the most abundant 
fatty acid in the phospholipid fraction of the n-6 PL diet was 18:2n-6 and this was 
also significantly less digestible leading to the lowest total C18PUFA digestibility. 
These reductions in digestibility most likely also led to the poor FCR observed in 
that treatment group. However, it is unclear whether these effects are caused by the 
phospholipid composition or another feature of the ingredient as the same effects 
were not replicated in the krill oil fed fish.   
A further interesting result of the present study was that the n-6 NL fed fish 
ate less and consequently grew less than the n-3 treatments with no difference in 
FCR. The digestibility was also high for the total lipid and all the dominant fatty 
acids in fish fed the n-6 NL diet. This reduction in growth might be explained by 
several mechanisms. Firstly, soybean oil lacks any measureable n-3 LC-PUFA and to 
some extent is also likely to be pro-inflammatory due to the high proportion of 
omega-6 fatty acids (Brown and Hart, 2011; Turchini et al., 2009). However, the 
reduced growth response should also have been expected in the n-6 PL fed fish as the 
fatty acid composition of the raw ingredients is quite similar.  
Of all the studies investigating the use of soybean oil, growth reduction is 
rarely reported in fish (Brown and Hart, 2011; Glencross, 2009). In a study by Raso 
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and Anderson (2003) they found that although juvenile barramundi fed soybean oil 
grew slightly less than the controls it was not confirmed statistically and the FCR 
also remained unchanged. However, in a select group of marine species, such as the 
black sea bream (Acanthopagrus schlegeli), Japanese flounder (Paralichthys 
olivaceous), red sea bream (Pagrus auratus), silver bream (Rhabdosargus sarba) and 
cobia (Rachycentron canadum), feeding exclusively with soybean oil has led to 
differences in growth performance. Most simply put, this was likely caused by 
essential fatty acid (EFA) deficiency rather than another unique feature of the 
soybean oil itself (Brown and Hart, 2011; Trushenski et al., 2012).   
Another more recent hypothesis is that certain fatty acids including 18:2n-6 
may influence feed intake by modulating the expression of ‘satiety’ and ‘hunger’ 
hormones via various signalling pathways, for example neuropeptide Y or Agouti-
related protein (NPY and AGRP respectively), however, this is yet to be thoroughly 
explored in teleost fish (Coccia et al., 2014; Liland et al., 2013; Schwartz et al., 
2000). Therefore, in light of the many possibilities, the fish fed the n-6 NL (soybean 
oil) diet in the present study were likely to be EFA deficient. However, the same 
effect did not manifest itself in the n-6 PL fish, indicating a marginal improvement 
owing to the phospholipid content of the diet. 
In the present study, the whole body fatty acid composition mostly resembled 
the diet profiles as previously reported in the vast majority of studies (Rosenlund et 
al., 2011). Despite the varied NL and PL composition of the diets used in the present 
study, it was clear that the proportion of NL and PL in the whole body was tightly 
regulated. However, there were some changes to the fatty acid composition of both 
the NL and PL fraction of the whole body, consistent with other studies. In larval fish 
such as sea bream, increasing marine derived PL led to better assimilation of n-3 FA 
whereas soybean lecithin PL increased assimilation of n-6 FA (Saleh et al., 2015). 
Alhazzaa et al. (2011b) correlated the up regulation of fatty acid synthesis genes 
(FADS2 and ELOVL5) with highly selective fatty acid retention in muscle and liver 
PL of juvenile barramundi fed vegetable oils. Other studies have also demonstrated 
that the LC-PUFA composition of the PL fraction of certain tissues is tightly 
regulated in the absence of adequate dietary supply (Skalli et al., 2006). In the 
present study, this effect was seen with the n-6 NL (soybean oil) fish able to retain 
numerically more n-3 LC-PUFA than the n-6 PL fish. Moreover, 18:2n-6 was 
preferentially retained in the n-6 NL fed fish.  
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In the present study, the apparent in vivo whole body mass-balance of specific 
fatty acids was calculated to determine discrete differences in metabolism (Turchini 
et al., 2007). The LC-PUFA β-oxidation activity was highest in the n-3 NL followed 
by the n-3 PL fish, typical of when barramundi and other species are fed excess LC-
PUFA (Salini et al., 2015c; Stubhaug et al., 2007).  The high elongation of SFA and 
delta-9 desaturation activity in the n-6 NL fish suggests an attempt to generate 18:1n-
9 as an available energy source. However, there was no corresponding increase in β-
oxidation of MUFA and moreover the same effect was not recorded in the n-6 PL 
fish.  It is unclear as to why they would invest energy into elongation and delta-9 
desaturation processes with no further downstream effect; however, it clearly 
indicates a modified metabolic function that could be part of a compensatory 
mechanism when EFA are deficient. Moreover, it is difficult to correlate the mass-
balance computations with the quantitative gene expression analysis used in the 
present study as different enzymes are involved throughout the fatty acid metabolic 
pathway. However, the mass-balance results do correlate with those previously 
reported in barramundi and other species fed alternative oils (Francis et al., 2007; 
Salini et al., 2015c; Turchini et al., 2013). 
The biochemical analysis of the plasma and the hepatic gene expression 
potentially indicate a modified metabolic pattern, particularly as a result of the n-6 
lipids, soybean lecithin and to a lesser extent soybean oil. However, there were no 
dramatic sub-clinical pathologies noted indicating the potential relevance of these 
changes. Creatinine kinase (CK) levels were numerically highest in the n-3 NL fed 
fish and although there is a general lack of data in this and other teleost species it 
could be argued that these fish were in a diseased state (Nanji, 1983; Sandnes et al., 
1988). However, it may also be reasoned that these are the normal enzyme levels as 
they are the control group of this study. The elevated glutamate dehydrogenase 
(GLDH) activity, creatinine level and total protein in the plasma of the n-6 PL fish 
are potentially indicative of organ failure or dehydration that can be characterised by 
the depletion of hepatic LC-PUFA stores (Van Waes and Lieber, 1977; Videla et al., 
2004). However, the plasma enzyme markers (eg GLDH and ALT) are typically used 
in combination to confirm a clinical diagnosis and in the present study there is not 
adequate evidence to support this. In contrast, none of the plasma markers were 
elevated in the n-6 NL fed fish. In addition, several authors have reasoned that 
together elevated GLDH and plasma urea are implicated in osmoregulatory processes 
leading to clinical pathologies such as subcutaneous haemorrhaging (Glencross and 
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Rutherford, 2011; Morton et al., 2014). However, in the present study these 
pathologies were not present and moreover the plasma urea content was unaffected 
suggesting that the lipid sources used were nutritionally adequate unlike those of the 
previously mentioned studies. Further work is clearly warranted in this area to 
resolve some of the discrepancies relating to clinical diagnosis in barramundi and 
other teleosts.  
The hepatic expression of genes related to fatty acid synthesis (Lc ACYL and 
Lc FAS) and delta-6 and delta-9 desaturation (Lc FADS2 and Lc SCD), were also 
significantly up regulated in n-6 PL fed fish. These transcriptional changes suggest 
that there was potentially a metabolic modification in the liver and that the fish might 
have a limited ability to respond to the soybean lecithin. Recent studies have shown 
similar nutritional regulation of fatty acid metabolism related genes with soybean oil 
(Li et al., 2016); however, the same effect of soybean oil (diet n-6 NL) was not 
replicated to the same extent in the present study. Interestingly, the expression of Lc 
CPT1α, which is considered to be the initial step in the mitochondrial β-oxidation of 
fatty acids, was dependent on the omega status being significantly down regulated in 
the n-3 PL fish compared to the n-3 NL fish (Frøyland et al., 1998). Moreover, the 
apparent in vivo β-oxidation of SFA, MUFA and PUFA was also significantly lower 
in the n-3 PL treatment which may indicate an active anti-oxidant effect of 
phospholipid rich lipids of marine origin such as krill (Saito and Ishihara, 1997).  
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6.0 Rapid effects of essential fatty acid deficiency on growth and 
development parameters and transcription of key fatty acid 
metabolism genes in juvenile barramundi Lates calcarifer 
 
 
 
 
 
 
Adapted from 
Salini, M.J., Turchini, G.M., Wade, N., Glencross, B.D., 2015. Rapid effects of 
essential fatty acid deficiency on growth and development parameters and 
transcription of key fatty acid metabolism genes in juvenile barramundi Lates 
calcarifer. Br. J. Nutr. 114, 1784-1796 
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6.1 Aims 
Essential fatty acids (EFA) play an important physiological role in both larval and 
juvenile barramundi while less is known about the effects on larger fish. Despite the 
efforts of numerous studies so far, there remains to be a clear analysis of the onset 
and progression of EFA deficiency in barramundi. Therefore, the aim of this 
experiment was to document the aetiology of essential fatty acid deficiency in 
juvenile barramundi. It was hypothesised that once the endogenous reserves of LC-
PUFA were progressively depleted then sub-clinical EFA deficiency symptoms 
would develop before further gross clinical signs become evident. 
6.2 Materials and methods 
The methodology used in the present experiment are detailed in the section 2.0 
General methodology. Ethical clearance was approved for the experimental 
procedures by the CSIRO Animal Ethics Committee (Application A10/2013). The 
chemical composition of the main dietary ingredients is presented in Table 6.1. The 
formulation and chemical composition of the three diets are presented in Table 6.2. 
Real-Time PCR primers specific to each gene are presented in Table 6.3. 
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Table 6. 2 Formulation and composition of experimental diets, all values are 
g/kg DM unless stated. 
a Ridley aquafeeds, Narangba, QLD, Australia. Fish meal defatted using hexane. 
b Manildra Group, Rocklea, QLD, Australia 
c Bulk Powders, www.bulkpowders.com.au  
d Vitamin and mineral premix (g/kg of premix): vitamin A, 0.75 mg; vitamin D3, 6.3 mg; 
vitamin E, 16.7 g; vitamin K3, 1.7 g; vitamin B1, 2.5 g; vitamin B2, 4.2 g; vitamin B3, 25 g; 
vitamin B5, 8.3 g; vitamin B6, 2.0 g; vitamin B9, 0.8 g; vitamin B12, 0.005 g; biotin, 0.17 g; 
vitamin C, 75 g; choline, 166.7 g; inositol, 58.3 g; ethoxyquin, 20.8 g; copper, 2.5 g; ferrous 
iron, 10.0 g; magnesium, 16.6 g; manganese, 15.0 g; zinc, 25.0 g 
e Yttrium oxide; Stanford Materials, Aliso Viejo, California, United States  
f Sydney Essential Oil Co. (Sydney, NSW, Australia)  
    FO CTRL FO LOW FO FREE 
Formulation       
  Defatted fish meal a 150 150 150 
  Poultry meal a 150 150 150 
  Soy protein isolate b 150 150 150 
  Wheat gluten b 150 150 150 
  Wheat flour b 109 109 109 
  Casein c 100 100 100 
  Pregelled wheat starch 80 80 80 
  DL-Methionine 10 10 10 
  Di-calcium phosphate 10 10 10 
  Pre-mix vitamins d 8 8 8 
  Yttrium oxide e 1 1 1 
  Fish oil a 82 10 0 
  Olive oil f 0 36 41 
  Palm Oil f 0 18 20 
  Palm Flake f 0 18 20 
Composition       
  Dry matter 940 939 945 
  Protein 598 588 603 
  Ash 64 64 66 
  Lipid 126 123 122 
  Carbohydrate 204 219 202 
  Gross energy (MJ/kg) 21.5 21.3 21.6 
Fatty acids (% total)        
  Total FA (mg/g lipid) 681.8 708.4 717.4 
  22:6n-3 10.6 2.0 0.9 
  22:5n-3 1.6 0.1 0.1 
  20:5n-3 8.1 1.3 0.5 
  20:4n-6 1.2 0.3 0.1 
  18:3n-3 1.3 1.1 1.0 
  18:2n-6 10.0 13.0 13.2 
  18:1 22.7 38.8 41.1 
  18:0 5.5 11.9 12.6 
  16:0 22.9 27.0 27.6 
  SFA 34.5 41.2 41.8 
  MUFA 31.3 41.1 42.5 
  PUFA 12.7 14.1 14.3 
  LC-PUFA 21.5 3.7 1.4 
  Total n-3  22.9 4.4 2.4 
  Total n-6  11.3 13.4 13.2 
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6.3 Results 
6.3.1 Growth and feed utilisation 
During the 56 d growth assay, the fish responded readily to the experimental diets 
and growth in the control group was consistent with the predicted model growth, 
achieving 106% of the modelled potential (Glencross and Bermudes, 2012). When 
analysed by one-way ANOVA there was a significant difference in live-weight after 
two weeks of feeding on the experimental diets, with the fish fed the FO LOW and 
FO FREE diets being smaller from those fed the FO CTRL diet. By six weeks of 
feeding there was a significant difference among all three groups of fish and this 
remained the same at eight weeks. The same results were found with weight gained 
(Table 6.4). When the live-weight, weight gain and FCR data were analysed with a 
repeated measures design there was a significant interaction effect of the diets after 
controlling for time (repeated) measurements (Table 6.5). There was no difference in 
feed intake among the groups of fish, however, there was a significant difference in 
feed conversion (FCR) between the FO CTRL and FO FREE fed fish (Table 6.4 and 
6.5). There were no differences in terms of survival with only one fish removed from 
the system. 
The total lipid was significantly more digestible in the FO CTRL fed fish than 
the FO FREE fed fish (Table 6.6). There were several significant differences in 
specific fatty acid digestibility. The n-3 LC-PUFA including EPA and DHA were all 
completely digested by the fish fed FO LOW and FO FREE diets whereas the FO 
CTRL fed fish digested less of these fatty acids (Table 6.6). Although significant, the 
numerical differences were minor. The digestibility of total saturated fatty acids 
(SFA) was significantly different with fish fed the FO FREE diet able to digest more 
than the fish fed the FO CTRL diet.  
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Table 6. 4 Growth performance and feed utilisation of barramundi fed 
experimental diets for eight weeks. 
FCR, Feed conversion ratio  
P SEM, Pooled standard error mean, 
P<0.001***  P<0.01**  P<0.05*. Superscript letters indicate significant differences 
among means. One-way ANOVA df 2,6, post-hoc Tukey's HSD 
Percentage data were arcsine transformed prior to analysis   
Any values <0.01 are reported as 0.1; NA, Not analysed. 
  
  FO CTRL FO LOW FO FREE 
P 
SEM ANOVA 
Live-weight initial (g) 46.9 46.9 46.8 0.07 F=0.1, P=0.89 
Live-weight WK2 (g) 92.7b 85.8a 87.4a 1.18 F=10.8 * 
Live-weight WK4 (g) 139.2b 130.6a 125.9a 2.07 F=23.7 ** 
Live-weight WK6 (g) 185.0c 173.9b 162.9a 3.40 F=22.3 ** 
Live-weight WK8 (g) 238.3c 218.9b 202.8a 5.26 F=56.4 *** 
Gain (g/fish) 191.4c 172.1b 156.0a 5.24 F=58.5 *** 
Feed intake (g/fish) 209.6 196.3 207.9 3.91 F=1.2, P=0.36 
FCR 1.10a 1.14ab 1.33b 0.04 F=12.9 ** 
Protein retention (%) 34.1a 30.3b 27.8b 1.01 F=13.7 ** 
Lipid retention (%) 74.8a 61.7a 44.8b 4.61 F=24.2 ** 
Energy retention (%) 37.8a 34.5a 29.8b 1.30 F=11.4 ** 
Survival (%) 98 100 100 0.01 NA 
Abnormalities (%) 4.0a 2.0a 41.0b 0.08 F=6.8 * 
Behaviour index 1.9 1.7 1.8 2.8 F=4.0, P=0.08 
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Table 6. 5 Split-plot analysis of variance for repeated measures design of growth 
performance and feed utilisation parameters in juvenile barramundi. 
Two-way repeated measures ANOVA, df residuals 6,24 (live-weight), df residuals 
6,18 (Gain, FCR, Intake).  
FCR, Feed conversion ratio 
  
  Source of variation Degrees of freedom F value P (>F) 
Live-weight (g) Diet 2 44.6 < 0.001 
  Week 4 7341 < 0.001 
  Diet:Week 8 26.4 < 0.001 
Gain (g/fish) Diet 2 48.7 < 0.001 
  Week 3 4659 < 0.001 
  Diet:Week 6 20.9 < 0.001 
Feed intake (g/fish) Diet 2 2.3  0.18 
  Week 3 1681 < 0.001 
  Diet:Week 6 0.9  0.52 
FCR Diet 2 11.7  < 0.01 
  Week 3 345.8 < 0.001 
  Diet:Week 6 11.5 < 0.001 
129 | P a g e  
Table 6. 6 Apparent digestibility of macro nutrients and fatty acids present in 
the experimental diets. 
P SEM, Pooled standard error mean  
P<0.05 *. Superscript letters indicate significant differences among means. One-way 
ANOVA df 2,6, post-hoc Tukey's HSD.  
Percentage data were arcsine transformed prior to analysis  
Any values <0.01 are reported as 0.1; NA, Not analysed. 
  
    FO CTRL FO LOW FO FREE PSEM ANOVA 
Dry matter (%)  64.3 70.8 65.4 1.5 F=4.3, P=0.10 
Protein (%)  91.6 93.0 94.1 0.4 F=4.4, P=0.08 
Total lipid (%)   90.7a 87.1ab 84.6b 1.5 F = 8.1 * 
Energy (%)  87.3 85.7 88.7 0.7 F=2.4, P=0.19 
22:6n-3 (%)  98.5 100.0 100.0 0.6 NA 
22:5n-3 (%)  100.0 100.0 100.0 0.0 NA 
20:5n-3 (%)  99.0 100.0 100.0 0.2 NA 
20:4n-6 (%)  100.0 100.0 100.0 0.0 NA 
18:3n-3 (%)  98.6 100.0 100.0 0.6 NA 
18:2n-6 (%)  95.8 96.0 95.6 0.6 F=0.2, P=0.84 
18:1 (%)  92.1 93.9 92.9 0.6 F=1.6, P=0.30 
18:0 (%)  76.7a 70.9ab 65.6b 2.6 F=9.4* 
16:0 (%)  81.5 77.0 73.7 2.1 F=4.7, P=0.9 
SFA (%)  82.3a 76.0ab 71.8b 2.4 F = 8.0 * 
MUFA (%)  92.6 94.0 92.8 0.5 F=1.1, P=0.41 
PUFA (%)  96.5 96.3 96.0 0.6 F=0.5, P=0.66 
LC-PUFA (%)  98.9 100.0 100.0 0.4 NA 
Total n-3 (%)  98.9 100.0 100.0 0.4 NA 
Total n-6 (%)  96.3 96.1 95.6 0.5 F=0.5, P=0.64 
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6.3.2 Biochemical analysis 
There were significant differences in macro nutrient retention of the fish after eight 
weeks of feeding with the control fed fish retaining more protein, lipid and gross 
energy than the FO LOW and FREE fed fish (Table 6.4). Generally, the fatty acid 
composition of the diets was reflected in the whole fish and also the liver tissue 
(Table 6.7). There were significant differences in most of the dominant fatty acids in 
the whole-body with the only exceptions being 18:3n-3 and 16:0 (Table 6.7). 
Similarly, in the liver, there were significant differences in most of the dominant 
fatty acids with the exception of 18:2n-6, 18:3n-3 and 16:0 (Table 6.7).  
After eight weeks, there was a significant decrease in the retention of SFA, 
MUFA and PUFA in the FO LOW and FO FREE fed fish compared to the FO CTRL 
fed fish while the LC-PUFA retention was highest in the FO LOW fed fish (Figure 
6.1). In terms of calculated β-oxidation values there was significantly less oxidation 
of total SFA and MUFA in the FO CTRL fed fish. There was no difference in PUFA 
oxidation yet significantly more LC-PUFA was oxidised in the FO CTRL fed fish 
(Figure 6.1).  
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Figure 6. 1 (A-D) Mass-balance computations of fatty acid retention and β-
oxidation in juvenile barramundi, mean (±SEM) n=3. Saturated fatty acid (a; 
SFA) retention F=82.5***, β-oxidation F=5.2*; Monounsaturated fatty acid (b; 
MUFA) retention F=44.5***, β-oxidation F=7.0*; Polyunsaturated fatty acid (c; 
PUFA) retention F=10.8*, β-oxidation F=1.4, P=0.32; Long-chain 
polyunsaturated fatty acid (d; LC-PUFA) retention F=6.1*, β-oxidation 
F=241.5***. Significant differences are indicated by letters (*, P<0.05; **, 
P<0.01; ***, P<0.001), one - way ANOVA df 2,6., post-hoc Tukey’s HSD. 
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Retention β-oxidation  
LC
-P
U
FA a
b
a
a
b
c
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Retention β-oxidation  
M
U
FA
a
b
c
a
b
b
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Retention β-oxidation  
P
U
FA
a
a
b
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Retention β-oxidation  
S
FA
 
b
b
a
c
b
a
(A) (B)
(C) (D)
133 | P a g e  
6.3.3 Clinical observations 
A range of abnormalities were observed during the experiment. These included red 
fins (typically caudal and pectoral), red skin, fin erosion, lesions and non-
contributing (feed refusal) fish. The fish fed the FO FREE diet were significantly 
more affected by a range of abnormalities than the fish fed the FO LOW and FO 
CTRL diets (Table 6.4). There was no significant difference in the behavioural 
response of fish assessed by the methods described earlier (Table 6.4).  
6.3.4 Sub-clinical parameters 
A range of plasma chemistry parameters were assessed and some significant 
differences were observed among the dietary treatments (Table 6.8 and Table 6.9). In 
all measured parameters, with the exception of glutamate dehydrogenase (GLDH) 
and creatinine, there was a significant time effect. In most parameters the numerical 
differences were relatively minor. Phosphate, iron, haemoglobin and haptoglobin all 
increased significantly after week six. There was a significant diet effect on plasma 
cholesterol with the lowest values recorded in the FO LOW and FREE fed fish. 
There was also a significant diet effect in plasma iron being highest in the FO LOW 
fed fish. Similarly, plasma haptoglobin was highest in the FO FREE fed fish (Table 
6.8). 
Expression of lipid metabolism related genes in the liver of the FO CTRL and 
FO FREE fish were analysed by real-time quantitative PCR and several significant 
differences were observed (Figure 6.2). Repeated measures analysis showed that 
there were no significant effects on the expression of Lc CPT1α and Lc ELOVL5 
genes. There was a significant diet effect on the expression of Lc ACYL with the 
highest expression in the FO FREE fed fish at week four. Similarly, the expression of 
Lc FAS was approximately 2.5-fold higher in the FO FREE fish. The expression of 
Lc SCD was significantly affected by the dietary treatment with levels of expression 
in the FO FREE fish approximately 3- to 4-fold higher than the FO CTRL fish. There 
was a significant diet effect in the expression of Lc FADS2 with approximately 2-
fold higher expression among the FO FREE fed fish. There were no significant time 
or interaction effects for the genes analysed. 
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Figure 6. 2 (A-F) Expression of lipid metabolism genes in the liver of juvenile 
barramundi. All data are normalised to EF1α and Luc reference genes, log 2 
transformed and expressed relative to the initial fish (WK 0), mean (±SEM) 
n=6. The FO CTRL (control) groups are indicated by light bars and the FO 
FREE groups are indicated by dark bars. Two-way repeated measures 
ANOVA, df of residuals 10,30. Lc ACYL, Diet F=15.5**, Week F=2.3, P=0.09, 
Diet:Week F=1.0, P=0.39; Lc CPT1a, Diet F=0.2, P=0.69, Week F=0.6, P=0.65, 
Diet:Week F=06, P=0.62; Lc FAS, Diet F=48.5***, Week F=1.4, P=0.28, 
Diet:Week F=0.8, P=0.50; Lc SCD, Diet F=126.6***, Week F=0.6, P=0.62, 
Diet:Week F=0.6, P=0.62; Lc ELOVL5, Diet F=0.2, P=0.66, Week F=0.4, 
P=0.78, Diet:Week F=0.2, P=0.92; Lc FADS2, Diet F=75.4***, Week F=0.7, 
P=0.59, Diet:Week F=0.2, P=0.91. Please refer to Table 6.3 for individual gene 
details. 
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6.4 Discussion 
The onset of essential fatty acid (EFA) deficiency on growth and feed utilisation in 
juvenile barramundi was evident after only two weeks of feeding the experimental 
diets. After eight weeks growth was clearly different among all three groups 
suggesting that a primary feature of EFA deficiency is growth potential. In addition, 
there was a significant difference in the treatment by time interaction term for growth 
performance parameters. This interaction shows a clear progression towards the 
development of EFA deficiency in the FO LOW and FO FREE fed fish. This is in 
agreement with other studies showing reduced growth when carnivorous marine fish 
were fed with high levels of FO substitution (Glencross et al., 2003b; Izquierdo et al., 
2005; Montero et al., 2005). In addition, consistent with the feed intake but with 
reduced growth, the feed conversion of FO FREE fed fish was significantly poorer. 
The ability to define a response to a nutrient relies on being able to define any 
symptoms that may occur in its absence. The defatted fish meal used in the present 
study contained trace amounts of lipid and LC-PUFA. However, the inclusion of 
15% defatted fish meal was based on previous recommendations to achieve what is 
considered normal growth for this species (Glencross et al., 2011b; Glencross and 
Bermudes, 2012).  
Early studies with barramundi demonstrated that decreased dietary lipid is 
associated with reduced growth and in some cases EFA deficiency was inferred 
(Buranapanidgit and Boonyaratpalin, 1988; Catacutan and Coloso, 1995; Williams et 
al., 2003; Williams et al., 2006). In the present study, the macro nutrient levels were 
kept constant as barramundi, like most other species, have an interdependent demand 
for energy and specific nutrients (Glencross, 2006). The total lipid level was 
formulated to be lower than the known optimal requirement (>14%) for fish of this 
size (<100 g) so that in this experimental design the lipid would theoretically be 
limiting and therefore cause the supply of this nutrient (and vagaries in its 
composition) to be the point of sensitivity in the study (Glencross, 2006). Therefore, 
the differences in the present study are directly attributable to the fatty acid profile of 
the diets, resulting in EFA deficiency.  
In the present study, the digestibility of total lipid was lowest in the FO FREE 
fed fish consistent with other studies investigating FO replacement (Caballero et al., 
2002; Ng et al., 2004; Torstensen et al., 2000). The apparent digestibility of specific 
fatty acids was not greatly modified by the dietary treatments with the exception of 
the saturated fatty acids. In the study of Olsen et al. (1998), 18:0 was reported to be 
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less digestible than other saturates such as 16:0 and 14:0 and in agreement, the 
reduction of total lipid digestibility of the present study is likely to be caused by the 
18:0 composition of the feeds. Several studies have concluded that changes in lipid 
or fatty acid digestibility can result in reduced growth (Hansen et al., 2008; 
Karalazos et al., 2011; Menoyo et al., 2007) whereas others have found no such 
effect (Caballero et al., 2002; Torstensen et al., 2000). The whole-body and liver 
fatty acid profiles in the present study showed some clear differences in terms of 
their composition; however, the tissue composition largely resembled that of the fed 
diet, also consistent with other studies (Glencross et al., 2014b; Pratoomyot et al., 
2008; Turchini et al., 2011b). A caveat of the present study was that the initial EFA 
composition of the fish was reflective of the commercial diet fed prior to 
experimentation. There was a slight reduction of total SFA in the whole body and a 
lack of any change in the liver, despite the different digestibility values and growth. 
Moreover, the LC-PUFA composition of the tissues in the FO FREE fed fish was 
almost entirely depleted after eight weeks suggesting that the reduced digestibility of 
total SFA had no bearing on the overall composition of the fish.  
Examination of the mass-balance relationship of dietary nutrients or indeed 
specific fatty acids in the tissues was used to reveal discrete differences in their 
utilisation. Improved protein retention and consequently weight gain was evident in 
the control group, consistent with previous studies on barramundi (Williams et al., 
2006). The disproportionately low lipid and energy retention of the FO LOW and FO 
FREE fed fish is a response to the diets without adequate LC-PUFA. The FO CTRL 
fed fish, selectively retained more of the dietary SFA, MUFA and PUFA than the 
other fish, however, LC-PUFA were catabolised when in surplus to optimal tissue 
concentration, similar to observations from other carnivorous species such as 
Atlantic salmon, European sea bass, Murray cod and rainbow trout (Eroldogan et al., 
2013; Stubhaug et al., 2007; Turchini and Francis, 2009; Turchini et al., 2011b).  
The aetiology of deficiency was less apparent in the FO LOW fed fish. The 
total LC-PUFA concentration in the FO LOW diet with 1% added FO was equivalent 
to 4.3 g/kg of the diet compared to 25.6 g/kg in the control diet. Currently available 
requirement data for barramundi suggest that an adequate dietary LC-PUFA supply 
should be at least 12 g/kg in growing barramundi (Williams et al., 2006). In 
agreement, Glencross and Rutherford (2011) reasoned that provided EFA are kept in 
balance the total LC-PUFA requirement could be further revised. Despite the very 
low inclusion of LC-PUFA (FO LOW and FO FREE diets) there were no apparent 
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effects of the diets on survival or behavioural changes. However, a range of physical 
abnormalities were observed in the FO FREE fed fish including; erosion of the fins, 
reddening of the fins and extremities, gross lesions and physical deformities, 
symptoms which are associated with EFA deficiency in fish (Castell et al., 1972). 
This observation suggests that even at very low inclusion levels of FO there was a 
marked improvement in the physical health of fish despite the reduced growth. 
Moreover, the whole-body composition data suggest that the FO LOW fed fish 
maintained a proportion of LC-PUFA similar to that of the initial fish fed a 
commercially available diet. Therefore in support of the previous studies on this 
species, we too support that LC-PUFA supply should be at least 12 g/kg in growing 
barramundi. 
A range of plasma biochemical markers were used in the assessment of EFA 
deficiency over the eight week time course. The results suggest that only minor 
changes occurred and mostly on a temporal basis. There were no significant diet or 
interaction effects observed for the enzyme markers creatine kinase (CK), alanine 
transferase (ALT) or glutamate dehydrogenase (GLDH). Elevated ALT and GLDH 
activity is considered a reliable marker of liver cell necrosis that can be characterised 
by the depletion of hepatic LC-PUFA stores (Morton et al., 2014; Van Waes and 
Lieber, 1977; Videla et al., 2004). However, in support of previous work with the 
same species, CK, ALT and GLDH levels in the present study were not affected by 
the lipid composition of the diets (Glencross and Rutherford, 2011). In the 
identification of underlying organ failure or disease there can be a concomitant 
change in concentration of circulating urea, calcium, magnesium, phosphate and 
albumin (Hjelte et al., 1990). However, in the present study these markers only 
differed significantly on a temporal basis, generally increasing after week two. It 
could be argued that the general increase in the markers is due to an adaptation to the 
experimental diets rather than a treatment effect.  
In the present study, there was a marked decrease in plasma cholesterol levels 
in the FO LOW and FREE fed fish after only two weeks of feeding the experimental 
diets. Increasing DHA alone in barramundi did not result in any change in plasma 
cholesterol (Morton et al., 2014). While the replacement of FO with vegetable oil in 
Atlantic salmon diets led to hypocholesterolemia (Glencross et al., 2014b; Richard et 
al., 2006). In light of these findings, it is likely that cholesterol derived from FO is 
beneficial in fish, including the barramundi, as it can potentially modulate energy 
expenditure and FA metabolic pathways (Norambuena et al., 2013a). 
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Consistent with other studies, nutritionally regulated gene expression in the 
FO CTRL fed fish appear to follow a normal progression of desaturation and 
elongation of FA to their longer chain and less-saturated derivatives (Mohd-Yusof et 
al., 2010; Tu et al., 2013; Wade et al., 2014). Transcription of ATP citrate lyase (Lc 
ACYL) produces acetyl-CoA which is a substrate for many biosynthetic pathways 
including lipogenesis and in the present study Lc ACYL was up-regulated in the EFA 
deficient fish (Dias et al., 1998). There was no significant effect in the expression of 
elongation (Lc ELOVL5) or carnitine palmitoyltransferase (Lc CPT1α); however, 
there was a tendency towards higher expression in the FO FREE fed fish. CPT1α is 
considered a key enzyme in the regulation of mitochondrial oxidation and in the 
present study CPT1α was down regulated in both treatments compared to the initial 
fish (Torstensen et al., 2000). This effect is likely to be caused by the low lipid levels 
of all three diets, a strategy that was intended to highlight the potential effects of 
EFA deficiency. This study also found that desaturase enzymes (Lc SCD and Lc 
FADS2) in barramundi were significantly up-regulated in fish fed the FO FREE diet. 
This is in agreement with other studies, on a range of species, showing an up-
regulation of desaturase enzymes (including both SCD and FADS2) in response to 
reduced FO (Alhazzaa et al., 2011b; Betancor et al., 2014; González-Rovira et al., 
2009; Tocher et al., 2006a). Fatty acid synthase (Lc FAS) expression in the present 
study was also significantly up-regulated in fish fed the FO FREE diet. Although the 
FAS enzyme system has rarely been investigated in fish in response to FO 
replacement, it is an important step in the initial synthesis of palmitate from acetyl-
CoA.  
 
  
141 | P a g e  
7.0 Eicosapentaenoic acid, arachidonic acid and eicosanoid 
metabolism in juvenile barramundi Lates calcarifer 
 
 
 
 
 
 
Adapted from 
Salini, M.J., Wade, N.M., Araújo, B.C., Turchini, G.M., Glencross, B.D., 2016. 
Eicosapentaenoic acid, arachidonic acid and eicosanoid metabolism in juvenile 
barramundi Lates calcarifer. Lipids. 51(8), 973-988  
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7.1 Aims 
The present study hypothesised that increasing the dietary inclusion level of EPA or 
ARA independently may lead to improvements in growth performance, feed 
conversion and also the utilisation efficiency of supplied EPA and ARA. Therefore, a 
two part, dose-response experimental design was used to determine the effect of 
increasing the dietary EPA or ARA. To achieve this, commercial preparations of an 
EPA rich fish oil and an ARA rich fungal oil were incrementally added to a series of 
barramundi diets. It was also hypothesised that high levels of ARA may alter the 
transcription of nutritionally inducible genes involved in eicosanoid synthesis. The 
genes regulating eicosanoid synthesis have not been identified in barramundi, and no 
information is available on their nutritional regulation. 
7.2 Materials and methods 
The methodology used in the present experiment are detailed in the section 2.0 
General methodology. Ethical clearance was approved for the experimental 
procedures by the CSIRO Animal Ethics Committee (Application A05/2014). The 
chemical composition of the main dietary ingredients is presented in Table 7.1. The 
formulation and chemical composition of the ten diets are presented in Table 7.2. 
The pairs of degenerate primers that were subsequently synthesised by Sigma-
Aldrich are presented in Table 7.3. The real-time PCR primers specific to each target 
gene are presented in Table 7.4. 
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7.3 Results 
7.3.1 Growth performance and feed utilisation 
The results of the 42 d growth assay demonstrated that the barramundi responded 
well to the experimental diets in both experiments exceeding over 400% of their 
original weight at a rate of more than 1 g/d. The growth parameters for each 
experiment were analysed separately using polynomial contrasts (Table 7.4 and 7.5). 
When the fish were fed increasing EPA there were no significant contrasts in any of 
the growth parameters (Table 7.4). Similarly, the barramundi did not show any 
significant contrasts in response to the increasing ARA in the second experiment 
(Table 7.5). The only exception being a slight improvement in feed conversion with 
the addition of ARA, however, the numerical differences were minor. Survival was 
similar among all of the treatments. Several moribund fish were removed from the 
system after a weight check at day 28. These fish were considered non-contributing 
as they had not consumed any feed. Additionally, the growth performance of the fish 
fed different EPA and ARA treatments were compared by one-way ANOVA against 
the control. There were no significant differences in any of the growth parameters 
measured (data not reported).  
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7.3.2 Digestibility analysis of the diets 
While no differences were recorded in the digestibility of dry matter, protein or 
energy across the treatments, the digestibility of lipid was significantly higher in the 
control (FO CTRL) fed fish compared to the EPA 1, EPA 10 and ARA 1 fed fish 
(Table 7.6). There was significantly higher digestibility of 18:0 in the EPA 1 fish 
compared to the EPA 10, EPA 20 and ARA 18 fish. The digestibility of 18:1 was 
significantly higher in the EPA 10, EPA 20 and ARA 18 fish compared to the FO 
CTRL fish. Similarly there was a significantly higher digestibility of 18:2n-6 in the 
EPA 20 fish compared to the FO CTRL fish. EPA digestibility was significantly 
higher in the EPA 20 fish compared to the ARA 1 and FO CTRL fish. The combined 
SFA digestibility was significantly highest in the EPA 1 fish compared to the EPA 
20 and ARA 18 fish. There was a significantly higher digestibility of MUFA in the 
ARA 20 fish compared to the FO CTRL fish. C18PUFA digestibility was 
significantly highest in the EPA 1 and EPA 20 compared to the FO CTRL fish. The 
digestibility of LC-PUFA was significantly highest in the EPA 1, EPA 10 and EPA 
20 fish compared to the ARA 1 fish. 
7.3.3 Whole-body composition.  
When compared against the control (FO CTRL), there were significant differences in 
whole body composition for many parameters (Table 7.7). Whole body dry matter 
was significantly higher in the EPA 20 and FO CTRL fish compared to the EPA 1 
fish. The lipid composition was significantly higher in the FO CTRL fish compared 
to all the other fish groups with the only exception being the ARA 18 fish. While the 
energy composition was lowest in the EPA 1 fish compared to all the other fish 
groups with the only exception being the ARA 1 fish. There was a significantly 
higher 16:0 composition in the FO CTRL fish compared to the EPA 10 and EPA 20 
while the ARA 18 fish had the lowest 16:0 composition. The 18:0 composition was 
significantly higher in the EPA 1, EPA 10 and ARA 18 fish compared to the EPA 20 
fish. The 18:1 composition was significantly highest in the EPA 1 and ARA 1 fish 
followed by the EPA 10 fish then followed by the EPA 20 and ARA 18 fish, with the 
lowest value recorded in the FO CTRL fish. As expected, there was a significant 
elevation of ARA (20:4n-6) in the ARA 18 fed fish. Similarly, the EPA (20:5n-3) 
composition was significantly increased with increasing dietary EPA while the FO 
CTRL fish had a significantly higher composition of EPA than the ARA 1 and ARA 
18 fish. The DHA (22:6n-3) body composition was significantly highest in the FO 
154 | P a g e  
CTRL fed fish. There was also a significant increase in the EPA/ARA ratio in the 
EPA fed fish with the EPA 10 equivalent to the FO CTRL fish, while there was a 
significant decrease in the EPA/ARA ratio from the ARA 1 and ARA 18 fish.  
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7.3.4 Fatty acid retention efficiency 
The retention efficiency of each fatty acid in the control fed fish (FO CTRL) did not 
differ from the fish fed either increasing EPA or ARA (Fig. 7.1a-j). There was a 
concave quadratic effect of increasing EPA, rising to a plateau at 94.9% retention of 
20:4n-6 (Fig. 7.1c; Table 7.8). There was a convex quadratic effect of increasing 
ARA, falling to a nadir at 68.8% on the retention efficiency of 20:4n-6 (Fig. 7.1h; 
Table 7.8). There was a significant quadratic effect on 20:5n-3 retention in response 
to increasing dietary EPA diets with values ranging between 55.6 to 71.2%; whereas 
increasing ARA had no effect on 20:5n-3 retention (Fig.7.1d, i; Table 7.8). Retention 
efficiency of 22:6n-3 was not affected by increasing dietary EPA with values ranging 
between 78.3 to 88.4%; however, there was a significant quadratic effect in response 
to increasing dietary ARA with values ranging between 83.8 to 109.3% (Fig. 7.1e, j; 
Table 7.8).  
7.3.5 Marginal utilisation efficiencies 
The marginal utilisation efficiencies are presented for both EPA and ARA fed fish 
(Fig. 7.2a, 7.2b respectively). Based on the linear assessment of marginal EPA intake 
against marginal EPA gained, a significant difference was observed (P<0.01). The 
positive y intercept value indicates that no maintenance demand could be established 
for 20:5n-3. Using the live-weight exponent value of 0.687 the EPA fed fish had a 
20:5n-3 utilisation efficiency of 62.1% described by the linear equation of y = 0.621x 
+ 0.0003, R2 = 0.975 (Fig. 7.2a). Similarly, there was a significant linear relationship 
of marginal ARA intake against marginal ARA gain (P < 0.05). The negative y 
intercept value suggests that a maintenance value of around 0.012 g/kg0.796/d could 
be determined for 20:4n-6. Using the live-weight exponent of 0.796 the ARA fed fish 
had a 20:4n-6 utilisation efficiency of 91.9% described by the linear equation of y = 
0.919x – 0.011, R2 = 0.965 (Fig. 7.2b). A summary of the maintenance demand and 
utilisation efficiencies is presented in Table 7.9. 
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Figure 7. 1 Specific fatty acid retention efficiency by barramundi fed increasing 
EPA (a-e) or ARA (f-j). The control (FO CTRL) fed fish are represented in each 
Figure with a triangle (∆). Bars indicate standard error means (n=3). 
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Table 7. 8 Retention efficiency of selected fatty acids in barramundi fed either 
increasing EPA or ARA analysed by polynomial contrasts. 
  EPA Polynomial contrasts ^ ARA Polynomial contrasts ^ 
  Linear Quadratic Cubic Linear Quadratic Cubic 
18:2n-6 retention 0.000 0.242 0.006 0.000 0.660 0.001 
18:3n-3 retention 0.020 0.989 0.104 0.001 0.094 0.001 
20:4n-6 retention 0.057 0.006 0.209 0.911 0.000 0.178 
20:5n-3 retention 0.167 0.047 0.165 0.303 0.339 0.682 
22:6n-3 retention 0.965 0.201 0.061 0.004 0.006 0.180 
^ Degrees of freedom EPA 4, 10; ARA 3, 8; linear, quadratic and cubic values are P 
values at an alpha level of 0.05 
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Figure 7. 2 Marginal utilisation efficiency assessments of 20:5n-3 (a) and 20:4n-
6 (b) gain with varying intake by juvenile barramundi. Efficiency functions are 
described by the linear regression for 20:5n-3 gain y = 0.621x + 0.0003, R2 = 
0.975 and 20:4n-6 gain y = 0.919x - 0.011, R2 = 0.965). 
  
0.00
0.02
0.04
0.06
0.08
0.10
0.12
0.00 0.05 0.10 0.15 0.20
M
ar
gi
na
l 2
0:
5n
-3
 g
ai
n 
(g
/k
g0
.6
87
/d
)
Marginal 20:5n-3 intake (g/kg0.687/d)
(a)
0.00
0.05
0.10
0.15
0.20
0.25
0.00 0.05 0.10 0.15 0.20 0.25
M
ar
gi
na
l 2
0:
4n
-6
 g
ai
n 
(g
/k
g0
.7
96
/d
)
Marginal 20:4n-6 intake (g/kg0.796/d)
(b)
161 | P a g e  
Table 7. 9 Summary of maintenance demand and utilisation efficiencies by 
barramundi fed either increasing EPA or ARA. 
 
Maintenance 
demand (g/kg 
LWx/t) 
Efficiency 
constant k 
Intake:Gain  
ratio R
2 P value 
20:5n-3; 
EPA 0.000 0.621 1.610 0.975 <0.01 
20:4n-6; 
ARA 0.011 0.919 1.088 0.966 <0.05 
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7.3.6 Gene identification and quantitative expression 
Partial cDNA sequences of Lc COX1a, Lc COX1b, Lc COX2 and Lc ALOX-5 were 
identified through degenerate PCR. BLAST similarity searches showed that 
barramundi gene orthologs shared between 88 and 91% similarity with other teleost 
fish at the amino acid level, and protein alignments showed similarity with other 
teleost fish (Supplementary Figure 1a-d). The expression of eicosanoid pathway 
genes (Lc COX1a, Lc COX1b, Lc COX2 and Lc ALOX-5), as well as the 
mitochondrial ß-oxidation gene (Lc CPT1a) were analysed by quantitative real-time 
RT-PCR in the liver and kidney of fish fed the highest and lowest EPA and ARA 
diets and compared with the control fed fish.  
The expression of Lc COX1b was significantly upregulated in the liver of the 
EPA 1 fed fish compared the EPA 20 fed fish. (Fig. 7.3a). No other genes were 
nutritionally regulated in the liver or kidney tissue of fish fed increasing EPA. In the 
case of the ARA fed fish, the expression of Lc COX2 was significantly upregulated in 
the liver of the ARA 20 fish compared to the ARA 1 fish (Fig. 7.4a). Similarly, the 
expression of Lc ALOX-5 in the liver was significantly upregulated in the ARA 20 fish 
compared to the ARA 1 fish (Fig. 7.4a). There was a significant down regulation of 
the Lc COX1b in the kidney of the ARA 1 fish compared to the ARA 20 fish. The 
expression of Lc COX2 was significantly upregulated in the kidney of the ARA 18 fish 
compared to the ARA 1 fish. The Lc CPT1a expression in the kidney tissue was 
significantly downregulated in the ARA 1 compared to the ARA 18 fish (Fig. 7.4b). 
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Figure 7. 3 Eicosanoid pathway and mitochondrial fatty acid oxidation gene 
expression in the liver (a) and kidney (b) of juvenile barramundi fed increasing 
EPA. Gene expression is normalised to the EF1α and Luc reference genes and 
expressed relative to the control fish. Data were analysed by students t-test with 
significant differences defined as P<0.05. 
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Figure 7. 4 Eicosanoid pathway and mitochondrial fatty acid oxidation gene 
expression in the liver (a) and kidney (b) of juvenile barramundi fed increasing 
ARA. Gene expression is normalised to the EF1α and Luc reference genes and 
expressed relative to the control fish. Data were analysed by students t-test with 
significant differences defined as P<0.05.  
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7.4 Discussion 
The growth performance of juvenile barramundi in the present study, using a pair-fed 
feeding regime, was not affected by increasing dietary EPA or ARA content. 
Moreover, there were no significant differences in growth performance compared to 
a control diet containing only fish oil. Although it is an unlikely real-world scenario 
to include high levels of any one LC-PUFA, these observations and those of a 
previous study (Glencross and Rutherford, 2011), confirm that there are no growth 
stimulatory effects owing to any individual LC-PUFA in juvenile barramundi . In 
many species, EPA can exert cardio-protective benefits such as lowering 
triglycerides and low-density lipoprotein levels (Aarsland et al., 1990; Cottin et al., 
2011). Whereas ARA on the other hand, is an essential and necessary precursor to 
the 2-series and 4-series eicosanoids that mediate homeostasis during times of 
environmental or physiological stress (Bell and Sargent, 2003). 
Studies examining the dose-response of EPA in juvenile or growing fish are 
relatively scarce and mostly concentrate on larval fish requirements (Izquierdo, 
1996). Consistent with the present study, several studies in larval and juvenile fish 
such as the Atlantic salmon Salmo salar (Thomassen et al., 2012), cobia 
Rachycentron canadum (Trushenski et al., 2012), gilthead sea bream Sparus aurata 
(Atalah et al., 2011), Senegalese sole Solea senegalensis (Villalta et al., 2008), 
striped jack Pseudocaranx dentex (Watanabe et al., 1989) and turbot Scophthalmus 
maximus (Bell et al., 1995) all concluded that EPA does not stimulate an improved 
growth response. However, larval and juvenile red seabream Pagrus major were 
found to have an EPA requirement with linear improvements in growth and survival 
observed (Furuita et al., 1996; Takeuchi et al., 1990). The results of the present study 
are consistent with the general consensus that size and species differences exist and 
that an appropriate balance between these essential fatty acids is probably more 
critical than their absolute inclusion (Tocher, 2003). 
Also in agreement with the present study, a range of larval and juvenile 
marine species such as Atlantic cod Gadus morhua (Bransden et al., 2005), gilthead 
sea bream (Alves Martins et al., 2012; Atalah et al., 2011; Fountoulaki et al., 2003), 
Senegalese sole (Villalta et al., 2005) and turbot (Estévez et al., 1999), were able 
tolerate a wide range of dietary ARA levels with growth and survival found to be 
independent of ARA inclusion. Recent studies have further demonstrated that 
balanced ARA and EPA levels in the diet are more critical than either of these 
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individually in terms of growth and other metabolic processes (Norambuena et al., 
2015). 
Consistent with recent studies on juvenile barramundi held under similar 
conditions, the diets in the present study were readily digested (Salini et al., 2015c). 
There was a significant reduction in total lipid digestibility in the fish fed the diets 
with the lowest levels of EPA and ARA compared to the control fish however this is 
likely to be caused by the unavoidable higher SFA content of those diets. 
Interestingly, the digestibility of the total SFA appears higher in those same 
treatments as the fish attempt to cope with the changed fatty acid composition. 
Despite this, the energy digestibility remained the same and confirms that there was 
no dramatic effects caused by the different dietary strategies. Many studies, including 
the present study, have demonstrated that the fatty acid composition of the tissues is 
representative of the profile of the fed diet (Rosenlund et al., 2011). However, the 
efficiency by which fatty acids are retained may represent a more metabolic or 
biological importance to the fish. The DHA retention of the fish in the present study 
fed increasing EPA did not change. However, the EPA and ARA retention were 
inversely related and responded in a curvilinear fashion. Although the effect was not 
dramatic, it indicated a point of sensitivity as EPA in the diet increased and the 
barramundi retained more of the endogenous ARA. Glencross and Rutherford (2011) 
reported disproportionate EPA and ARA retention in barramundi; however, this was 
likely an effect of the increasing DHA level in combination with either EPA or ARA. 
Atlantic salmon were also shown to conserve ARA (Norambuena et al., 2015), 
whereas Senegalese sole attempted to synthesise ARA when dietary supply was 
limited (Norambuena et al., 2013b). 
Past work in our laboratory has suggested that the marginal efficiency of LC-
PUFA utilisation is low in growing barramundi, indicative of a higher turnover of 
these fatty acids relating to their biological importance (Salini et al., 2015a). The 
present study describes an assessment of the marginal efficiency of EPA and ARA 
on restrictively pair-fed barramundi, while simultaneously controlling for other LC-
PUFA (rather than FO substitution). Under these experimental conditions, we report 
the maintenance requirement of ARA to be 0.012 g/kg LW0.796/d, with a marginal 
efficiency value of 91.9%. Although the requirement was low, this potentially 
confirms that ARA is unusual in its characteristic metabolic requirement for this 
species compared to other LC-PUFA. EPA on the other hand is apparently not 
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required for maintenance in juvenile barramundi, suggesting that their maintenance 
demands are easily met by endogenous reserves. The differences between the 
marginal efficiency values of these studies warrant further investigation. In addition, 
the EPA retention figures were modest with a calculated intake to gain ratio of 1.6:1, 
further supporting this concept. This is consistent with other studies on barramundi 
and red sea bream in that EPA is only modestly retained unless there is a gross 
imbalance of other LC-PUFA (Glencross et al., 2003c; Glencross and Rutherford, 
2011).  
There is a very large body of research into the mechanisms of action of n-3 
LC-PUFA on inflammatory pathways (Rangel-Huerta et al., 2012). The data from 
the present study take the first steps in our understanding in barramundi by 
identifying the key eicosanoid pathway enzymes and quantifying their nutritional 
regulation. The current work verifies that barramundi possess at least two variants of 
the cyclooxygenase 1 enzyme (Lc COX1a, Lc COX1b), a single cyclooxygenase 2 
(Lc COX2) and an arachidonate 5-lipoxygenase (Lc ALOX-5). The fish in the present 
study were not exposed to any form of physical or environmental stressors (apart 
from being in research aquaria) that could cause an inflammatory response and 
therefore the only trigger for a response is of a nutritional nature.  
The present study demonstrated that either a high or low inclusion of EPA did 
not modify the expression of any eicosanoid pathway gene in either the liver or the 
kidney tissue. However, the only exception to this was the increased expression of Lc 
COX1b in the liver of the EPA 1 fed fish. Conversely, there was a significant 
downregulation of this gene in the kidney tissue of the ARA 1 fed fish. COX1 
isoforms are widely distributed and generally constitutively expressed, however this 
homeostatic function is now considered to be an oversimplified view (Rouzer and 
Marnett, 2009). In agreement with the present study, there were non-significant (P = 
0.06) yet quite measurable differences in COX1b expression in larval tongue sole 
(Cynoglossus semilaevis) fed increasing ARA (Yuan et al., 2015). Further supporting 
this notion, there was a nutritionally induced upregulation of COX1 and COX2 
expression in rat mammory gland tissue by n-6 rich safflower oil (Badawi et al., 
1998). The results of the present study confirm that the Lc COX1b gene in 
barramundi is inducible and the differences warrant further investigation into the 
potential for pathophysiological effects. Some explanation for these inconsistencies 
may be found in whole-body composition of wild barramundi collected from 
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different environments (Nichols et al., 2014; Sinclair et al., 1983). These authors 
found that Northern Australian barramundi, maintain a characteristically high ARA 
content regardless of their environment. Therefore, it is suggested that barramundi 
can modify the transcription of these genes depending on the potentially transient 
nature of dietary ARA supply.  
The EPA derived or anti-inflammatory eicosanoids are known to be 
correlated with changes in transcription of fatty acid synthesis and β-oxidation genes 
(Aarsland et al., 1990; Sijben and Calder, 2007) . However, the Lc CPT1α expression 
in the present study was not affected by the inclusion level of either EPA or ARA, 
with the exception of a slight decrease in the kidney tissue of the ARA 1 fish. This 
may suggest that some other characteristic, perhaps of the fish oil base used in the 
control diet caused this response. Additionally, Lc ALOX-5 expression was 
upregulated in the liver tissue of the ARA 18 fish consistent with a modified 
metabolic function. In a recent study, changes in ALOX-5 were also observed in 
marine fish larvae in response to increasing dietary ARA (Yuan et al., 2015). In 
contrast to the present study, these authors reported improved growth of larvae, 
despite the potential for excessive generation of pro-inflammatory leukotrienes and 
lipoxins (Rowley et al., 1995). 
Past studies have demonstrated that nutritionally inducible COX2 genes exist 
in several teleost species (Montero et al., 2015a; Yuan et al., 2015; Zuo et al., 2015). 
The role of Lc COX2 as an active and rapidly inducible gene has undoubtedly played 
a role in the modified metabolic function of the ARA fed fish during the present 
study. The Lc COX2 expression was significantly increased in both liver and kidney 
tissues suggesting that the highest inclusion of ARA was excessive or that the EPA 
to ARA ratio was unbalanced. 
To conclude, the present study supports that there is no phenotypic response 
by barramundi to the addition of either EPA or ARA to the diets. However, there are 
some metabolic changes to the retention and marginal utilisation efficiencies as a 
result of the diets. Increasing the dietary EPA or ARA level also modulated the 
expression of several eicosanoid metabolism and fatty acid oxidation genes. Further 
studies should focus on the most appropriate balance of dietary LC-PUFA in light of 
the current levels of fish oil substitution in aquafeeds. Further refinements could also 
be made to factorial growth and feed utilisation models for barramundi with respect 
to specific fatty acids and their marginal utilisation efficiencies.  
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8.0 Defining the allometric relationship between size and nutrient 
turnover in barramundi Lates calcarifer 
 
 
 
 
 
 
Adapted from 
Salini, M.J., Poppi, D.A., Turchini, G.M., Glencross, B.D., 2016. Defining the 
allometric relationship between size and nutrient turnover in barramundi Lates 
calcarifer. Comp. Biochem. Physiol. Part A. 201, 79-86   
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8.1 Aims 
Bioenergetic modelling of the nutrient flows in barramundi has been extensively 
researched and ‘user friendly’ simulation programs are used routinely (Glencross, 
2008; Glencross and Bermudes, 2010; 2011; 2012). One of the key assumptions and 
constraints in the application of these models is that the live-weight (LW) exponent 
values are constant. Studies have shown with barramundi, over a range of normal 
temperatures, that this is generally the case for the energy, protein and lipid 
exponents (Glencross and Bermudes, 2011). However, it is assumed that when 
broken down into constituent fatty acids the body weight exponents are also 
equivalent to that of the lipid as a complete nutrient.  
A further refinement of those factorial bioenergetic models could include 
consideration of the individual fatty acids and potentially amino acids in order to 
better understand their utilisation in terms of productivity on a size independent 
basis. Therefore, the aim of the present study was to determine the allometric scaling 
effect of individual fatty acids in barramundi for use in future bioenergetic studies. In 
addition, a re-evaluation of previously published data is used to refine the fatty acid 
demands for maintenance and growth of barramundi using in silico predictive 
modelling. 
8.2 Materials and methods 
The methodology used in the present experiment are detailed in the section 2.0 
General methodology. Ethical clearance was approved for the experimental 
procedures by the CSIRO Animal Ethics Committee (Application A3/2015).  
8.3 Results 
8.3.1 Fish compositional changes 
The initial and final weights of the fish are presented in Table 8.1. In all size groups 
of fish weight loss was between 12.9% for the smallest fish to 5.3% for the largest 
fish. The condition factor was also lower in the fish after fasting. No fish died during 
the experiment. The initial and final chemical composition of the fish were analysed 
and reported in Table 8.1. The energy density of the barramundi of varying size 
before and after fasting was best fitted to a power function with high R2 values of 
0.845 and 0.844 respectively (Fig. 8.1). There was a decrease in the energy density of 
the fasted fish (Fig. 8.1). The lipid density of the barramundi was best fitted to a 
logarithmic function with initial and final R2 values of 0.711 and 0.744 respectively 
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(Fig. 8.2). The logarithmic response after fasting appears to be driven by Treatment 
F.  
The individual fatty acid density of barramundi for each of the treatment size classes 
is presented in Table 8.2 and the LC-PUFA density is plotted in Fig. 8.3. There was a 
general increase in the fatty acid density with increasing size, concomitant with the 
lipid composition of the fish (Table 8.1). The response after fasting was best fitted to 
a logarithmic function that appears to be driven by the lipid content of Treatment F. 
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Figure 8. 1 Energy density of barramundi of varying live-weight before 
(●=4.221(±0.010)x0.088(±0.001), R2 = 0.845) and after 
(○=3.359(±0.011)x0.118(±0.001), R2 = 0.844) fasting for 21 days. 
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Figure 8. 2 Lipid density of the barramundi of varying live-weight before 
(●=0.807(±0.019)ln(x) + 2.312(±0.002), R2 = 0.711) and after 
(○=0.981(±0.014)ln(x) – 0.083(±0.003), R2 = 0.744) fasting for 21 days. 
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Figure 8. 3 Fatty acid density (mg/g lipid) in barramundi of varying live-weight 
after fasting for 21 days. Values were fitted to a logarithmic curve and 
equations are presented in Table 8.2. 
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8.3.2 Determination of metabolic live-weight exponents 
Somatic losses of energy, lipid and individual fatty acids were well described by the 
function a*Xb (Table 8.3). A bootstrapping approach was used to generate 
replications of coefficient (slope) and exponent values of energy, lipid and fatty acid 
loss. An energy live-weight (LW) exponent of 0.817 was derived based on energy 
losses after fasting and the equation is presented in Eqn. 8.1. Similarly, a lipid loss 
LW exponent of 0.895 was derived based on lipid loss after fasting and the equation 
is presented in Eqn. 8.2. The relationships between fatty acid losses and the 
geometric mean weight over the range of sizes in the present study are presented in 
Fig. 8.4 (A and B). 
Energy loss (kJ/fish/day) = 0.104(±0.003)*(Live-weight) 0.817(±0.010), R2 = 0.949 (8.1) 
Lipid loss (g/fish/day) = 0.002(±0.000)*(Live-weight) 0.895(±0.007), R2 = 0.985 (8.2) 
There was a significant difference in the derived LW exponent values for specific 
fatty acids confirming that they are for the most part, different from that of the total 
lipid (LW0.895). However, there was no difference in the exponent values of 16:0 and 
18:3n-3 and 18:0 and 20:4n-6 (ARA) (Table 8.3). The LW exponent values for 
22:6n-3 (DHA), 22:5n-3 (DPA) and 20:5n-3 (EPA), 0.792, 0.748 and 0.687 
respectively, were all significantly lower than that of lipid while 18:1n-9 was higher 
at 0.954 (Table 8.3). The weighted exponent values were calculated and the sum of 
all fatty acids presented was equal to 0.854 ± 0.033 (Table 8.3; sum not presented) 
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Table 8. 3 Coefficient and exponent values derived from the power function 
(y=aXb) of fatty acid loss over a wide range of fish sizes from ~10 g to ~440 g. 
Replication was derived by manually bootstrapping each individual value and 
presented as mean ± SEM (n=18). 
 Coefficient (a) 
Exponent 
(b) R
2 Weighted  Exponent* 
Energy 0.104 ± 0.003 0.817 ± 0.010 0.949 NA 
Lipid 0.002 ± 0.000 0.895 ± 0.007a 0.985 NA 
16:0 0.346 ± 0.010 0.890 ± 0.024a 0.992 0.208 ± 0.012 
18:0 0.107 ± 0.003 0.876 ± 0.010b 0.991 0.061 ± 0.004 
18:1n-9 0.399 ± 0.011 0.954 ± 0.008c 0.992 0.350 ± 0.007 
18:2n-6 0.182 ± 0.005 0.915 ± 0.009d 0.992 0.120 ± 0.003 
18:3n-3 0.026 ± 0.001 0.899 ± 0.007a 0.991 0.013 ± 0.000 
ARA 0.012 ± 0.000 0.796 ± 0.007b 0.942 0.009 ± 0.001 
EPA 0.114 ± 0.002 0.687 ± 0.005e 0.990 0.021 ± 0.001 
DPA 0.038 ± 0.001 0.748 ± 0.008f 0.985 0.015 ± 0.001 
DHA 0.138 ± 0.003 0.792 ± 0.006g 0.990 0.058 ± 0.004 
P value NA <2.2-16 NA NA 
NA, not analysed. Superscript letters indicate significant differences. 
* Calculated as geometric mean weight of each fatty acid x exponent (b). 
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8.3.3 Metabolic demands for fatty acids 
A re-evaluation of the marginal utilisation efficiencies of individual fatty acids using 
the fatty acid LW exponents derived from the present experiment is presented in 
Table 8.4. This re-evaluation was performed on data from three separate experiments 
(Glencross and Rutherford, 2011; Salini et al., 2015a; Salini et al., 2016). The linear 
equations of the marginal intake to marginal gain ratio were extrapolated to zero (0 = 
b(x) + a) in order to obtain estimated maintenance requirement values. In the first 
experiment, the LC-PUFA all produced negative requirement values whereas all 
other shorter-chain length and more saturated fatty acids have a determined 
requirement. In the subsequent studies, the marginal utilisation efficiencies for ARA, 
EPA and DHA were higher, contrasting those of the first study. There was no 
requirement value established for EPA and DHA, however, there was a maintenance 
requirement of 0.012 g/kg0.880/d determined for ARA. 
Iteratively determined fatty acid maintenance, fatty acid gain, fatty acid for growth 
and total requirements are presented in Table 8.5. For each of the size classes the 
values are presented for barramundi fed either 100% fish oil or 100% poultry oil 
diets adapted from Salini et al. (2015a). 
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Table 8. 4 Re-evaluation of the marginal efficiency of fatty acid utilisation in 
barramundi. Data were transformed to LW exponent values determined from 
the present study. Maintenance requirements and intake to gain ratio for each 
fatty acid are presented 
Fatty acid Slope Intercept R2 Req# 1/k* 
Salini et al., (2015a) 
16:0 2.258 -0.536 0.712 0.237 0.443 
18:0 1.539 -0.068 0.837 0.044 0.650 
18:1 1.111 -0.178 0.951 0.161 0.900 
18:2n-6 0.821 -0.025 0.751 0.031 1.218 
18:3n-3 1.040 -0.010 0.881 0.010 0.962 
ARA 0.192 0.005 0.427 -0.025 5.222 
EPA 0.305 0.005 0.953 -0.017 3.279 
DPA 0.340 0.008 0.783 -0.023 2.943 
DHA 0.271 0.014 0.952 -0.050 3.693 
Salini et al., (2016) 
ARA 0.919 -0.011 0.965 0.012 1.088 
EPA 0.621 0.000 0.975 -0.000 1.610 
Glencross and Rutherford, (2011) 
DHA 1.065 0.046 0.961 -0.043 0.939 
# Maintenance requirement (g/kgx/d) determined by extrapolation to 0 = b (x) + a. 
* Intake to gain ratio. 
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Figure 8. 4 Fatty acid (A and B) loss in fasted barramundi of varying live-
weight. Data are (n=3) mean ± SEM. Values were fitted to a power function and 
equations are presented in Table 8.3. 
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8.4 Discussion 
One of the key assumptions of nutritional modelling is that the allometric scaling 
exponent values for biological variables ascribed to transform live-weight (LW) are 
constant (Glencross and Bermudes, 2011; Lupatsch et al., 2003). In reality, exponent 
values for the metabolic LW for energy in aquatic species usually fit around an 
average value of 0.80, which has been adopted and used routinely (Bureau et al., 
2002; Cho and Kaushik, 1990; Cui and Liu, 1990; Lupatsch et al., 2003; NRC, 
2011). Similarly for protein, a range of LW exponents have been used to describe the 
allometric relationship and the value of 0.70 is routinely used under normal 
physiological conditions (Lupatsch et al., 1998; Pirozzi et al., 2010). Arguably the 
average of the weighted LW exponents for lipid and protein energy should be equal 
to that of gross energy, therefore 0.90 can be ascribed to LW exponent of lipid 
(Glencross and Bermudes, 2011). The development of predictive models of energy 
transactions that also consider the individual compounds of nutrients rather than 
aggregates of energy would help in understanding the discrete biochemical 
relationships that exist and some attempts at compartmentalising these have been 
made in monogastric animals (Birkett and Lange, 2007). However, these are not 
common in the literature or in practice for aquatic species. The present study 
therefore investigated the allometric scaling effect of individual fatty acids in 
barramundi held at a constant temperature.  
In the present study, the assessment of somatic energy before and after fasting was 
highly consistent with the study of Glencross and Bermudes (2011). This suggests 
that over the variable size range of fish used in the present study and held at an 
optimal temperature, fasting losses are quite predictable, further validating the 
methodology to be extended to individual fatty acids. One caveat of the present study 
was that the size class selection of the fish was limited to two initial shipments of 
fish that were held in stock aquaria and subsequently graded. Therefore we cannot 
conclude on what may happen outside this range or within the range if additional 
treatments were available. The increasing live-weight as a function of energy and 
lipid density of the fish was best fitted to power and natural logarithmic equations 
respectively. The lower than expected analytical values obtained for lipid in 
Treatment F are likely related to the nutritional status of the fish prior to the 
commencement of the study however there is no consistent explanation for this. 
Consistent with other studies, the loss of lipid was concomitant to the loss of energy, 
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confirming that lipid is preferentially metabolised under fasting conditions in order to 
retain protein (Glencross and Bermudes, 2011; Lupatsch et al., 1998). 
The somatic losses determined in the present study were best described by power 
functions, following the equation y=a*Xb, where a represents a temperature 
dependent coefficient, X is the live-weight (LW) and b the scaling exponent. An 
important finding of the present study was that the energy LW exponent value (0.817 
± 0.010) is consistent with the commonly reported value of 0.80. This is an important 
finding as previous studies have found that even slight variations in the reported 
exponent values can lead to substantially different outcomes when applied to the 
determination of maintenance energy demands (Pirozzi, 2009). The lipid exponent 
value of 0.895 ± 0.007 was also highly consistent with the values previously 
described for barramundi (Glencross and Bermudes, 2011). One caveat of the present 
study was that only a single temperature range was examined; however, it is reported 
that provided barramundi are held within their normal temperature range then the 
values should be mostly consistent (Glencross and Bermudes, 2011). 
The fatty acid allometric scaling exponent values derived in the present study were 
significantly different and ranged from 0.687 ± 0.005 for EPA to 0.954 ± 0.008 for 
18:1n-9. With the exception of ARA, all the LC-PUFA exponent values were 
significantly lower than the more dominant shorter-chain length and more saturated 
fatty acids. The individual fatty acids presented as weighted exponent values are also 
consistent with that of lipid as a complete nutrient (0.854 ± 0.033 vs. 0.895 ± 0.007 
respectively). The lower exponent values recorded for the LC-PUFA suggest that 
there is likely to be a greater turnover of these fatty acids in the juvenile fish 
indicating more specific biological demands. While the higher exponents (eg. 18:1n-
9) suggest there is less effect of size and lower biological demands for those fatty 
acids. Additionally, the LC-PUFA with lower exponent values also have marginal 
utilisation efficiencies that are considerably lower than other more dominant fatty 
acids (Salini et al., 2015a). This lends further support to the theory that they are more 
biologically important and that they are selectively retained in the tissues, 
corroborating evidence from past studies in barramundi (Glencross and Rutherford, 
2011; Salini et al., 2015c). Moreover, the significance of LC-PUFA is also be 
supported by their anti-inflammatory role in the production of eicosanoids and 
specialised pro-resolving mediators (Bannenberg and Serhan, 2010; Rowley et al., 
1995; Serhan, 2010). 
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The energy from metabolizable food in juvenile animals can only really be 
partitioned into maintenance and growth as reproductive effort is essentially zero 
(Lucas, 1996; NRC, 2011). Moreover, the concept of maintenance and growth 
demands are additive in terms of productivity (Bureau et al., 2002; Clarke and 
Fraser, 2004). A range of data pools were used in the analysis of the present study in 
order to iteratively determine the metabolic demands for specific fatty acids in 
growing barramundi. The partial (marginal) efficiency values from Salini et al. 
(2015a) were re-calculated with the newer exponent values derived in the present 
study. The LW exponent of lipid (0.90) was applied to individual fatty acids and 
acknowledged as an assumption in that earlier study. This re-calculation allowed a 
more accurate determination of maintenance fatty acid demands given the 
acknowledged impact that this transformation can have on the determination of that 
parameter (Pirozzi, 2009). We also assessed the suitability of marginal efficiency 
values for ARA, EPA and DHA determined from subsequent studies (Glencross and 
Rutherford, 2011; Salini et al., 2016). However, these values were inconsistent with 
those of Salini et al. (2015a) and not included in the final analysis (Table 5). Reasons 
for these inconsistencies are likely to be due to the large differences in the initial size 
of the fish and the feeding regime utilised. 
The results of the present study demonstrate that the different fatty acids are utilised 
with different efficiencies. However, contrary to what might be expected, the levels 
of LC-PUFA required in barramundi fed a fish oil based diet are numerically higher 
than those fed a poultry oil based diet. This apparent difference is driven largely by 
the deposition demands of individual fatty acids rather than catabolism or other 
processes. Based on the demands (requirements) for maintenance presented in Table 
8.5, we could conclude that the LC-PUFA requirements are negligible (Birkett and 
Lange, 2007). This conclusion may be more generally applied to larger growing 
barramundi however, evidence suggests that essential fatty acid requirements are 
more pronounced during the rapid growth phase of juveniles, and virtually negligible 
at larger fish sizes (Salini et al., 2015c).  
The relative contribution of the more dominant shorter-chain length and more 
saturated fatty acids for the provision of energy is clear. This corroborates with data 
recently obtained in barramundi where the monounsaturated and to a lesser extent 
saturated fatty acids ‘spared’ LC-PUFA for deposition and were preferentially 
utilised as energy sources (Salini et al., 2015b). This supports that the available lipids 
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are partitioned into either those fatty acids directed towards oxidative fates for 
generating energy or those directed towards other downstream biological purposes 
such as eicosanoid production.  
There are many potential assumptions in the application of energetic models 
(Glencross, 2008). The current allometric assessment only considers a single 
phenotypic parameter (live-weight). Not surprisingly, past reports have concluded 
that temperature plays a key role in the metabolism of ectotherms, including fish 
(Clarke and Johnston, 1999; Clarke and Fraser, 2004; Glencross and Bermudes, 
2011; Pirozzi et al., 2010). With barramundi, Glencross and Bermudes (2011) 
demonstrated that the allometric scaling over a range of temperatures did change; 
however, the response was not dramatic under normal thermal conditions for the 
species. Therefore, we assume that the effect of temperature would be minimised by 
using a constant ‘optimal’ temperature of 30 °C. 
Additionally, there are many studies investigating the metabolic rate in animals and 
these relationships with size can usually be described similarly using non-linear 
power equations or variants of these (Clarke and Johnston, 1999; White, 2011). The 
assumption in the present study is that the standard metabolic rate does not change 
under fasting conditions as this could further impact the somatic losses incurred. 
There is evidence to suggest that in fish and crustaceans, the standard metabolic rate 
is reduced by up to 50% during fasting and this is due partly to decreased protein 
synthesis (O'Connor et al., 2000; Simon et al., 2015). Without an estimation of 
oxygen consumption or another measure of standard metabolic rate, we cannot 
conclude on what might happen on a temporal basis under fasting conditions. 
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Conclusions 
The series of studies presented within this thesis explored many aspects of lipid 
metabolism in barramundi (Lates calcarifer). The experimental chapters each 
provide an appropriately referenced, comprehensive discussion section that was 
adapted from the corresponding published manuscripts. The conclusions from each 
chapter are presented below. The first experiment followed an applied approach in 
understanding the effect of diluting FO with PF in barramundi diets. This study also 
developed methodology in order to predict the fillet composition of LC-PUFA in an 
attempt to meet the minimum intake requirements proposed by the FAO for humans. 
The study demonstrated that PF can completely substitute fish oil in growing 
barramundi. There were no aberrations to fish growth performance or feed utilisation 
parameters, however, there were clear differences in the retention and marginal 
efficiencies of LC-PUFA utilisation. The fish responded to increasing PF by 
improving the retention of LC-PUFA; however, the marginal efficiency of LC-PUFA 
was relatively low, and reasons for this need to be further explored. Moreover the 
increasing use of PF had a clear impact on the fillet LC-PUFA content, which needs 
to be carefully considered in order to manage the defined impacts on meat LC-
PUFA. 
 
After establishing that the effect of poultry fat (rich in monounsaturated fatty acids) 
was minimal in growing barramundi we conducted a more comprehensive 
investigation into the effect of fatty acid class on the performance of juvenile 
barramundi. The fatty acids can be assembled into classes based on their biochemical 
structure, including the saturated fatty acids (SFA) and monounsaturated fatty acids 
(MUFA). The results demonstrated that the inclusion of a 2:1 or 1:2 ratio of SFA to 
MUFA did not lead to a reduction in growth performance of juvenile barramundi. 
However, a range of other metabolic modifications were observed. Notable was the 
LC-PUFA sparing effect of both MUFA and SFA. Additionally, SFA and MUFA 
were preferentially metabolised and deposited in the whole body and liver tissue 
proportional to their respective intake. The low digestibility of specific fatty acids 
(18:0 and 16:0) is consistent with other studies and may have an impact in the long 
term utilisation of the SFA rich diet. These results clearly indicate that consideration 
must be given to the proportion of either SFA or MUFA during diet formulation, as 
these two classes of fatty acids can influence the in vivo metabolism of fatty acids 
and the final fatty acid composition of the whole fish. 
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After consideration of the different classes of fatty acids, a subsequent study was 
designed to investigate the effect of different lipid classes, both neutral lipid and 
polar lipid (NL and PL respectively), from marine or non-marine sources. Studies 
have consistently demonstrated a range of advantages when using phospholipid-rich 
lipid sources in diets for larval and juvenile fish. In this study, we reported for the 
first time the use of phospholipid-rich krill oil (KO) and also soybean lecithin (SL) 
compared to neutral lipid sources including fish oil (FO) and soybean oil (SO). In 
support of the vast majority of studies, we demonstrated that the inclusion of either 
marine or non-marine phospholipid maintains performance of juvenile barramundi 
equivalent to a FO based control diet. An interesting result of the study was the 
differences observed between both the non-marine (omega-6 rich) diets. The fish fed 
SL avoided gross signs of EFA deficiency which was in contrast to the SO fed fish. 
However, the dietary SO affected the FCR and some sub-clinical markers indicating 
a modified metabolic function.  
 
After these preliminary studies, we concluded that barramundi of a larger size 
(~200g fish) generally tolerated diets mostly devoid of FO. In order to test whether 
this would hold true on smaller baramundi, we conducted an experiment that 
comprehensively investigated the aetiology of the onset and progression of EFA 
deficiency in juvenile barramundi. Juvenile barramundi showed signs of modified 
metabolic function and potentially signs of essential fatty acid (EFA) deficiency in 
the absence of n-3 LC-PUFA. The EFA deficient diets clearly impacted growth 
performance and feed utilisation in as little as two weeks. Discrete differences in the 
utilisation of dietary lipid and also specific fatty acids suggest that in the absence of 
EFA, signs of deficiency were evident substantiating their essentiality in juvenile 
barramundi. In addition, a range of clinical abnormalities manifested in the fish fed 
the EFA deficient diet. Transcription of genes involved in fatty acid metabolism 
consistently demonstrated that those fish receiving the EFA deficient diet were 
affected after as little as two weeks. This lends support to the hypothesis that juvenile 
barramundi have a determined requirement for EFA. The importance of developing 
and then testing an appropriate hypothesis in nutritional studies is also highlighted. 
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Following this study, a dose-response experiment was conducted in order to clarify 
the biological role of EPA and ARA in juvenile barramundi. This study builds on an 
already published assessment of the quantitative DHA requirements in barramundi 
and provides a more complete understanding of LC-PUFA metabolism and 
requirements in the species. Past studies had indicated that the effect of DHA on 
growth was negligible and our study supports this conclusion in that there was no 
phenotypic response by barramundi to the addition of either EPA or ARA to the 
diets. However, there were some modification to the retention and marginal 
utilisation efficiencies as a result of the diets. Increasing the dietary EPA or ARA 
level also modulated the expression of several eicosanoid metabolism and fatty acid 
oxidation genes. The role of Lc COX2 as an active and rapidly inducible gene has 
undoubtedly played a role in the modified metabolic function of the ARA fed fish 
during the present study. It is therefore recommended that further studies should 
focus on the most appropriate balance of dietary LC-PUFA in light of the current 
levels of fish oil substitution in aquafeeds.  
 
A bioenergetic modelling approach was used in several experiments throughout this 
thesis in order to generate an understanding of and eventually predict certain 
parameters such as LC-PUFA deposition in the tissues and fatty acid utilisation 
efficiencies. Different nutrients will almost certainly have different energetic 
efficiencies depending on many factors and therefore, we designed a final 
experiment that assessed the allometric scaling effect of specific fatty acids after 
fasting for 21 days in barramundi. The underlying assumption so far has been that the 
scaling exponent of lipid (0.90) could be applied at a nutrient level to any situation 
involving fatty acids, including the calculation of maintenance demands. The results 
of the study indicate that there are differences in the utilisation efficiencies of fatty 
acids, corroborating evidence from past studies. After re-evaluating data from three 
separate experiments, we have concluded that the biggest driver in our understanding 
of LC-PUFA metabolism in barramundi is that of deposition demand. We have also 
suggested that the metabolizable lipid can be broadly separated into that destined for 
catabolism and that which is conserved in the tissues for downstream biological 
purposes. Empirically based models should now attempt to consider the energetic 
costs associated with the lipid metabolic pathway, as this would be the logical 
progression of the current work. 
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General conclusions 
The research presented within this thesis collectively provides the reader and the 
scientific community with a coherent, up-to-date body of work that makes a 
significant contribution to the understanding of lipid metabolism and physiology in 
the barramundi (Lates calcarifer). After several decades of research and commercial 
development of the barramundi industry, there is now a greater understanding of 
their overall nutritional management. Significant advances were made in 
understanding the utilisation of alternative oils, the effect of lipid and fatty acid 
classes, essential fatty acid deficiency and long-chain polyunsaturated fatty acid 
requirements. In addition, advances were made in the bioenergetic modelling of LC-
PUFA. It is anticipated that the knowledge gained throughout this work will become 
more commercially relevant in light of the volatile global fish oil market. While there 
are potentially other avenues that could be investigated, the present work addressed 
many aspects of lipid nutrition in barramundi from an applied approach towards a 
more detailed fundamental understanding of lipid metabolism.  
 
Overall, the results presented within this thesis build on published data and several 
recommendations could be made that may become practical solutions for the 
growing industry: 
x A minimum requirement of at least 20 g/kg LC-PUFA in growing barramundi 
up to ~200g should be respected.  
x Larger barramundi are more tolerant to reduced FO, however, a more optimal 
LC-PUFA in the flesh could be achieved with appropriate blending strategies. 
x Barramundi adapt well to oils rich in SFA or MUFA, however, the reduced 
digestibility of SFA is a concern.  
x n-6 fatty acids from soybean oil and ARA rich oil can impact negatively on 
performance, suggesting that n-3/n-6 balance is critical in maintaining 
metabolic homeostasis. 
x Factorial modelling of LC-PUFA deposition and LC-PUFA maintenance 
requirements and utilisation efficiencies is now made possible.  
 
Future investigations may be warranted particularly from a nutritional health aspect. 
There is a growing area of research focusing on the welfare of cultured aquatic 
animals. There is also a growing range of products available for the prevention of 
disease and nutritional management of fish and examination of many of these is still 
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ongoing. Further to this, as more complex instrumentation is becoming routinely 
available in laboratories there is significant potential to expand areas of research 
particularly in the nutritional health area, at a cellular or molecular level. For 
example the specialised pro-resolving mediators have scarcely been investigated in 
fish despite their relative importance in inflammatory response and tissue 
homeostasis. Lastly, we still have a limited understanding of the complex vitamin 
and mineral interactions in the barramundi and many other species. Therefore, future 
research should invest in more understanding of these issues with obvious animal 
welfare and commercial benefits. 
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